triazoles has been researched along with Aspergillosis in 772 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (1.30) | 18.7374 |
| 1990's | 32 (4.15) | 18.2507 |
| 2000's | 358 (46.37) | 29.6817 |
| 2010's | 326 (42.23) | 24.3611 |
| 2020's | 46 (5.96) | 2.80 |
| Authors | Studies |
|---|---|
| Dumoulin, A; Van Hoecke, F; Vangheluwe, T; Vogelaers, D | 1 |
| Lagrou, K; Maertens, J; Merckx, R; Resendiz-Sharpe, A; Verweij, PE | 1 |
| Beauchemin, C; Claveau, D; Dufresne, SF; Guinan, K; Rotstein, C | 1 |
| Bernards, S; de Boer, MGJ; Hendriks, BJC; Jolink, H; Koopmans, JG; van de Peppel, RJ; van der Beek, MT; van Grootveld, R; van Paassen, J; von dem Borne, PA | 1 |
| Clark, NM; Croos-Dabrera, R; Fisher, CE; Garcia-Diaz, J; Greenberg, RN; Kontoyiannis, DP; Kovanda, L; Miceli, MH; Nguyen, MH; Ostrosky-Zeichner, L; Spec, A; Thompson, GR; Young, JH | 1 |
| Chandrasekar, PH; Sivasubramanian, G | 1 |
| Berastegui, C; Bravo, C; Campany-Herrero, D; Castells, L; Deu, M; Gavaldà, J; Len, O; Los-Arcos, I; Márquez-Algaba, E; Martín-Gómez, MT; Monforte, A; Moreso, F; Nuvials, X; Sacanell, J; Sempere, A | 1 |
| Godinas, L; Spriet, I; Verfaillie, S; Verleden, GM; Vos, R | 1 |
| Brock, M; da Silva, RP; Geib, E; Hupko, C; Lagrou, K; Resendiz-Sharpe, A; Seldeslachts, L; Vande Velde, G; Vanderbeke, L | 1 |
| Kludjian, G; Miller, M; Mohrien, K; Morita, K | 1 |
| Abo Kandil, A; Handelman, M; Harish, E; Kontoyiannis, DP; Osherov, N; Sarkar, A; Shadkchan, Y; Wurster, S | 1 |
| Aram, JA; Cao, G; Cornely, OA; Desai, A; Fayyad, R; Guo, X; Hamed, K; Wu, D; Zhang, J; Zhang, Y | 2 |
| Amich, J; Bin Shuraym, H; Bromley, MJ; Goldman, GH; Gsaller, F; Hemmings, S; Storer, ISR; Valero, C; van Rhijn, N | 1 |
| Akashi, K; Izumikawa, K; Kakeya, H; Kamei, K; Kanda, Y; Kimura, SI; Kishida, M; Kohno, S; Matsuda, M; Miyazaki, T; Miyazaki, Y; Mukae, H; Niki, Y; Ogawa, K; Okada, F; Suzuki, J; Takazono, T; Taniguchi, S; Tateda, K; Yoshida, M | 1 |
| Aguado, JM; Bodro, M; Carratalà, J; Cordero, E; Fariñas, MDC; Fernández-Ruiz, M; Fortún, J; Goikoetxea, J; Gutiérrez Martín, I; Illaro, A; López-Viñau, T; Moreno, A; Muñoz, P; Ramos-Martínez, A; Rodriguez-Álvarez, R; Ruiz-Ruigómez, M; Sabé, N; Salto-Alejandre, S; Valerio, M; Vidal, E | 1 |
| Feng, S; Shen, Y; Zhang, T | 1 |
| Cornely, OA; Franz, J; Jakobs, F; Jeck, J; Kron, A; Kron, F; Wingen-Heimann, SM | 1 |
| Bart, A; Biemond, BJ; Boelens, J; Bruns, AHW; Buil, JB; Cornelissen, JJ; de Jonge, N; Demandt, AMP; Doorduijn, JK; Dunbar, A; Godschalk, P; Haas, PA; Huygens, S; Janssen, JJWM; Kampinga, GA; Klaassen, CHW; Klein, SK; Lagrou, K; Maertens, J; Mercier, T; Moors, I; Oudhuis, G; Postma, DF; Reynders, M; Rijnders, BJA; Schauwvlieghe, AFAD; Selleslag, D; Span, LFR; van der Beek, MT; van der Velden, WJFM; van Dijk, K; Verweij, PE; von dem Borne, P; Zandijk, W | 1 |
| Denis, B; Madelaine, I; Pieragostini, R; Sauvageon, H; Touratier, S; Xhaard, A | 1 |
| Chen, H; Chen, X; Du, M; Jiang, Y; Lei, W; Meng, H; Xue, X; Zhang, S | 1 |
| Fortwendel, JR; Ge, W; Rogers, PD; Rybak, JM; Souza, ACO; Wiederhold, NP | 1 |
| Aram, JA; Engelhardt, M; Hamed, K; Huang, JJ; Kovanda, LL; Yan, J | 1 |
| Grandhi, A; Haider, S; Han, S; Klimko, N; Lee, DG; Maertens, JA; Ponce-de-León, A; Rahav, G; Ramirez-Sanchez, IC; Waskin, H; Winchell, GA; Wrishko, R | 1 |
| Danion, F; Dureault, A; Goldwirt, L; Guéry, R; Herbrecht, A; Jullien, V; Lanternier, F; Lapusan, S; Lortholary, O; Morgand, M; Palmier, B; Puget, S; Rouzaud, C | 1 |
| Catano, G; Jaramillo, R; Najvar, LK; Olivo, M; Patterson, TF; Wickes, BL; Wiederhold, NP | 1 |
| Batres Baires, G; Heilmaier, M; Huber, W; Kinzig, M; Lahmer, T; Mayr, U; Rasch, S; Schmid, RM; Sörgel, F | 1 |
| Arendrup, MC; Buil, JB; Hare, RK; Melchers, WJG; Verweij, PE; Zwaan, BJ | 1 |
| Chowdhary, A; Nelson-Sathi, S; Radhakrishna Pillai, M; Sharma, C; Singh, A | 1 |
| Anguita, J; Bailén, R; Balsalobre, P; Buño, I; Diez-Martin, JL; Dorado, N; Guinea, J; Kwon, M; Machado, M; Oarbeascoa, G; Padilla, B; Pradillo, V; Sancho, M; Serrano, D | 1 |
| Arbona-Haddad, E; Bold, TD; Chen, K; Cheng, MP; Cummins, KC; Hammond, SP; Koo, S; Kusztos, AE; Liakos, A; Marty, FM; Orejas, JL; Pandit, A; Solomon, IH | 1 |
| Blijlevens, NMA; Brüggemann, RJM; Buil, JB; Cornelissen, JJ; Henriet, SSV; Hoek, RAS; Rijnders, BJA; Schauwvlieghe, AFAD; Verweij, PE | 1 |
| Alkhazraji, S; Alqarihi, A; Gebremariam, T; Gu, Y; Ibrahim, AS; Shaw, KJ; Singh, S | 1 |
| Baron, R; Berthou, C; Couturier, MA; Guillerm, G; Ianotto, JC; Le Bars, H; Le Clech, L; Narbonne, V; Nevez, G; Payan, C; Quinio, D; Saliou, P; Uguen, M | 1 |
| Anderson, A; Camargo, JF; Komanduri, KV; Lekakis, L; Martinez, OV; Mendoza, MA; Morris, MI; Prado, CE; Simkins, J | 1 |
| Dobiáš, R; Hošková, L; Hubka, V; Jaworská, P; Kautznerová, D; Kubánek, M; Lysková, P; Mrázek, J; Němcová, D; Skružná, M; Sumerauerová, P; Vrbská, J; Žáčková, P | 1 |
| Carvalhaes, CG; Castanheira, M; Messer, SA; Pfaller, MA | 1 |
| Bennis, Y; Boone, M; Chouaki, T; Delette, C; Joseph, C; Mabille, C; Maizel, J; Marolleau, JP; Nyga, R | 1 |
| Abastabar, M; Ahangarkani, F; Badali, H; Fakhim, H; Haghani, I; Ilkit, M; Javidnia, J; Meis, JF; Taheri Rizi, Z | 1 |
| Brüggemann, RJM; Buil, JB; Chen, L; Knibbe, CAJ; Krekels, EHJ; Verweij, PE | 1 |
| Bandettini, R; Barco, S; Carrega, G; Castagnola, E; Dallorso, S; Dufour, C; Mesini, A; Miano, M; Palmisani, E; Saffioti, C | 1 |
| Farooqi, J; Jabeen, K; Laiq, S; Moin, S; Zafar, A | 1 |
| Brito Devoto, T; Cuestas, ML; Finquelievich, JL; García-Effrón, G; Hermida-Alva, K; Posse, G | 1 |
| Verweij, PE; Wiederhold, NP | 1 |
| Doub, JB; Mathur, P | 1 |
| Li, X; Wei, XC; Xiao, X; Zhao, MF | 1 |
| Azanza, JR; Grau, S; López-Gómez, V; López-Ibáñez de Aldecoa, A; Peral, C; Rebollo, P; Vázquez, L | 1 |
| Brito Devoto, T; Carmona, M; Cuestas, ML; Formento, N; Gordó, M; Hermida-Alava, K; Luque, A; Sautua, F; Scandiani, M | 1 |
| Fortwendel, JR; Nywening, AV; Rogers, PD; Rybak, JM | 1 |
| Garcia-Vidal, C; Lamoth, F; Lichtenstern, C; Neofytos, D; Perrella, A; Vehreschild, JJ | 1 |
| Azmanis, P; Naidoo, V; Pappalardo, L; Sara, ZAJ; Silvanose, C | 1 |
| Mammen, MD; Rupa, V; Sahni, RD; Varghese, GM | 1 |
| Durand, ML; Kitt, TM; Marty, FM; Song, Y | 1 |
| Barcelo-Vidal, J; Carballo, N; Conde-Estévez, D; De-Antonio Cuscó, M; Echeverria-Esnal, D; Ferrández, O; Grau, S; Horcajada, JP; Martín-Ontiyuelo, C; Navarrete-Rouco, ME | 1 |
| Crusz, SA; Denning, D; Mitchell, S; Simmonds, L; White, B | 1 |
| Arendrup, MC; Brillowska-Dabrowska, A; Kurzyk, E; Mroczynska, M; Nawrot, U; Niewinska, K; Sulik-Tyszka, B; Ussowicz, M; Wlodarczyk, K; Wróblewska, M; Zdziarski, P | 1 |
| Bassetti, M; Bouza, E | 1 |
| Denis, J; Herbrecht, R; Ledoux, MP; Toussaint, E | 1 |
| Dunne, K; Hagen, F; Meis, JF; Pomeroy, N; Rogers, TR | 1 |
| Ivulich, S; Jeong, W; Kong, DCM; Levvey, BJ; Morrissey, CO; Neoh, CF; Slavin, MA; Snell, GI; Westall, GP | 1 |
| Albert, ND; Heo, ST; Jiang, Y; Jiménez-Ortigosa, C; Kontoyiannis, DP; Lewis, RE; Meis, JF; Mikos, AG; Perlin, DS; Tarrand, J; Tatara, AM; Tverdek, F; Verweij, PE | 1 |
| D'Inzeo, T; De Carolis, E; Mello, E; Posteraro, B; Sanguinetti, M; Torelli, R; Vella, A; Verweij, PE | 1 |
| Bianco, D; Stewart, J | 1 |
| Al Abdallah, Q; Fortwendel, JR; Hill, AM; Lovingood, RV; Norton, TS | 1 |
| Ashu, EE; Korfanty, GA; Xu, J | 1 |
| Baker, KK; Chin, A; Fredricks, DN; Hoofnagle, AN; Jain, R; Pergam, SA | 1 |
| Hassan, FAM; Tartor, YH | 1 |
| Lewis, RE; Verweij, PE | 1 |
| Andes, D; Bonate, PL; Desai, AV; Hope, WW; Kovanda, LL; Kowalski, DL; Mouton, JW; Mujais, S; Townsend, RW | 1 |
| Byun, SA; Choi, MJ; Jung, JS; Kim, SH; Park, YJ; Shin, JH; Shin, MG; Suh, SP; Won, EJ | 1 |
| Brüggemann, RJM; Buil, JB; Meis, JF; Melchers, WJG; Mouton, JW; Verweij, PE; Wasmann, RE; Zoll, J | 1 |
| Chen, Z; Zhao, H; Zhou, L; Zhu, L | 1 |
| Behr, J; Ceelen, F; Ihle, F; Kneidinger, N; Matthes, S; Neurohr, C; Schramm, R; Stelzer, D; Vogeser, M; Weber, A; Winter, H; Zimmermann, G; Zoller, M | 1 |
| Fritz, J; Hagleitner, M; Jukic, E; Lackner, M; Lass-Flörl, C; Rambach, G; Sartori, B; Seger, C; Speth, C | 1 |
| Birkenbach, M; Faizer, R; Green, JS; Ustun, C; Wasko, JA | 1 |
| Bader, O; Becker, K; Groß, U; Idelevich, EA | 1 |
| Chowdhary, A; Lagrou, K; Lockhart, SR; Meis, JF; Resendiz Sharpe, A; Verweij, PE | 1 |
| Ader, F; Aguado, JM; Akova, M; Arendrup, MC; Arikan-Akdagli, S; Barnes, RA; Beigelman-Aubry, C; Blot, S; Bouza, E; Brüggemann, RJM; Buchheidt, D; Cadranel, J; Castagnola, E; Chakrabarti, A; Cornely, OA; Cuenca-Estrella, M; Denning, DW; Dimopoulos, G; Fortun, J; Gangneux, JP; Garbino, J; Groll, AH; Heinz, WJ; Herbrecht, R; Heussel, CP; Kibbler, CC; Klimko, N; Kullberg, BJ; Lagrou, K; Lange, C; Lass-Flörl, C; Lehrnbecher, T; Lewis, RE; Löffler, J; Lortholary, O; Maertens, J; Marchetti, O; Meis, JF; Munoz, P; Pagano, L; Ribaud, P; Richardson, M; Roilides, E; Ruhnke, M; Sanguinetti, M; Sheppard, DC; Sinkó, J; Skiada, A; Ullmann, AJ; Vehreschild, MJGT; Verweij, PE; Viscoli, C; Warris, A | 1 |
| Denis, J; Herbrecht, R; Ledoux, MP; Nivoix, Y | 1 |
| Cornely, OA; Croos-Dabrera, R; Giladi, M; Lademacher, C; Lu, Q; Maher, RM; Marty, FM; Mullane, KM; Oren, I; Ostrosky-Zeichner, L; Perfect, JR; Rahav, G; Schmitt-Hoffmann, AH | 1 |
| McCarthy, MW; Moriyama, B; Petraitiene, R; Petraitis, V; Walsh, TJ | 1 |
| Castanheira, M; Pfaller, MA; Rhomberg, PR | 1 |
| Buchheidt, D; Hoenigl, M; Jenks, JD; Krause, R; Prattes, J; Salzer, HJ | 1 |
| Ho, CL; Lee, CH; Lin, C; Lin, JC | 1 |
| Bagshaw, E; Blackney, M; Enoch, DA; Kuessner, D; Posthumus, J | 1 |
| Bollmann, T; Ewert, R; Nowak, S; Rathmann, E; Ribback, S; Rosenstengel, C; Schroeder, HWS | 1 |
| Escrig, C; Herbrecht, R; Kuessner, D; Pooley, N; Posthumus, J | 1 |
| Abdolrasouli, A; Armstrong-James, D; Elborn, JS; Fisher, MC; Rhodes, J; Schelenz, S; Scourfield, A; Shah, A | 1 |
| Fukushima, S; Hirose, M; Hiruma, M; Ihn, H; Matsumoto, T; Noguchi, H; Yaguchi, T | 1 |
| Folić, M; Janković, SM; Jović, Z; Kostić, M; Milovanović, D; Milovanović, J; Ružić Zečević, D; Stefanović, S | 1 |
| French, B; Mandell, K; Martinez, R | 1 |
| Andes, DR; Ghannoum, MA; Hope, WW; Jones, ME; Kovanda, LL; Lademacher, C; Lu, Q; Mukherjee, PK; Santerre Henriksen, A | 1 |
| Alastruey-Izquierdo, A; Bongomin, F; Masania, R; Moore, CB; Novak-Frazer, L; Richardson, MD; Rowbotham, E | 1 |
| Girmenia, C; Goffredo, BM; Marchesi, F; Mengarelli, A; Menna, P; Minotti, G; Romano, A; Salvatorelli, E | 1 |
| Andes, D; Engelhardt, M; Groll, AH; Kaindl, T; Larger, P; Saulay, M | 1 |
| Fortwendel, JR; Rogers, PD; Rybak, JM | 1 |
| Capellier, G; Clairet, AL; Lagoutte-Renosi, J; Millon, L; Navellou, JC; Piton, G; Rougny, AC; Winiszewski, H | 1 |
| Lestrade, PPA; Meis, JF; Melchers, WJG; Verweij, PE | 1 |
| Adamsick, ML; Elshaboury, RH; Gandhi, RG; Gift, T; Kotton, CN; Mansour, MK | 1 |
| Abastabar, M; Aslani, N; Badali, H; Bowyer, P; Gholami, S; Haghani, I; Hedayati, MT; Hosseini, T; Lagzian, M; Nazeri, M; Nouripour-Sisakht, S; Shokohi, T; Vakili, M; Valadan, R | 1 |
| Bagshaw, E; Floros, L; Kuessner, D; Posthumus, J; Sjölin, J | 1 |
| Chen, H; Chen, X; Liu, H; Qiu, S; Shen, Z; Wang, W; Yang, L; Zhang, Q | 1 |
| Cheng, MP; Cornely, OA; Dufresne, PJ; Lawandi, A; Lee, TC; Seidel, D; Sheppard, DC; Verweij, PE | 1 |
| Fortwendel, JR; Ge, W; Kelly, SL; Parker, JE; Rogers, PD; Rybak, JM; Wiederhold, NP | 1 |
| Dolgov, E; Lee, A; Lee, MH; Perlin, DS; Prideaux, B; Zhao, Y; Zimmerman, M | 1 |
| Corcoran, TE; Ensor, CR; Hussain, S; Iasella, CJ; McDyer, JF; Moore, CA; Morrell, MR; Nero, JA; Nguyen, MH; Thanukrishnan, H; Venkataramanan, R | 1 |
| Arendrup, MC; Cuenca-Estrella, M; Hope, WW; Lass-Flörl, C | 2 |
| Gao, Y; Ping, B; Wu, B; Yue, C; Zhu, Y | 1 |
| Celkan, T; Eroğlu, AG; Ozdemir, N; Tüysüz, G; Uludağ, D | 1 |
| Abdi, R; Basiri, A; Hedayati, MT; Najafi, N; Parvin, M; Shokohi, T; Taghavi, F; Yadegarinia, D | 1 |
| Aram, JA; Barbers, RG; Equils, O; Mardekian, J; McLaughlin, JM; Schlamm, HT; Somerville, KT; Welch, VL | 1 |
| Ahmad, S; Al-Wathiqi, F; Khan, Z | 1 |
| De la Serna, J; Fernández-Navarro, JM; Gómez, V; Jarque, I; Jurado, M; López-Jiménez, J; Pascual, A; Romero, M; Serrano, J; Vallejo, C | 1 |
| Angebault, C; Bougnoux, ME; Didier, E; Groh, M; Lelièvre, L; Maherault, AC | 1 |
| Huitema, AD; Schellens, JH; Schouten-van Meeteren, AY; van Eijkelenburg, NK; van Hasselt, JG | 1 |
| Brock, M; Galiger, C; Ibrahim-Granet, O; Jouvion, G; Parlato, M; Savers, A | 1 |
| Bonhomme, J; de la Blanchardière, A; Hamon, M; Hitier, M; Leclercq, R; Nicolle, A | 1 |
| Hatipoglu, H; Hatipoglu, N | 1 |
| Amsden, JR; Anaissie, E; Gubbins, PO; McConnell, S | 1 |
| Duettmann, W; Fruhwald, S; Hoenigl, M; Krause, R; Prueller, F; Raggam, RB; Seeber, K; Troppan, K; Valentin, T; Wagner, J; Wölfler, A; Zollner-Schwetz, I | 1 |
| Azzam, R; Katirji, B; Serra, A; Shaikh, AG | 1 |
| Arends, JP; Camps, SM; Debets-Ossenkopp, YJ; Haas, PJ; Kampinga, GA; Karawajczyk, A; Kuijper, EJ; Melchers, WJ; Rijnders, BJ; van der Linden, JW; van Tiel, FH; Varga, J; Verweij, PE; Zoll, J | 1 |
| Bowyer, P; Denning, DW | 1 |
| Bader, O; Buchheidt, D; Christner, M; Groß, U; Held, J; Kuhns, M; Lugert, R; Peter, S; Reichard, U; Schumacher, U; Tintelnot, K; Weig, M | 1 |
| Chowdhary, A; Espinel-Ingroff, A; Gonzalez, GM; Lass-Flörl, C; Martin-Mazuelos, E; Meis, J; Peláez, T; Pfaller, MA; Turnidge, J | 1 |
| Castanheira, M; Jones, RN; Messer, SA; Pfaller, MA; Rhomberg, PR | 1 |
| Bhaskaran, A; Hosseini-Moghaddam, SM; Husain, S; Rotstein, C | 1 |
| Einsele, H; Grau, A; Heinz, WJ; Helle-Beyersdorf, A; Klinker, H; Lenker, U; Schirmer, D; Zirkel, J | 1 |
| Alffenaar, JW; Greijdanus, B; Kosterink, JG; Span, LF; Uges, DR; van der Elst, KC; van der Werf, TS; van Hateren, K; Vermeulen, KM | 1 |
| Cicora, F; Mos, F; Paz, M; Roberti, J | 1 |
| Gnanalingham, K; Nadig, A; Pal, P; Singh, N; Subudhi, CP | 1 |
| Arendrup, MC; Cuenca-Estrella, M; Gomez-Lopez, A; Howard, SJ; Lass-Flörl, C | 1 |
| Blitz, A; Burger, P; Gallia, G; Ishii, M; Leyngold, I; Olivi, A; Subramanian, PS | 1 |
| Coignard-Biehler, H; Hermine, O; Jullien, V; Lecuit, M; Lortholary, O; Pilmis, B; Touraine, P | 1 |
| Brüggemann, RJ; Mouton, JW; Seyedmousavi, S; Verweij, PE | 1 |
| Chen, SC; Meyer, W; Middleton, PG | 1 |
| Cai, J; Chen, S; Cheng, X; Dong, H; Dong, W; Dong, Y; Sun, J; Wang, T; Wang, X; Xing, J; Yao, H | 1 |
| Dupont, L; Lagrou, K; Maertens, J; Meersseman, P; Saegeman, V; Vermeulen, E | 1 |
| Leroux, S; Ullmann, AJ | 1 |
| Bierings, MB; Boelens, JJ; Gerhardt, CE; Hol, JA; Lindemans, CA; Versluys, AB; Wildt de, A; Wolfs, TF | 1 |
| Dominelli, GS; Shaipanich, T | 1 |
| Hirose, Y; Kokuzawa, S; Mochizuki, K; Suemori, S; Yaguchi, T | 1 |
| Hoenigl, M; Krause, R; Seeber, K | 1 |
| Dorazilova, Z; Maly, J; Netuka, I; Pirk, J; Szarszoi, O | 1 |
| Badoual, C; Devars Du Mayne, M; El Naderi, S; Rodriguez, C | 1 |
| Bakır, M; Ermerak, NO; Kepenekli, E; Kuzdan, C; Soysal, A; Yüksel, M | 1 |
| Ahmad, S; Alkharashi, M; Jun, AS | 1 |
| Halderman, A; Shrestha, R; Sindwani, R | 1 |
| Dalbøge, CS; Gøtzsche, PC; Johansen, HK; Jørgensen, KJ | 1 |
| Chai, LY; Earnest, A; Herbrecht, R; Johnson, EM; Kullberg, BJ; Netea, MG; Schlamm, HT; Teerenstra, S; Troke, PF; Vonk, AG | 1 |
| Balasubramanian, S; Dhanakodi, N; Shashidhar, N; Tripathy, SK; Venkataramaiah, S | 1 |
| Billaud, E; Borget, I; Boussion, H; Burlacu, R; Chachaty, E; de Botton, S; Desplanques, PY; Gachot, B; Micol, JB; Netzer, F; Poinsignon, V; Wyplosz, B | 1 |
| Luo, L; Tong, Z | 1 |
| Cogliati, M; De Lorenzis, G; Esposto, MC; Prigitano, A; Tortorano, AM; Venier, V | 1 |
| Cooke, RP; Denning, DW; Ellenbogen, JR; Javadpour, M; Lesser, T; Skinner, DW; Waqar, M | 1 |
| Chowdhary, A; Hagen, F; Meis, JF; Sharma, C | 1 |
| Brüggemann, RJ; Melchers, WJ; Mouton, JW; Seyedmousavi, S; Verweij, PE | 2 |
| Aquino, VR; Bergamasco, MD; Castro, PT; Colombo, AL; Gonçalves, SS; Negri, CE; Xafranski, H | 1 |
| Arendrup, MC; Cuenca-Estrella, M; Howard, S; Lass-Flörl, C; Meletiadis, J; Mouton, JW | 1 |
| Fouant, MM; Katragkou, A; Kovanda, LL; McCarthy, M; Meletiadis, J; Moradi, PW; Petraitiene, R; Petraitis, V; Roilides, E; Strauss, GE; Walsh, TJ | 1 |
| Arnan, M; Ayats, J; Cuenca-Estrella, M; Cuesta, I; Duarte, RF; Fernández de Sevilla, A; Gudiol, C; Patiño, B; Sánchez-Ortega, I | 1 |
| Albert, ND; Kontoyiannis, DP; Lewis, RE | 1 |
| Guarro, J; Pastor, FJ | 2 |
| Panackal, AA; Parisini, E; Proschan, M | 1 |
| Chen, SC; Gilroy, NM; Morrissey, CO; Slavin, MA; Szer, J; Tam, CS; Thursky, KA; van Hal, SJ; Worth, LJ | 1 |
| Bosschaerts, T; Boulet, G; Cos, P; Fortin, A; Maes, L; Paulussen, C | 1 |
| Almeida, AG; Lima da Silva, G; Pinto, FJ | 1 |
| Brüggemann, RJ; Meis, JF; Melchers, WJ; Mouton, JW; Seyedmousavi, S; Verweij, PE | 1 |
| Moss, RB | 1 |
| Goeman, E; Kidd, SE; Meis, JF; Slavin, MA; Verweij, PE | 1 |
| McCormack, PL | 1 |
| Chang, YC; Eckhaus, MA; Fedorova, N; Figat, A; Joardar, V; Kwon-Chung, KJ; Losada, L; Mounaud, S; Nierman, WC; Pakala, S; Pakala, SB; Sugui, JA; Venepally, P | 1 |
| Healy, JR; Kraft, WK; Moore, JN | 1 |
| Carver, PL; Pettit, NN | 1 |
| Ağca, H; Ak, S; Akalın, H; Cilo, BD; Ener, B; Özmerdiven, GE; Tunca, B | 1 |
| Arilla, MJ; Boluda, B; Calvillo, P; Cano, I; Carpio, N; Jarque, I; Lancharro, A; López-Chuliá, F; Lorenzo, I; Martínez, J; Martínez-Cuadrón, D; Montesinos, P; Navarro, I; Pemán, J; Rodríguez-Veiga, R; Salavert, M; Sanz, GF; Sanz, J; Sanz, MA | 1 |
| Bernal-Martínez, L; Cendejas, E; Forastiero, A; Gomez-Lopez, A; Mellado, E | 1 |
| Barrs, VR; Beatty, JA; Kidd, SE; Martin, P; Talbot, JJ | 1 |
| Maertens, J; Miceli, MH | 1 |
| Gregg, KS; Kauffman, CA | 1 |
| Patterson, TF; Wiederhold, NP | 1 |
| Capilla, J; Guarro, J; Martin-Vicente, A | 2 |
| Aftab, M; Almanfi, A; El-Sayed Ahmed, MM; Frazier, OH; Mallidi, HR; Singh, SK | 1 |
| Amorim, A; Araujo, R; Gungor, O | 1 |
| Dehghan, P; Hashemi, SJ; Melchers, WJ; Mohammadi, F; Rafati, H; Rezaie, S; Seyedmousavi, S; Tamadon, Y; Tolooe, A; van der Lee, HA; Verweij, PE; Zoll, J | 1 |
| Arendrup, MC; Cuenca-Estrella, M; Jensen, RH | 1 |
| Cogliati, M; De Lorenzis, G; Esposto, MC; Lazzarini, C; Prigitano, A; Tortorano, AM | 1 |
| Manavathu, EK; Vazquez, JA | 1 |
| Marx, KR; Nishimoto, AT; Rogers, PD; Rybak, JM | 1 |
| Gökbolat, E; Ilkit, M; Kiraz, N; Öz, Y; Özdemir, HG; Seyedmousavi, S | 1 |
| Badali, H; Dolatabadi, S; Fakhim, H; Mirhendi, H; Nabili, M; Poorzad, N; Vaezi, A; Zarei, F | 1 |
| Bouchnerova, J; Hadrabova, M; Kocmanova, I; Lengerova, M; Mayer, J; Palackova, M; Pavlovsky, Z; Racil, Z; Ricna, D; Volfova, P; Weinbergerova, B | 1 |
| Aoun, M; Baddley, JW; Bow, EJ; Cornely, OA; Giladi, M; Heinz, WJ; Herbrecht, R; Hope, W; Karthaus, M; Kontoyiannis, DP; Lee, DG; Lee, M; Lortholary, O; Maertens, JA; Maher, RM; Marr, KA; Morrison, VA; Neofytos, D; Oren, I; Patterson, TF; Raad, II; Rahav, G; Schmitt-Hoffmann, AH; Selleslag, D; Shoham, S; Thompson, GR; Ullmann, AJ; Zeiher, B | 1 |
| Ashu, E; Chang, H; Chowdhary, A; Kathuria, S; Sharma, C; Xu, J | 1 |
| Aala, F; Amirizad, K; Aslani, N; Badali, H; Hashemi, SJ; Khodavaisy, S; Nazeri, M; Nouripour-Sisakht, S; Rezaie, S; Sorkherizi, MS | 1 |
| Azie, N; Franks, B; Goff, D; Horn, D; Khandelwal, N; Shi, F; Shorr, AF; Spalding, J | 1 |
| Alangaden, GJ; Brown, JM; Chetchotisakd, P; Cornely, OA; Engelhardt, M; Fredricks, DN; Heinz, WJ; Herbrecht, R; Ito, M; Jaruratanasirikul, S; Kanj, SS; Kaufhold, A; Klimko, N; Klyasova, G; Lee, M; Maertens, JA; Maher, RM; Marty, FM; Melinkeri, SR; Mullane, KM; Oren, I; Ostrosky-Zeichner, L; Pappas, PG; Perfect, JR; Ráčil, Z; Rahav, G; Santos, R; Sasse, C; Schwartz, S; Thompson, GR; Vehreschild, JJ; Vehreschild, MJGT; Young, JH; Zeiher, B | 1 |
| Cornely, OA; Farowski, F; Hartmann, P | 1 |
| Hope, WW; Kovanda, LL; Maher, R | 1 |
| Akhtar, S; Bonate, P; Desai, AV; Hope, WW; Kovanda, LL; Lu, Q; Townsend, RW | 1 |
| Bonate, PL; Desai, A; Kovanda, L; Kowalski, D; Lu, Q; Townsend, R | 1 |
| Mittal, A; Paliwal, S; Sharma, M; Sharma, S; Singh, A; Tilak, A; Tripathi, N | 1 |
| Hiruma, M; Ihn, H; Kano, R; Matsumoto, T; Noguchi, H | 1 |
| Bader, O; Buname, G; Groß, U; Mshana, SE; Mushi, MF | 1 |
| Debets, AJM; Meis, JF; Melchers, WJG; Schoustra, SE; van de Veerdonk, FL; Verweij, PE; Zhang, J; Zwaan, BJ | 1 |
| Scott, LJ; Shirley, M | 1 |
| Azie, N; Harrington, R; Lee, E; Messali, A; Spalding, J; Wei, J; Wu, EQ; Yang, H | 1 |
| Guo, H; Jiang, L; Li, DM; Li, SX; Song, YJ; Zhang, H; Zhao, YJ; Zhu, KJ | 1 |
| Desai, AV; Engelhardt, M; Hope, WW; Kovanda, LL; Lademacher, C; Lu, Q; Maertens, J; Marty, FM | 1 |
| Ikeda, T; Ishikawa, S; Kobayashi, K; Takeyama, H; Tokuda, Y; Wakabayashi, K; Yano, S | 1 |
| Chellamma, T; Cherian, KM; Verghese, S | 1 |
| Ben-Ami, R; Kontoyiannis, DP; Lamaris, GA; Lewis, RE | 1 |
| Boyken, L; Diekema, DJ; Hollis, RJ; Messer, SA; Pfaller, MA; Rice, C; Tendolkar, S | 1 |
| DeRemer, DL; Fisher, JF; Forseen, C; Jillella, AP; Steele, JC; Ustun, C | 1 |
| Zaas, AK | 1 |
| Annemans, L; Derde, MP; Marbaix, S; Van Campenhout, H | 1 |
| Karthaus, M | 2 |
| Bouza, E; Guinea, J; Peláez, T; Recio, S; Torres-Narbona, M | 1 |
| Ak, Ö; Batırel, A; Demirhan, G; Gençer, S; Özer, S | 1 |
| Baert, K; Beernaert, LA; Chiers, K; De Backer, P; Marin, P; Martel, A; Pasmans, F | 1 |
| Auberger, J; Bellmann, R; Buzina, W; Clausen, J; Gastl, G; Lass-Flörl, C; Nachbaur, D | 1 |
| Hoppe-Tichy, T; Lichtenstern, C; Störzinger, D; Swoboda, S; Weigand, MA | 1 |
| Kishel, JJ; Sivik, J | 1 |
| Alangaden, GJ; Chandrasekar, PH; Krishnan-Natesan, S; Manavathu, EK | 1 |
| Adani, GL; Baccarani, U; Baraldo, M; Cojutti, P; Franceschi, L; Furlanut, M; Londero, A; Pea, F; Tavio, M; Viale, P | 1 |
| Alexander, BD; Daly, JS; Graybill, JR; Hardalo, CJ; Patino, H; Perfect, JR; Restrepo, A; Tobón, AM | 1 |
| Graybill, JR; Hachem, RY; Langston, AA; Patino, H; Pedicone, LD; Perfect, JR; Raad, II | 1 |
| Cordier, JF; Cottin, V; Cristea, D; Meyronet, D; Persat, F | 1 |
| Chandrasekar, PH; Krishnan-Natesan, S; Manavathu, EK; Revankar, SG | 1 |
| Caira, M; Fianchi, L; Pagano, L | 1 |
| Doorduijn, JK; el Barzouhi, A; Lugtenburg, PJ; Polinder, S; Rijnders, BJ; Slobbe, L; Steyerberg, EW | 1 |
| Donders, AR; Kuijpers, J; Melchers, WJ; Mellado, E; Rijs, AJ; Samson, RA; Snelders, E; van der Lee, HA; Varga, J; Verweij, PE | 1 |
| Hoffman, J; Howard, A; Sheth, A | 1 |
| Bearman, G; Pakyz, A | 1 |
| van Rijswijk, J; van Tol, A | 1 |
| Antonius, T; Brüggemann, RJ; Burger, DM; Heijst, Av; Hoogerbrugge, PM; Warris, A | 1 |
| Baba, T; Endo, T; Hagiwara, E; Komatsu, S; Matsumoto, Y; Nishihira, R; Ogura, T; Sato, T; Sekine, A; Shinohara, T; Sogo, Y; Takahashi, H | 1 |
| Fujita, N; Oyake, M; Sugai, A; Umeda, M; Umeda, Y | 1 |
| Dolman, KM; Hodiamont, CJ; Melchers, WJ; Pajkrt, D; Ten Berge, IJ; Verweij, PE | 1 |
| Bienvenu, B; Bougnoux, ME; Chandesris, MO; Herman, P; Lanternier, F; Lecuit, M; Lortholary, O; Mamzer, MF; Méchai, F; Mimoun, M; Parize, P; Poirée, S; Viard, JP | 1 |
| Gerlach, U; Guckelberger, O; Jörres, D; Kohler, S; Neuhaus, P; Pascher, A; Pratschke, J; Sauer, IM | 1 |
| Alp, S; Arikan, S; Hascelik, G; McNicholas, P; Sancak, B | 1 |
| Baltadakis, I; Karakasis, D; Liapis, K; Manaka, K | 1 |
| Grobosch, T; Lampe, D; Reinwald, M; Schwartz, S; Thiel, E; Uharek, L | 1 |
| Naeger-Murphy, N; Pile, JC | 1 |
| Horn, D; Neofytos, D; Sae-Tia, S | 1 |
| Beernaert, LA; Dorrestein, GM; Haesebrouck, F; Martel, A; Pasmans, F; Van Waeyenberghe, L; Vercammen, F; Verstappen, F | 1 |
| Amrein, C; Batisse, A; Berge, M; Billaud, EM; Boussaud, V; Chevalier, P; Dannaoui, E; Guillemain, R; Lillo-Le Louet, A; Loriot, MA; Pham, MH | 1 |
| Ayats, J; Fernández, N; Gasch, O; Santin, M | 1 |
| Aşik, G; Ayçiçek, A; Cetinkaya, Z; Kenar, F; Kiraz, N; Kiyici, H | 1 |
| Kida, M | 1 |
| Inagaki, N; Mori, T; Yasuda, H | 1 |
| Amrein, C; Benammar, M; Berge, M; Billaud, EM; Boussaud, V; Chevalier, P; Guillemain, R; Lefeuvre, S | 1 |
| Huis In 't Veld, RA; Kema, GH; Melchers, WJ; Rijs, AJ; Snelders, E; Verweij, PE | 1 |
| Demchok, JP; Meletiadis, J; Roilides, E; Walsh, TJ | 1 |
| Baggen, L; Chisholm, J; Sharland, M; Thomas, L | 1 |
| Segal, BH | 1 |
| Han, FC; Jureen, R; Tew, CW; Tey, BH | 1 |
| Bhavna, B; Kumar, K; Narayan, SK; Roopeshkumar, VR; Swaminathan, RP | 1 |
| Angerer, K; Bonatti, H; Geltner, C; Lass-Floerl, C; Lechner, M; Schmid, T; Singh, N; Singh, R; Stelzmueller, I | 1 |
| Abboud, I; Antoine, C; Benammar, M; Berge, M; Billaud, EM; Glotz, D; Lefeuvre, S | 1 |
| Barozzi, P; Forghieri, F; Luppi, M; Messino, M; Morselli, M; Pecorari, M; Potenza, L; Rossi, G; Rumpianesi, F; Torelli, G; Vallerini, D | 1 |
| Clemons, KV; Kass, PH; Kline, Y; Martinez, M; Stevens, DA; Tell, LA; Woods, L | 1 |
| Aoyagi, I; Hidaka, H; Katori, Y; Kobayashi, T; Kudo, T; Nakaya, K; Oda, K; Oshima, T; Ota, J | 1 |
| Baert, K; Beernaert, LA; Chiers, K; Haesebrouck, F; Martel, A; Pasmans, F; Van Waeyenberghe, L | 1 |
| Laporta, R; Lázaro, MT; Ramos, A; Sánchez-Romero, I; Ussetti, P | 1 |
| Albarrag, A; Anderson, MJ; Arendrup, MC; Cerar, D; Denning, DW; Fisher, MC; Howard, SJ; Laverdiere, M; Pasqualotto, AC; Perlin, DS | 1 |
| Feder, RS; Gupta, G; Lyon, AT | 1 |
| Balajee, SA; Brandt, ME; Gade, L; McCloskey, CB | 1 |
| Alexander, BD; Andes, D; Brown, SD; Chaturvedi, V; Diekema, DJ; Espinel-Ingroff, A; Fowler, CL; Ghannoum, MA; Johnson, EM; Knapp, CC; Motyl, MR; Ostrosky-Zeichner, L; Pfaller, MA; Rex, JH; Sheehan, DJ; Walsh, TJ | 1 |
| Genzen, JR; Kenney, B | 1 |
| Bahador, A; Dehghani, M; Gholami, S; Hashemi, SB; Janghorban, P; Kakaei, F; Kazemi, K; Malek-Hosseini, SA; Nikeghbalian, S; Salahi, H; Shishegar, M | 1 |
| George, E; Shinohara, MM | 1 |
| Damon, L; Guglielmo, BJ; Hwang, J; Kaplan, L; Linker, C; Martin, T; O'Malley, R; Sharma, M; Working, M | 1 |
| Fujii, A; Hamano, T; Itoh, H; Kuriyama, M; Matsunaga, A; Naganuma, S; Ueno, A; Yoneda, M | 1 |
| Aloisi, T; Aversa, F; Bonini, A; Caira, M; Candoni, A; Caramatti, C; Cattaneo, C; Chierichini, A; de Waure, C; Fadda, RM; Fanci, R; Ferrara, F; Fianchi, L; Invernizzi, R; Leone, G; Luppi, M; Martino, B; Melillo, L; Mitra, ME; Nosari, A; Offidani, M; Pagano, L; Pastore, D; Picardi, M; Potenza, L; Riva, M; Rossini, F; Specchia, G; Stanzani, M; Vacca, A | 1 |
| Gómez-Bueno, M; Lázaro, MT; Pulpón, L; Ramos, A; Salas, C; Sanchez, I; Segovia, J | 1 |
| Al-Abdely, HM; Al-Tawfiq, JA | 1 |
| In, KH; Kang, EH; Kim, MJ; Yoon, YK | 1 |
| Blanch-Iribarne, P; Garcia-Ramirez, M; Martin-Carballido, S; Martinez-Ferriz, MC; Martinez-Pajares, JD; Moreno-Perez, D | 1 |
| Brüggemann, RJ; Mavridou, E; Melchers, WJ; Mouton, JW; Verweij, PE | 2 |
| Kema, GH; Melchers, WJ; Mellado, E; Snelders, E; Verweij, PE | 1 |
| Blisard, D; Capitano, B; Han, K; Husain, S; Johnson, HJ; Kwak, EJ; Linden, PK; Marcos, A; Paterson, DL; Potoski, B; Romkes, M; Venkataramanan, R | 1 |
| Christen, S; Egger, SS; Gratwohl, A; Haschke, M; Krähenbühl, S; Leu, C; Meier, S | 1 |
| Jiménez Caballero, PE; Mollejo Villanueva, M | 1 |
| Friedstrom, S; Gersch, K; Nebel, C; Rodersheimer, LR; Smith, JM | 1 |
| Kumar, P; Matsumoto, C; Pien, E; Rosen, J; Shanmugam, VK; Steen, V; Whelton, S | 1 |
| Barlow, G; Lillie, P; Moss, PJ; Parsonage, MJ; Stafford, ND; Thaker, H | 1 |
| Bakker-Woudenberg, IA; Tavakol, M; van de Sande, WW; van Vianen, W | 1 |
| Ben-Ami, R; Kontoyiannis, DP; Latgé, JP; Leventakos, K; Lewis, RE | 1 |
| Curfs-Breuker, IM; de Valk, HA; Klaassen, CH; Meis, JF | 1 |
| Borse, N; Jain, V; Natarajan, S; Shome, D | 1 |
| Fuqua, TH; Knoll, M; Said-Al-Naief, N; Sittitavornwong, S | 1 |
| Dirr, F; Ebel, F; Echtenacher, B; Heesemann, J; Hoffmann, P; Wagener, J | 1 |
| Anyfantakis, V; Camus, M; Dammak, A; Delouane, H; Guillet, G; Riche, A; Roblot, F | 1 |
| Hoffman, SB; Smith, LN | 1 |
| Kagoshima, Y; Kamai, Y; Kobayashi, N; Konosu, T; Kubota, M; Mori, M; Shibayama, T; Suzuki, E | 1 |
| de Hoon, J; Meersseman, P; Meersseman, W; Spriet, I; Willems, L | 1 |
| Canton, E; Diekema, DJ; Espinel-Ingroff, A; Fothergill, A; Johnson, E; Pelaez, T; Pfaller, MA; Rinaldi, MG; Turnidge, J | 1 |
| McCormack, J; Pollard, J | 1 |
| Hou, Z; Li, C; Liu, G; Liu, Z; Lu, M; Sha, X; Tan, D; Xie, J; Xie, Y | 1 |
| Aversa, F; Caira, M; Candoni, A; Leone, G; Luppi, M; Martino, B; Nosari, A; Offidani, M; Pagano, L; Specchia, G; Tosti, ME; Valentini, CG | 1 |
| Cordonnier, C; Cornely, OA; Flückiger, U; Frêre, P; Gachot, B; Heinz, WJ; Herbrecht, R; Lass-Flörl, C; Maertens, J; Marchetti, O; Ribaud, P; Thiebaut, A | 1 |
| Bowyer, P; Bueid, A; Denning, DW; Harrison, E; Howard, SJ; Moore, CB; Richardson, MD | 1 |
| Ehlert, K; Fegeler, W; Groll, AH; Kerl, K; Koch, B; Rossig, C | 1 |
| Atalay, H; Erekul, S; Nar, A; Ozbek, O; Solak, Y; Turk, S; Turkmen, K | 1 |
| Danna, R; Herbrecht, R; Papadopoulos, G; Rajagopalan, S | 1 |
| Bello, I; Golmia, R; Hamerschlak, N; Marra, A; Osawa, A; Scheinberg, M | 1 |
| Jiang, HR; Wu, XG; Xin, M; Yang, LN | 1 |
| Ho, MW; Lin, HC; Lu, MY; Peng, CT; Weng, TF; Wu, KH | 1 |
| Amrein, C; Beaune, PH; Berge, M; Billaud, EM; Boussaud, V; Chevalier, P; Guillemain, R; Laurent-Puig, P; Le Beller, C; Lillo-Lelouet, A; Loriot, MA; Trégouet, DA | 1 |
| Bellmann, R; Bellmann-Weiler, R; Dunzendorfer, S; Fiegl, D; Joannidis, M; MacFarland, R; Stienecke, E; Weiler, S | 1 |
| Higaki, T; Itokawa, T; Kami, M; Komatsu, T; Miura, Y; Murashige, N; Murata, K; Takei, N; Tsubokura, M | 1 |
| Falcone, M; Massetti, AP; Russo, A; Venditti, M; Vullo, V | 1 |
| Calvo, E; Guarro, J; Mayayo, E; Pastor, FJ; Rodríguez, MM; Salas, V | 1 |
| Boyken, L; Diekema, D; Hollis, R; Kroeger, J; Messer, S; Pfaller, M; Tendolkar, S | 1 |
| Ayuk, FA; Dahlke, J; Kröger, N; Lellek, H; Waldenmaier, D; Wolschke, C; Zander, AR | 1 |
| Alanio, A; Botterel, F; Bretagne, S; Cordonnier, C; Costa, JM; Farrugia, C; Foulet, F; Hicheri, Y; Liance, M; Sitterlé, E | 1 |
| Gyo, K; Hato, N; Hinohira, Y; Hyodo, J; Takahashi, H; Ugumori, T; Wakisaka, H | 1 |
| Stevens, DA; Studemeister, A | 1 |
| Durrani, OM; Joganathan, V; Mehta, P; Oppenheim, B | 1 |
| Hagelberg, NM; Laine, K; Neuvonen, M; Neuvonen, PJ; Nieminen, TH; Olkkola, KT; Saari, TI | 1 |
| Chiba, S; Hara, A; Homma, M; Kohda, Y; Momo, K; Okoshi, Y; Wada, T; Watanabe, M | 1 |
| Giguère, P; Kravcik, S; la Porte, CJ; Toy, J | 1 |
| Bienvenu, AL; Kraghel, S; Michallet, M; Morisset, S; Nicolini, FE; Nicolle, MC; Picot, S; Sobh, M; Thomas, X; Vanhems, P | 1 |
| Jones, B; Lang, S; Lappin, DF; Majithiya, JB; McCulloch, E; Mowat, E; Rajendran, R; Ramage, G; Warn, P; Williams, C | 1 |
| Bouza, E; Escribano, P; Guinea, J; Peláez, T; Recio, S | 1 |
| Hao-Ran, J; Li-Na, Y; Meng, X; Xiang-Gen, W | 1 |
| Azim, S; Fadoo, Z; Manzoor, NF | 1 |
| Actis Dato, GM; Bardi, G; Casabona, R; Del Ponte, S; Flocco, R; Forsennati, P; Parisi, F; Punta, G; Sansone, F; Zingarelli, E | 1 |
| Türel, O | 1 |
| Ruiz-Camps, I | 1 |
| Agarwal, P; Sharma, N; Sinha, R; Titiyal, JS; Vajpayee, RB; Velpandian, T | 1 |
| Katragkou, A; Roilides, E | 1 |
| Caira, M; Fianchi, L; Pagano, L; Valentini, CG | 1 |
| Brüggemann, RJ; de Sévaux, RG; Heesakkers, JP; Kuipers, S; Melchers, WJ; Mouton, JW; Verweij, PE | 1 |
| Reisman, A; Schwartz, S; Troke, PF | 1 |
| Chakrabarti, A; Geertsen, E; Meis, JF; Mouton, JW; Shivaprakash, MR | 1 |
| Arendrup, MC; Fuursted, K; Gahrn-Hansen, B; Howard, SJ; Jensen, RH; Johansen, HK; Knudsen, JD; Mortensen, KL | 1 |
| Dong, X; Min, X; Wu, X; Xie, L; Yang, L | 1 |
| Delaunay, J; Fraissinet, F; Gastinne, T; Gibas, CF; Le Pape, P; Miegeville, M; Morio, F; Sigler, L | 1 |
| Aki, ŞZ; Akyürek, N; Şenol, E; Sucak, G; Tunçcan, ÖG | 1 |
| Bajaj, MS; Kashyap, S; Meel, R; Pushker, N; Sen, S | 1 |
| George, J; Reboli, AC | 1 |
| Jang, IJ; Kim, KH; Kim, NJ; Lee, S; Oh, MD; Park, WB; Yu, KS; Yun, NR | 1 |
| Baxter, CG; Denning, DW; Felton, TW; Marshall, A; Roberts, M | 1 |
| Miller, CJ; Seykora, JT; Shinohara, MM | 1 |
| Katragkou, A; Roilides, E; Tsikopoulou, F; Zaoutis, TE | 1 |
| Stirbu, O; Suriano, MM; Vila Arteaga, J | 1 |
| Clifton, IJ; Conway, SP; Metcalfe, R; Peckham, DG; Phillip, M; Shaw, N; Whitaker, P | 1 |
| Choi, JH; Choi, SM; Han, S; Kim, SH; Kwon, EY; Kwon, JC; Lee, DG; Park, C; Park, SH; Yim, DS; Yoo, JH | 1 |
| Afshari, NA; Goldhagen, BE; Majka, CP; Perfect, JR; Rebong, RA; Santaella, RM; Steinbach, WJ | 1 |
| Beguin, H; Detandt, M; Hendrickx, M | 1 |
| Chakrabarti, A; Geertsen, E; Meis, JF; Mouton, JW; Rudramurthy, SM | 1 |
| Aoun, M; Gadisseur, A; Jacobs, F; Selleslag, D; Sonet, A | 1 |
| Joukhadar, C; Konz, KH; Popovic, M; Smolle-Jüttner, FM; Traunmüller, F | 1 |
| Camps, SM; Kuijper, EJ; Li, Y; Melchers, WJ; van der Linden, JW; van Dissel, JT; Verweij, PE | 1 |
| Bouza, E; Escribano, P; González-Rivera, M; Guinea, J; Peláez, T; Recio, S | 1 |
| Blosser, SJ; Cramer, RA | 1 |
| Hirano, K; Hosogaya, N; Ide, S; Imamura, Y; Iwanaga, N; Izumikawa, K; Kakeya, H; Kohno, S; Kurihara, S; Mihara, T; Minematsu, A; Miyazaki, T; Morinaga, Y; Nakamura, S; Nishino, T; Takazono, T; Tashiro, M; Tashiro, T; Tsukamoto, M; Yamamoto, Y; Yanagihara, K; Yasuoka, A | 1 |
| Bahlaoui, A; Bakhatar, A; Chakib, A; El Fane, M; El Filali, KM; Ouladlahsen, A; Sodqi, M | 1 |
| Hope, WW | 1 |
| Al-Saigh, R; Meletiadis, J; Roilides, E; Velegraki, A; Walsh, TJ; Zerva, L | 1 |
| Fedorova, ND; Gibbons, JG; Klaassen, CH; Meis, JF; Rokas, A | 1 |
| Wintenberger, C | 1 |
| Calvo, E; Guarro, J; Mayayo, E; Pastor, FJ; Salas, V | 1 |
| Gyotoku, H; Ikeda, H; Imamura, Y; Izumikawa, K; Kakeya, H; Kamei, K; Kanda, T; Kohno, S; Miyazaki, T; Miyzaki, Y; Morinaga, Y; Nakamura, S; Nishino, T; Ohno, H; Takazono, T; Yaguchi, T; Yamamoto, Y; Yanagihara, K; Yasuoka, A | 1 |
| Kontoyiannis, DP | 1 |
| Bouza, E; Giannella, M; Guinea, J; Klaassen, CH; Muñoz, P; Peláez, T; Valerio, M | 1 |
| Kontoyiannis, DP; Lewis, RE; Lortholary, O; Roilides, E; Spellberg, B; Walsh, TJ | 1 |
| Fortún, J | 1 |
| Bu, D; Chen, W; Li, R; Liu, W; Sun, Y; Wan, Z | 1 |
| Mavridou, E; Melchers, WJ; Meletiadis, J; Mouton, JW; Verweij, PE | 1 |
| Andrés, R; Elías, T; Fernandez de Orueta, L; Pintado, V | 1 |
| Couderc, L; Dominique, S; Favennec, L; Leguillon, C; Marguet, C; Masseline, B; Pramil, S; Rondeau, S | 1 |
| Cook, G; Cordonnier, C; Hicheri, Y | 1 |
| Mittal, R; Mittal, V | 1 |
| Buresova, L; Cetkovsky, P; Kocmanova, I; Kouba, M; Lengerova, M; Malaskova, L; Mayer, J; Racil, Z; Rolencova, M; Timilsina, S; Toskova, M; Weinbergerova, B; Winterova, J; Zak, P | 1 |
| Aouri, M; Buclin, T; Calmy, A; Decosterd, LA; Hirschel, B; Livio, F | 1 |
| Barreiro, GC; Leite, PF; Samano, MN; Siciliano, RF; Strabelli, TM; Tuma Júnior, P; Waisberg, DR | 1 |
| Biswas, J; Gopal, L; Selvakumar, P; Sofia, O | 1 |
| Hoenigl, M; Krause, R; Raggam, RB; Salzer, HJ; Seeber, K; Sill, H; Strohmeier, AT; Valentin, A; Valentin, T; Wölfler, A; Zollner-Schwetz, I | 1 |
| Corso, V; Drudi, F; Fantini, M; Imola, M; Mianulli, AM; Pasini, G; Ravaioli, A; Santelmo, C; Veneroni, L | 1 |
| Aubin, GG; Bretagne, S; Danner-Boucher, I; Garcia-Hermoso, D; Haloun, A; Le Pape, P; Miegeville, M; Morio, F; Sacchetto, E | 1 |
| Bai, C; Chen, B; Huang, HD; Huang, Y; Li, Q; Wang, Q; Wu, N; Yao, XP | 1 |
| Al-Nakeeb, Z; Felton, TW; Goodwin, J; Gregson, L; Hope, WW; Howard, SJ; Jeans, AR; Sudan, A; Warn, PA | 1 |
| Kuroki, K; Murakami, T | 1 |
| Andes, DR; Baddley, JW; Boeckh, M; Brizendine, KD; Chiller, T; Ito, JI; Kauffman, CA; Kontoyiannis, DP; Lyon, GM; Marr, KA; Oster, RA; Pappas, PG; Patterson, TF; Schuster, MG | 1 |
| Alanio, A; Bretagne, S; Brisse, S; Cabaret, O; Cordonnier, C; Costa, JM; Sitterlé, E | 1 |
| Ganesan, P; Philip, A; Sagar, TG; Sivaprakasam, P | 1 |
| Fukushima, K; Goto, H; Miharu, M; Mori, M; Shoji, S; Yoshida, M | 1 |
| Kema, GH; Melchers, WJ; van de Sande-Bruisma, N; Verweij, PE | 1 |
| Choe, PG; Jang, IJ; Kim, KH; Kim, NH; Kim, NJ; Lee, SH; Nam, WS; Oh, MD; Park, WB; Song, KH; Yoon, SH; Yu, KS | 1 |
| Deniz, K; Karakukcu, M; Ozdemir, MA; Patiroglu, T; Tucer, B; Unal, E; Yikilmaz, A | 1 |
| Becce, F; Lecouvet, FE; Malghem, J; Omoumi, P; Vande Berg, BC | 1 |
| Das, S; Gupta, N; Jain, S; Malik, JN | 1 |
| Baden, LR; Boukedes, S; Camp, PC; Dietzek, A; Fuhlbrigge, AL; Goldberg, HJ; Issa, NC; Koo, S; Kubiak, DW; Marty, FM | 1 |
| Andersen, CB; Carlsen, J; Iversen, M; Jensen, C; Tofte, N; Tvede, M | 1 |
| Egli, A; Fuller, J; Humar, A; Kapasi, A; Kumar, D; Lien, D; Nador, R; Weinkauf, J | 1 |
| Grimault, A; Lyoen, M; Minello, A; Rostain, F; Sgro, C | 1 |
| Clark, LP; Folio, L; Henderson, CM; Holland, SM; Kwon-Chung, KJ; Nardone, G; Peterson, SW; Riedlinger, G; Shea, Y; Sugui, JA; Zelazny, AM; Zerbe, CS | 1 |
| Calvo, E; Fothergill, AW; Guarro, J; Pastor, FJ; Rinaldi, MG; Salas, V; Sutton, DA | 1 |
| Denning, DW; Felton, S; Haylett, AK; Rhodes, LE | 1 |
| Choi, SH; Hwang, JY; Kim, YJ; Koo, HH; Lee, SH; Lee, SY; Sung, KW; Yoo, KH | 1 |
| Bhavan, KP; Boyd, NK; Swancutt, MA; Zoellner, CL | 1 |
| Huang, XE; Shen, ZS; Su, AL; Xu, YL; Zhang, XQ; Zhang, XZ | 1 |
| Acharya, NR; Keenan, JD; Krishnan, T; Lalitha, PS; Lietman, TM; Mascarenhas, J; Oldenburg, CE; Porco, TC; Prajna, VN; Srinivasan, M; Sy, A; Vaitilingam, CM | 1 |
| Curtis, LT | 1 |
| Bos, B; Buchheidt, D; Cornely, OA; Halbsguth, TV; Hallek, M; Hamprecht, A; Kahl, P; Kutsch, N; Persigehl, T; Plum, G; Spiess, B; Steinbach, A; Stippel, D; Vehreschild, JJ; Vehreschild, MJ | 1 |
| Cherian, T; Giakoustidis, A; Heaton, DN; Heneghan, M; O'Grady, J; Rela, M; Verma, A; Wendon, J; Yokoyama, S | 1 |
| Auzinger, G; Bernal, W; Heneghan, MA; López, JC; Solís-Muñoz, P; Verma, A; Wendon, J; Willars, C | 1 |
| Fiehler, J; Gerloff, C; Kruetzelmann, A; Rosenkranz, M; Sobottka, I; Tolosa, E | 1 |
| Choi, YL; Joo, H; Kang, SW; Kim, E; Kim, TH; Kim, YH; Park, SJ; Shin, JG; Son, JH; Song, IS; Yoon, YC | 1 |
| Bojtarova, E; Cetkovsky, P; Drgona, L; Foralova, R; Forsterova, K; Guman, T; Haber, J; Kandrnal, V; Kocmanova, I; Kouba, M; Mallatova, N; Masarova, L; Mayer, J; Mudry, P; Muzik, J; Racil, Z; Sejnova, D; Tothova, E; Vydra, J; Weinbergerova, B; Ziakova, B | 1 |
| Kema, GH; Melchers, WJ; Verweij, PE; Zwaan, B | 1 |
| Bartelink, IH; Bierings, M; Boelens, JJ; de Waal, M; Egberts, TC; Jonker, M; Ververs, TT; Wolfs, T | 1 |
| Brüggemann, RJ; Melchers, WJ; Mouton, JW; Rijs, AJ; Seyedmousavi, S; Verweij, PE | 1 |
| Allisy, C; Bougnoux, ME; Charlier, C; Hermine, O; Lecuit, M; Lortholary, O; Roth, P; Shoai Tehrani, M; Sicre de Fontbrune, F | 1 |
| Boehme, A; Egerer, G; Greiner, J; Heinz, WJ; Lellek, H | 1 |
| Aversa, F; Cesaro, S; de Rosa, FG; Girmenia, C; Micozzi, A; Mikulska, M; Novelli, A; Sanguinetti, M; Viscoli, C | 1 |
| Autmizguine, J; Krajinovic, M; Litalien, C; Marquis, C; Ovetchkine, P; Rousseau, J; Tapiéro, B; Théorêt, Y | 1 |
| Arikan-Akdagli, S | 1 |
| Auberger, J; Greil, R; Lass-Flörl, C | 1 |
| Hoenigl, M; Krause, R | 1 |
| Calvo, E; Fothergill, AW; Guarro, J; Pastor, FJ; Salas, V; Sutton, DA | 1 |
| Calvo, E; Fothergill, AW; Guarro, J; Mayayo, E; Pastor, FJ; Rinaldi, MG; Salas, V; Sutton, DA | 1 |
| Husain, S; Luong, ML; Rotstein, C | 1 |
| Askew, DS; Bick, G; Feng, X; Krishnan, K; Powers-Fletcher, MV; Richie, DL; Woollett, LA | 1 |
| Abe, K; Arakawa, H; Ishida, T; Notani, H; Ookubo, Y; Suto, C | 1 |
| Danner, RL; Figg, WD; Henning, SA; Jarosinski, PF; Moriyama, B; Penzak, SR; Walsh, TJ; Wayne, AS | 1 |
| Bastide, JM; Dannaoui, E; Grillot, R; Mallie, M; Meletiadis, J; Piens, MA; Rigoni, AL; Tortorano, AM; Viviani, MA | 1 |
| Coco, BJ; Kirkpatrick, WR; Patterson, TF; Perea, S | 2 |
| Bennett, JE; Caillot, D; Chandrasekar, PH; de Pauw, B; Denning, DW; Durand, C; Greene, RE; Herbrecht, R; Hodges, MR; Kern, WV; Lortholary, O; Marr, KA; Oestmann, JW; Patterson, TF; Ribaud, P; Rubin, RH; Schlamm, HT; Stark, P; Sylvester, R; Thiel, E; Troke, PF; Wingard, JR | 1 |
| Fothergill, AW; Gonzalez, G; Kirkpatrick, WR; Patterson, TF; Perea, S; Rinaldi, MG | 1 |
| Brown, NE; Chow, L; Kunimoto, D | 1 |
| Brown, J; Potoski, BA | 1 |
| Goa, KL; Muijsers, RB; Scott, LJ | 1 |
| Bacigalupo, A; Ferrua, MT; Gallamini, A; Ghirardo, D; Lo Nigro, C; Mattei, D; Mordini, N; Osenda, M; Viscoli, C | 1 |
| Fukuda, H; Hayase, T; Ichihara, S; Isshiki, Y; Mizuguchi, E; Ohwada, J; Oikawa, N; Sakaitani, M; Shimma, N; Shiratori, Y; Tsukazaki, M; Umeda, I; Yamazaki, T | 1 |
| Blot, F; Edé, C; Nitenberg, GM | 1 |
| Johnson, LB; Kauffman, CA | 1 |
| Herbrecht, R | 1 |
| Bernal, S; Chávez M, M; Claro, RM; Martín-Mazuelos, E; Pemán, J; Ramirez, M; Serrano, Mdel C; Valverde-Conde, A | 1 |
| Kontoyiannis, DP; Mantadakis, E; Samonis, G | 1 |
| Ruhnke, M | 1 |
| de la Torre-Cisneros, J; DuPont, B; Espinel-Ingroff, A; Greenberg, RN; Johnson, E; Just-Nübling, G; Lutsar, I; Marr, KA; Perfect, JR; Schlamm, HT; Walsh, TJ | 1 |
| Mori, T | 1 |
| Johnson, PD; Korman, TM; Stratov, I | 1 |
| Harris, GJ; Kim, JE; Perkins, SL | 1 |
| Feldmesser, M; Pamer, EG; Van Epps, HL | 1 |
| Avila, NA; Bacher, J; Casler, HE; Groll, AH; Kelaher, AM; Lyman, CA; Petraitiene, R; Petraitis, V; Sarafandi, AA; Sein, T; Walsh, TJ | 1 |
| Alvarez, ME; Fortún, J; Martín-Dávila, P; Moreno, S; Pintado, V; Sánchez, MA; Sánchez-Sousa, A | 1 |
| Ullmann, AJ | 1 |
| Fung, HB; Jeu, L; Lyakhovetskiy, AG; Piacenti, FJ | 1 |
| Cook, C; Fernandez, C; Fraser, R; McCully, B; Schmidt, M; Shouldice, E | 1 |
| Alaggio, R; Cecchetto, G; Cesaro, S; Cusinato, R; Pillon, M; Rigobello, L; Strugo, L; Zanesco, L | 1 |
| Cuenca-Estrella, M; Garcia-Effron, G; Gomez-Lopez, A; Mellado, E; Monzon, A; Rodriguez-Tudela, JL | 1 |
| Auner, HW; Dornbusch, HJ; Eibl, M; Linkesch, W; Sill, H; Zinke-Cerwenka, W | 1 |
| Garbino, J; Kolarova, L; Lew, D; Ondrusova, A; Rohner, P | 1 |
| Denning, D; Guiver, M; Sambatakou, H | 1 |
| Chávez, M; Claro, R; Espinel-Ingroff, A; Mazuelos, EM; Morilla, D; Ramírez, M; Serrano, MC; Valverde, A | 1 |
| Sims-McCallum, RP | 1 |
| Bilger, K; D'incan, E; Damaj, G; Doglio, MF; Faucher, C; Gastaut, JA; Ivanov, V; Le Brigand, B; Vey, N | 1 |
| Chow, E; Moore, T; Nielsen, K | 1 |
| Baden, LR; DelVecchio, A; Doran, M; Fishman, JA; Katz, JT; Koziol, C; Rubin, RH | 1 |
| Denning, DW; Hope, WW | 1 |
| Alangaden, GJ; Baskaran, I; Chandrasekar, PH; Manavathu, EK; Varanasi, NL | 1 |
| Díaz, MA; González-Vicent, M; Lassaletta, A; Madero, L; Perez, A; Sevilla, J | 1 |
| Bocanegra, R; Cacciapuoti, A; Graybill, JR; Gurnani, M; Halpern, J; Hernandez, S; Loebenberg, D; Menzel, F; Najvar, LK | 1 |
| Caliandro, R; Girard, P; Stern, JB | 1 |
| Baden, LR; Cosimi, LA; Marty, FM | 1 |
| Ashley, ED; Lodge, BA; Perfect, JR; Steele, MP | 1 |
| Dupont, B | 1 |
| Bastié, JN; Bretagne, S; Castaigne, S; Chehata, S; Cordonnier, C; Kuentz, M; Maury, S; Pautas, C; Ribaud, P | 1 |
| Contu, L; La Nasa, G; Ledda, A; Littera, R; Maccioni, A; Vacca, A | 1 |
| Mehta, J; Trifilio, S; Verma, A; Williams, S; Zembower, T | 1 |
| Aliyeva, SE; Frising, M; Kottler, UB; Schwenn, O; Ullmann, AJ | 1 |
| Schwartz, S; Thiel, E | 2 |
| Smilack, JD; Sohail, MR | 1 |
| Hahn, U; Küker, W; Lengerke, A | 1 |
| Rubin, ZA; Somani, J | 1 |
| Basso, C; Biffanti, R; Milanesi, O; Stellin, G; Thiene, G; Vida, V | 1 |
| Alaggio, R; Calore, E; Cesaro, S; Cusinato, R; Messina, C; Pillon, M; Toffolutti, T; Zanesco, L | 1 |
| Friedrich, W; Gahr, M; Hahn, G; Koch, A; Roesler, J; Rösen-Wolff, A | 1 |
| Antoniades, A; Giotakis, J; Imbrios, G; Manesis, EK; Tsiodras, S; Zafiropoulou, R | 1 |
| Peetermans, WE; Van Wijngaerden, E; Vandecasteele, SJ | 1 |
| Kantoyiannis, DP; Kontoyiannis, DP; Lewis, RE | 1 |
| Benjamin, DK; Jafri, H; Kontoyiannis, DP; Lionakis, MS; Lutsar, I; Marr, KA; Perfect, JR; Steinbach, WJ; Torres, HA; Walsh, TJ | 1 |
| Buysschaert, I; De Laere, E; De Man, R; Demuynck, H; Ide, L; Surmont, I; Verlinde, A | 1 |
| Balajee, SA; Englund, JA; Fredricks, DN; Imhof, A; Marr, KA | 1 |
| Bouteille, B; Debette-Gratien, M; Denes, E; Gaulier, JM; Pichon, N | 1 |
| Bonatti, H; Dierich, MP; Freund, MC; Gastl, G; Gschwendtner, A; Gunsilius, E; Kropshofer, G; Lass-Flörl, C; Petzer, A | 1 |
| Chandrasekar, PH; Cutright, JL; Manavathu, EK | 2 |
| Afif, C; Bodey, GP; Boktour, MR; Chatzinikolaou, I; Cooksley, C; Hachem, RY; Kantarjian, HM; Kontoyiannis, DP; Perego, C; Raad, II | 1 |
| Clemons, KV; Imai, JK; Singh, G; Stevens, DA | 1 |
| Gavaldá, J; Lumbreras, C | 1 |
| Azzola, A; Bubendorf, L; Eich, G; Gratwohl, A; Habicht, JM; Passweg, JR; Tamm, M | 1 |
| Boeckh, M; Carter, RA; Corey, L; Kim, HW; Marr, KA | 1 |
| Viscoli, C | 1 |
| Boyd, AE; Denning, DW; Howard, SJ; Keevil, BG; Modi, S; Moore, CB | 1 |
| Fujisaki, G; Kami, M; Kishi, Y; Kobayashi, K; Mitamura, T; Murashige, N | 1 |
| Benjamin, DK; Heitman, J; Miller, JL; Perfect, JR; Schell, WA; Singh, N; Steinbach, WJ | 1 |
| Beltramo, D; Levin, T; Samuel, R; Suh, B | 1 |
| Friedman, GS; Mathis, AS; Shah, NK | 1 |
| Perfect, JR | 2 |
| Marr, K | 1 |
| Birnbaum, DE; Jagiello, M; Liebold, A; Retzl, G; Wieland, T | 1 |
| Clezy, K; van Hal, SJ | 1 |
| Balwierz, W | 1 |
| Belohradsky, BH; Führer, M; Graubner, UB; Kammer, B; Moelter, C; Schmid, I; Schuster, F | 1 |
| Del Favero, A; Kibbler, C; Marciniak, A; Mauskopf, J; Morris, S; Rogers, T; Rotstein, C; Schlamm, H; Troke, P; Wenzel, R | 1 |
| Dupont, B; Fain, O; Herbrecht, R; Lescure, FX; Lortholary, O; Lutsar, I; Mouas, H | 1 |
| Dinser, R; Grgic, A; Kim, YJ; Pfreundschuh, M; Schubert, J | 1 |
| Cesaro, S; Visintin, G | 1 |
| Chaberny, IF; Fischer, S; Gastmeier, P; Gottlieb, J; Haubitz, B; Mattner, F; Mattner, L; Strueber, M; Weissbrodt, H | 1 |
| Ermert, L; Lohmeyer, J; Lommel, D; Ludwig, M; Schneider, H; Sziegoleit, A; Weidner, W | 1 |
| Albert, ND; Kontoyiannis, DP; Lewis, RE; Lionakis, MS; Raad, II; Torres, HA | 1 |
| Christmann, D; Eisenmann, B; Forestier, E; Hansman, Y; Lesens, O; Martinot, M; Remy, V | 1 |
| Cuenca-Estrella, M; Elia, M; Gutierrez, F; Masia, M; Ramos, JM; Rodriguez-Tudela, JL | 1 |
| Leather, H | 1 |
| Brown, J; Freeman, BB | 1 |
| Böhme, A; Haas, A; Maschmeyer, G | 1 |
| Ambegaonkar, AJ; Boucher, HW; Day, DL; Lewis, JS; Lubowski, TJ; Patterson, TF | 1 |
| Kofla, G; Ruhnke, M | 1 |
| Corey, L; Cornely, OA; Driscoll, T; Lutsar, I; Ribaud, P; Ruhnke, M; Schuler, U; Schwartz, S; Thiel, E; Troke, P | 1 |
| Athanassiadou, F; Kalogera, A; Kourti, M; Papageorgiou, T; Tragiannidis, A; Velegraki, A | 1 |
| Bedini, A; Cocchi, S; Codeluppi, M; Esposito, R; Guaraldi, G; Squillace, N; Venturelli, C | 1 |
| Barton, TD; McGarvey, M; Milas, B; Pochettino, A; Reboli, A; Reis, LJ; Schuster, MG; Velazquez, O | 1 |
| MacCallum, DM; Odds, FC; Whyte, JA | 1 |
| Aguado, JM; Cisneros, JM; Díaz Pedroche, C; Lumbreras, C | 1 |
| Bergeron, A; Dromer, F; Ferry, C; Feuilhade, M; Gluckman, E; Hermoso, DG; Lacroix, C; Molina, JM; Pavie, J; Ribaud, P; Robin, M | 1 |
| Steinbach, WJ | 1 |
| Bonatti, H; Dierich, MP; Freund, M; Gastl, G; Griff, K; Kropshofer, G; Lass-Flörl, C; Mayr, A; Nachbaur, D; Petzer, A | 1 |
| Bennett, JE; Boucher, HW; Denning, DW; DePauw, B; Herbrecht, R; Lortholary, O; Patterson, TF; Ribaud, P; Rubin, RH; Schlamm, HT; Troke, P; Wingard, JR | 1 |
| Blijlevens, NM; Jansen, JP; Meis, JF; van't Wout, JW | 1 |
| Balfour-Lynn, I; Buchdahl, R; Bush, A; Davies, J; Edwards, S; Francis, J; Hilliard, T; Rosenthal, M | 1 |
| Ballentine, CS; Glickman, RD; Graybill, JR; Harrison, JM; Kumar, N; Kurian, P; Lloyd, WC; Melendez, R; Miller, A; Miller, MM; Najvar, LK; Paris, G; Patel, AH; Pena, MA; Sponsel, WE; Trigo, Y; Trujillo, F | 1 |
| Blatny, J; Burgetova, D; Kren, L; Mudry, P; Prochazka, J; Skotakova, J; Sterba, J; Valik, D; Ventruba, J | 1 |
| Schoeni, MH | 1 |
| Bertz, H; Finke, J; Kern, WV; Sander, A; Wagner, D | 1 |
| Bennett, F; Cacciapuoti, A; Ganguly, AK; Girijavallabhan, VM; Hare, RS; Jao, E; Liu, YT; Loebenberg, D; Lovey, RG; Menzel, F; Moss, E; Nomeir, A; Patel, NM; Pike, R; Pinto, P; Saksena, AK; Wang, H | 1 |
| Devouassoux, G; Freymond, N; Harf, R; Le Loch, JB; Pacheco, Y; Rakotomalala, A | 1 |
| Nagino, K; Shirasawa, H | 1 |
| Decosterd, LA; Duchosal, MA; Gambillara, E; Kovacsovics, T; Laffitte, E; Panizzon, RG; Widmer, N | 1 |
| Conte, JV; Dropulic, LK; Girgis, R; Mcdyer, JF; Orens, JB; Shlobin, OA; Yang, SY | 1 |
| Clemons, KV; Espiritu, M; Parmar, R; Stevens, DA | 1 |
| Carpenter, J; Howell, A; Hurley, D; Midturi, J; Sierra-Hoffman, M; Winn, R | 1 |
| Curigliano, G; de Braud, F; De Pas, T; Fazio, N; Formica, V; Goldhirsch, A; Pietri, E; Spitaleri, G | 1 |
| Kumar, R; Naithani, R | 1 |
| Denning, DW; Jain, LR | 1 |
| Gøtzsche, PC; Johansen, HK; Jørgensen, KJ | 1 |
| Marik, PE; Raman, T | 1 |
| Alarcón L, P; Camacho A, J; Cruces R, P; Donoso F, A | 1 |
| Aguado, JM; Del Busto, R; Fisher, RA; Forrest, G; Houston, S; Husain, S; Klintmalm, GB; Kontoyiannis, DP; Lewis, RE; Limaye, AP; Miller, R; Montoya, JG; Muñoz, P; Patton, P; Pursell, K; Rosso, F; Safdar, N; Singh, N; Wagener, MM | 1 |
| Chamilos, G; Kontoyiannis, DP | 1 |
| Carde, A; Faure, P; Papy, E; Ribaud, P; Touratier, S | 1 |
| Abuhammour, W; Hasan, RA | 1 |
| Badet, M; Bayle, F; Guérin, C; Lemasson, S; Philit, F; Poupelin, JC; Richard, JC | 1 |
| Coco, BJ; Kirkpatrick, WR; Patterson, TF | 1 |
| Allamani, M; Falagas, ME; Michalopoulos, A; Vassiloyanakopoulos, A | 1 |
| Ada, E; Avkan Oğuz, V; Balci, P; Ceylan, E; Gülşen, A; Güngör, O; Kargi, A; Sanli, A; Tertemiz, KC; Uçan, ES; Uğural Sezak, N | 1 |
| Cobb, S; Diekema, DJ; Hoth, P; Magalheas-Silverman, M; Pfaller, MA; Polgreen, PM; Siwek, GT | 1 |
| Hasan, Y; Stableforth, P; Wandroo, F | 1 |
| Braun-Falco, M; Ring, J | 1 |
| Axer-Siegel, R; Bishara, J; Blau, H; Kramer, M; Kramer, MR; Weinberger, D | 1 |
| Black, TA; Hare, R; Loebenberg, D; Mann, PA; McNicholas, PM; Mendrick, CA; Norris, CC; Patel, R; Sabatelli, F | 1 |
| Akova, M; Sahin, GO | 1 |
| Aperis, G; Mylonakis, E | 1 |
| Denning, DW; Dupont, B; Lode, H; Sambatakou, H | 1 |
| Brandenburg, VM; Floege, J; Guetgemann, A; Ketteler, M; Riehl, J | 1 |
| Blijlevens, NM; Donnelly, JP; Klont, RR; van der Velden, WJ; Verweij, PE | 1 |
| Clemons, KV; Martinez, M; Parmar, R; Stevens, DA | 1 |
| Agarwal, R; Singh, N | 1 |
| Edwards, C; Garcia, RJ; Troya, P | 1 |
| Cacciapuoti, A; Halpern, J; Loebenberg, D; Mendrick, C; Norris, C; Patel, R | 1 |
| Blackwood, RA; Klein, KC | 1 |
| Carby, M; Hall, AV; Zoumot, Z | 1 |
| Almyroudis, NG; Bhatti, Z; Segal, BH; Shaukat, A | 1 |
| Asada, N; Komatsu, M; Koseki, M; Matsue, K; Takeuchi, M; Uryu, H | 1 |
| Bäsecke, J; Glass, B; Perske, C; Rüchel, R | 1 |
| Bal, AM | 1 |
| Eifinger, F; Frankenbusch, K; Kribs, A; Rengelshauseu, J; Roth, B | 1 |
| Kauffman, CA | 1 |
| Dikman, S; Huprikar, S; Linden, E; Murphy, B; Restrepo, D | 1 |
| Gottfredsson, M; Steingrímsdóttir, H | 1 |
| Kadota, J; Tokimatsu, I | 1 |
| Hapuarachchi, S; Jayasinghe, S; Perera, KN; Ranwala, R; Rodrigo, N; Warnakulasuriya, A | 1 |
| Bailey, TA; Di Somma, A; Silvanose, CD | 1 |
| Odds, FC | 1 |
| Bacher, J; Kelaher, AM; Lin, P; Meletiadis, J; Petraitiene, R; Petraitis, V; Schaufele, RL; Sein, T; Stergiopoulou, T; Walsh, TJ | 1 |
| Groll, AH; Walsh, TJ | 1 |
| Cornely, OA; Karthaus, M | 1 |
| Belohradsky, BH; Costantino, F; Friederici, D; Jansson, A; Notheis, G; Reinhardt, D; Rosenecker, J; Schweinitz, DV; Seger, R; Tarani, L; Wintergerst, U | 1 |
| Klastersky, J; Paesmans, M | 1 |
| Cornely, OA; Glöckner, A | 1 |
| Aperis, G; Mylonakis, E; Spanakis, EK | 1 |
| Bouges-Michel, C; Dannaoui, E; Garcia-Hermoso, D; Lortholary, O; Meneau, I; Naccache, JM; Sanglard, D; Valeyre, D | 1 |
| Alvarez-Lerma, F; Grau, S; Marín-Casino, M; Mateu-De, AJ; Torres-Rodríguez, JM | 1 |
| De Stefano, V; Fianchi, L; Leone, G; Murri, R; Pagano, L; Rossi, E | 1 |
| Denning, DW; Gardiner, RE; Howard, SJ; Moore, CB; Park, S; Perlin, DS; Webster, I | 1 |
| Crespo, M; Husain, S; Johnson, B; Kwak, EJ; McCurry, KR; Pakstis, DL; Paterson, DL; Pilewski, J; Shutt, K; Studer, S; Zaldonis, D; Zeevi, A | 1 |
| Denning, DW; Heep, M; Mosquera, J; Schmitt-Hoffmann, A; Sharp, A; Spickermann, J; Warn, PA | 1 |
| Donati, A; Gabbanelli, V; Nataloni, S; Pantanetti, S; Pelaia, P; Rossi, R | 1 |
| Garbino, J; Roberts, C; Schnetzler, G | 1 |
| Honda, M; Ichiyasu, H; Kohrogi, H; Matsumoto, M; Okamoto, S; Okamoto, T; Sato, K; Tsumori, K; Yamamura, A | 1 |
| Dierich, MP; Lass-Flörl, C; Lugger, H; Perkhofer, S | 1 |
| Chandrasekar, P; Corcoran, G; Donowitz, GR; Gogate, J; Graybill, R; Greene, RE; Hachem, R; Hadley, S; Hardalo, C; Herbrecht, R; Krishna, G; Langston, A; Louie, A; Patterson, TF; Pedicone, L; Perfect, JR; Raad, I; Ribaud, P; Segal, BH; Stevens, DA; van Burik, JA; Walsh, TJ; White, CS | 1 |
| Baumann, A; Caversaccio, M; Hausler, R; Zimmerli, S | 1 |
| Araujo, R; Pina-Vaz, C; Rodrigues, AG | 1 |
| Kantesaria, B; Krishna, G; Martinho, M; Pedicone, L; Sansone-Parsons, A | 1 |
| Hasegawa, Y; Hitomi, S; Imagawa, S; Ishii, Y; Kaneko, S; Kojima, H; Machino, T; Mukai, HY; Muto, H; Nagasawa, T; Okoshi, Y; Suzukawa, K | 1 |
| Boparai, N; Chandrasekar, P; Durrant, S; Greinix, H; Langston, A; Lipton, JH; Morais de Azevedo, W; Patino, H; Pedicone, L; Reddy, V; Tarantolo, SR; Ullmann, AJ; Vesole, DH | 1 |
| De Pauw, BE; Donnelly, JP | 1 |
| Del Castillo, A; Díaz, S; Domínguez-Gil, A; García Vargas, M; Martín, I; Sánchez, C | 1 |
| Baden, LR; Katz, JT; Koplan, BA; Marty, FM; Philips, JA; Stone, RM | 1 |
| Boumediene, A; Darde, ML; Denes, E; Durox, H; Gaulier, JM; Oksman, A; Saint-Marcoux, F | 1 |
| Lambert, JS; Poulton, MB; Scott, CJ; Taylor, CB | 1 |
| Easley, C; Kauffman, CA; Kirkpatrick, P; Malani, AN | 1 |
| Mylona, S; Ntai, S; Pomoni, M; Thanos, L; Tzavara, V | 1 |
| Melchers, WJ; Mellado, E; Verweij, PE | 1 |
| Benjamin, DK; Jafri, HS; Mejias, A; Patel, S; Sánchez, PJ; Santos, RP; Walsh, TJ | 1 |
| Handa, H; Irisawa, H; Karasawa, M; Matsushima, T; Murakami, H; Nojima, Y; Saitoh, T; Shimizu, H; Tsukamoto, N; Yokohama, A | 1 |
| Ajisawa, A; Honma, M; Imamura, A; Negishi, M; Suganuma, A; Suzuki, T; Takeshita, N; Yanagisawa, N | 1 |
| Bonatti, H; Lass-Floerl, C; Lechner, M; Lorenz, I; Piza, H; Rieder, J; Rieger, M | 1 |
| Petrikkos, G; Skiada, A | 1 |
| Soubani, AO; Zmeili, OS | 1 |
| Fincher, T; Fulcher, SF | 1 |
| Kontoyiannis, DP; Lewis, RE | 1 |
| Ament, AJ; de Groot, R; Donnelly, JP; Hübben, MW; Severens, JL; van 't Wout, J; Verweij, PE; Warris, A | 1 |
| Hosoki, T; Ikuta, K; Jimbo, J; Kohgo, Y; Nishimura, K; Sano, A; Sato, K; Shindo, M; Torimoto, Y | 1 |
| Ishida, H; Kanda, F; Kuga, A; Oishi, K | 1 |
| Evens, A; Frankfurt, O; Gordon, L; Mehta, J; Pi, J; Singhal, S; Tallman, M; Trifilio, S; Williams, S; Winter, J | 1 |
| Cantón, E; Chirivella, M; Crespo, M; Frasquet, J; Gobernado, M; Ortiz, R; Osseyran, F; Pemán, J; Pérez-Bellés, C; Quesada, A | 1 |
| Eschertzhuber, S; Hoefer, D; Hoermann, C; Lass-Florl, C; Velik-Salchner, C | 1 |
| Herbrecht, R; Marciniak, A; Mauskopf, J; Roberts, CS; Schlamm, HT; Wingard, JR | 1 |
| Lewis, RE | 1 |
| Kaye, SB; Neal, TJ; Quah, SA; Stewart, RM | 1 |
| Hamanaka, N; Hiroi, N; Homma, S; Isobe, K; Kikuchi, N; Kimura, K; Muraoka, S; Shibuya, K; Shimizu, K; Sugino, K; Takai, Y; Yamazaki, Y | 1 |
| Bongiovanni, M; Chalandon, Y; Meyer, M; Pache, JC; Van Delden, C; Waldvogel, S | 1 |
| Haas, A; Maschmeyer, G | 1 |
| Granowitz, E; Iarikov, D; Robertson, D; Skiest, D | 1 |
| Baden, LR; Marty, FM | 1 |
| Foo, H; Gottlieb, T | 1 |
| Bailey, T; Demiraj, F; Di Somma, A; Krautwald-Junghanns, ME; Schmidt, V; Ungemach, FR | 1 |
| Fujita, M; Harada, E; Ikegame, S; Inoshima, I; Nakanishi, Y; Ouchi, H | 1 |
| Kauffman, CA; Malani, AN | 1 |
| Denning, DW | 1 |
| Jain, A; Sun, Y; Ta, CN | 1 |
| Calvo, C; de Andoin, NG; Guerrero, R; Landa, J; Nogues, A; Onate, E; Uriz, J | 1 |
| Kontoyiannis, D | 1 |
| Kaya, AD; Kiraz, N | 1 |
| Dambrin, C; Durand, D; Garrouste, C; Kamar, N; Linas, MD; Rostaing, L; Tall, P; Wéclawiak, H | 1 |
| Hamada, S; Iwasaki, Y; Izumi, N; Kamoshima, Y; Okugawa, S; Sawamura, Y | 1 |
| Feldberg, E; Halperin, D; Lahav, J; Warman, M | 1 |
| Bergeron, A; de Latour, RP; Devergie, A; Ferry, C; Ghannoum, M; Gluckmana, E; Lacroix, C; Lapalu, J; Madureira, A; Ribaud, P; Robin, M; Rocha, V; Socié, G | 1 |
| Fung, HB; Schiller, DS | 1 |
| Stratakos, G; Zakynthinos, S | 1 |
| Greene, RE; Mauskopf, J; Roberts, CS; Schlamm, HT; Zyczynski, T | 1 |
| Endo, I; Matsuo, K; Morioka, D; Moroboshi, T; Sekido, H; Shimada, H; Takeda, K; Togo, S | 1 |
| Afif, C; Boktour, M; Hachem, RY; Hanna, HA; Jiang, Y; Kontoyiannis, DP; Raad, II; Torres, HA | 1 |
| Meessen, NE; Oosten, AW; Sprenger, HG; van Assen, S; van Leeuwen, JT | 1 |
| Cimino, G; Gentile, G; Girmenia, C; Martino, P; Pizzarelli, G; Pozzi, E | 1 |
| Bille, J; Bolay, S; Buclin, T; Calandra, T; Marchetti, O; Pascual, A | 1 |
| Fujishima, T; Hashimoto, M; Honda, Y | 1 |
| Aguirrebengoa, K; Arteaga, C; Chen, SC; Ellis, D; Heath, CH; Lutsar, I; Nguyen, Q; Rovira, M; Slavin, M; Troke, P | 1 |
| Arnaud, P; Desmonts, JM; Lasocki, S; Massias, L; Montravers, P; Papy, E; Quintard, H | 1 |
| Jones, A; Muhtaseb, M | 1 |
| Denning, DW; Pasqualotto, AC; Shah, M; Wynn, R | 1 |
| Chandrasekar, PH; Krishnan-Natesan, S | 1 |
| Berceanu, A; Herbrecht, R | 1 |
| Fabré, G; Maes, B; Peetermans, WE; Van Dorpe, J; Vanacker, A | 1 |
| Akhaddar, A; Albouzidi, A; Boucetta, M; Elmostarchid, B; Gazzaz, M; Lmimouni, B | 1 |
| de la Fuente-Trabado, M; Díaz, MA; González-Vicent, M; Lassaletta, A; López-Pino, MA; Romero-Tejada, JC | 1 |
| Amrein, C; Bergé, MM; Billaud, EM; Boussaud, V; Chevalier, P; Daudet, N; Guillemain, R; Le Beller, C; Lillo-Le Louet, A | 1 |
| Golinval, O; Louis, R | 1 |
| Anaissie, E; Buvé, K; Maertens, J | 1 |
| Herbrecht, R; Ribaud, P; Schlamm, HT; Wingard, JR | 1 |
| Bailey, T; Di Somma, A; Garcia-Martinez, C; Silvanose, C | 1 |
| Chirch, L; Fuhrer, J; Roche, P | 1 |
| Can, MF; Cetiner, S; Gorenek, L; Ozerhan, I; Tozkoparan, E; Yagci, G | 1 |
| Joshi, R; Kohli, V; Sachdev, P; Taneja, V | 1 |
| Begueret, H; Beylot-Barry, M; Couprie, B; Domergue, V; Doutre, MS; Huerre, M; Orlandini, V; Tunon de Lara, M | 1 |
| Graybill, JR; Lewis, JS | 1 |
| Athan, E; Campbell, P; Chang, CC; Cheng, AC; Devitt, B; Hughes, AJ; Low, J; Styles, K | 1 |
| Goel, M; Prakash, G; Sharma, N; Titiyal, JS; Vajpayee, RB | 1 |
| Kohno, S; Kurashima, A; Maesaki, S; Niki, Y; Ogawa, K | 1 |
| Frampton, JE; Scott, LJ | 1 |
| Alastruey-Izquierdo, A; Alcazar-Fuoli, L; Cuenca-Estrella, M; Mellado, E; Monzon, A; Rodriguez-Tudela, JL | 1 |
| Bocanegra, R; Fothergill, AW; Graybill, JR; Herrera, ML; Kinney, MC; Kirkpatrick, WR; Najvar, LK; Patterson, TF; Vallor, AC; Wickes, BL | 1 |
| Mavinkurve-Groothuis, AM; van Die, LE; van't Hek, LG; Verweij, PE; Warris, A; Zwitserloot, AM | 1 |
| Drutz, DJ; Graybill, JR; Kaster, SR | 1 |
| Plempel, M | 1 |
| Denning, DW; Hall, L; Hollis, S; Jackson, M | 1 |
| Allendoerfer, R; Graybill, JR; Loebenberg, D; Rinaldi, MG | 1 |
| Anaissie, EJ; Uzun, O | 1 |
| Lee, JW; Walsh, TJ | 1 |
| Kozuki, K; Miyauchi, H; Ohashi, N; Tanio, T | 2 |
| Andriole, VT; George, D; Miniter, P | 1 |
| Hata, K; Katsu, K; Kimura, J; Miki, H; Nakamura, T; Toyosawa, T | 1 |
| Hata, K; Katsu, K; Kimura, J; Miki, H; Moriyama, M; Toyosawa, T | 1 |
| Hitchcock, CA; Martin, MV; Yates, J | 1 |
| Annen, N; Araki, H; Fujimaki, K; Hayakawa, H; Hori, R; Imaizumi, H; Narita, H; Nishida, N; Shimizu, K; Watanbe, Y; Yamamoto, S; Yotsuji, A | 1 |
| Milatovic, D; Schwartz, S; Thiel, E | 1 |
| Denning, DW; Morrissey, G; Oakley, KL | 1 |
| Bouza, E; Muñoz, P | 1 |
| de Sévaux, RG; Kullberg, BJ; Meis, JF; van de Nes, JA; van der Meer, JW; Verweij, PE | 1 |
| Algueró, M; Bartroli, J; Boncompte, E; Conte, L; Forn, J; García-Rafanell, J; Merlos, M; Ramis, J; Turmo, E; Vericat, ML | 2 |
| Meis, JF; van 't Hek, LG; van Dalen, R; Verweij, PE; Weemaes, CM; Yntema, JB | 1 |
| Bocanegra, R; Graybill, JR; Loebenberg, D; Luther, MF; Najvar, LK | 2 |
| Brinkman, K; Kremer, HP; Kullberg, BJ; Meis, JF; Verweij, PE | 1 |
| Fothergill, AW; Revankar, SG; Rinaldi, MG; Sanche, SE; Sutton, DA | 1 |
| Arikan, S; Lozano-Chiu, M; Nangia, S; Paetznick, V; Rex, JH | 1 |
| Fothergill, AW; Kirkpatrick, WR; Loebenberg, D; McAtee, RK; Patterson, TF; Rinaldi, MG | 1 |
| Chandrasekar, PH; Cutright, J; Manavathu, E | 1 |
| Fukuoka, T; Habuki, S; Harasaki, T; Kamai, Y; Konosu, T; Nakamura, Y; Ohya, S; Oida, S; Somada, A; Tajima, Y; Tanaka, T; Yasuda, H | 1 |
| Niki, Y | 1 |
| Antonacci, B; Arnold, B; Cacciapuoti, A; Corcoran, E; Halpern, J; Hare, RS; Loebenberg, D; Mendrick, C; Menzel, F; Michalski, M; Miller, GH; Moss, EL; Norris, C; Parmegiani, R; Raynor, K; Yarosh-Tomaine, T | 1 |
| Chandrasekar, PH; Cutright, JL; Loebenberg, D; Manavathu, EK | 1 |
| Abdel-Rahman, SM; Sabo, JA | 1 |
| Fothergill, AW; Kirkpatrick, WR; McAtee, RK; Patterson, TF; Rinaldi, MG | 1 |
| Bretagne, S; Curfs, JH; Meis, JF; Verweij, PE; Weemaes, CM | 1 |
| Ernst, EJ; Hoffman, HL; Klepser, ME | 1 |
| Andriole, VT; Marino, S; Roberts, J; Schock, K | 1 |
| Amariglio, N; Bielorai, B; Golan, H; Kaplinisky, C; Keller, N; Mandel, M; Neumann, Y; Paswell, J; Rechavi, G; Toren, A; Weintraub, M; Wolach, B | 1 |
| Granier, F | 1 |
| Avila, N; Bacher, J; Candelario, M; Field-Ridley, A; Groll, AH; Petraitiene, R; Petraitis, V; Piscitelli, S; Sein, T; Walsh, TJ | 1 |
| Kämmerer, R; Klempien, I; Kujath, P; Muhl, E | 1 |
| Girija, R; Hwang, YK; Joo, NH; Tan, L; Tan, P; Tee, GY | 1 |
| Bacigalupo, A; Machetti, M; Mordini, N; Paola, D; Van Lint, MT; Veroni, L; Viscoli, C; Zotti, M | 1 |
| Atwal, H; Daneshtalab, M; Furukawa, T; Gandhi, A; Higashitani, F; Khan, JK; Micetich, RG; Montaseri, H; Nishida, K; Poglod, M; Saito, H; Salama, SM; Simon, J; Uji, T; Unemi, N | 1 |
| Denning, DW; Griffiths, CE | 1 |
| Caillot, D; Denning, DW; Haas, A; Herbrecht, R; Lode, H; Milpied, N; Ribaud, P; Ruhnke, M; Thiel, E | 1 |
| Hollis, RJ; Jones, RN; Messer, SA; Pfaller, MA | 1 |
| Driscoll, T; Dupont, B; Ghahramani, P; Groll, AH; Hodges, M; Lutsar, I; Perfect, JR; Roden, M; Walsh, TJ | 1 |
| De Vries-Hospers, HG; Meis, JF; Rijs, AJ; Te Dorsthorst, DT; Verweij, PE | 1 |
| Andrade, J; Armstrong, D; Edwards, F; Niki, Y; Schmitt, HJ | 1 |
| Antonacci, B; Cacciapuoti, A; Hare, RS; Loebenberg, D; Menzel, F; Miller, GH; Moss, EL; Norris, C; Parmegiani, R; Yarosh-Tomaine, T | 2 |
| Andriole, VT; George, D; Ingersoll, R; Miniter, P; Patterson, TF | 1 |
| Ackerbauer, H; Meingassner, JG; Mieth, H; Petranyi, G; Schaude, M | 1 |
| Hector, RF; Yee, E | 1 |
| Defaveri, J; Graybill, JR; Rinaldi, MG; Salazar, MH | 1 |
| Ichise, K; Nakajima, T; Okuda, T; Tanio, T | 1 |
| Nakashima, M | 1 |
| Hanawa, T; Hatakenaka, R; Ikeda, S; Katsura, A; Kosaba, S; Lee, Y; Matsubara, Y; Ninomiya, K; Shiota, T; Yagi, K | 1 |
| Adachi, M; Ikeda, H; Kawanishi, M; Matsushima, T; Nakamura, J; Tanabe, J; Tano, Y; Tomizawa, S | 1 |
| Yoneda, R | 1 |
| Akahonai, Y; Ikemoto, H; Kasai, M; Kawamura, K; Mikuni, C; Mori, T; Taniuchi, A; Watanabe, K; Yoshida, K; Yoshida, T | 1 |
| Polak, A | 1 |
| Ackerbauer, H; Meingassner, JG; Mieth, H | 1 |
| Andrews, RJ; Marriott, MS; Richardson, K; Troke, PF | 1 |
140 review(s) available for triazoles and Aspergillosis
| Article | Year |
|---|---|
Plain language summary: use of isavuconazole in Chinese patients with an invasive fungal disease.
Topics: Antifungal Agents; Aspergillosis; Drug-Related Side Effects and Adverse Reactions; Healthy Volunteers; Humans; Invasive Fungal Infections; Mycoses; Nitriles; Pyridines; Triazoles; Voriconazole | 2022 |
Clinical research advances of isavuconazole in the treatment of invasive fungal diseases.
Topics: Antifungal Agents; Aspergillosis; Candidiasis, Invasive; Humans; Invasive Fungal Infections; Mucormycosis; Nitriles; Triazoles | 2022 |
Pharmacokinetics and Pharmacodynamics of Posaconazole.
Topics: Administration, Oral; Animals; Antifungal Agents; Aspergillosis; Drug Compounding; Humans; Injections, Intravenous; Triazoles | 2020 |
Aspergillus fumigatus and pan-azole resistance: who should be concerned?
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Betacoronavirus; Coronavirus Infections; COVID-19; Drug Resistance, Multiple, Fungal; Environmental Exposure; Humans; Immunocompromised Host; Microbial Sensitivity Tests; Pandemics; Pneumonia, Viral; SARS-CoV-2; Triazoles | 2020 |
Mechanisms of triazole resistance in Aspergillus fumigatus.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Drug Resistance, Fungal; Humans; Microbial Sensitivity Tests; Triazoles | 2020 |
Pharmacological management of antifungal agents in pulmonary aspergillosis: an updated review.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Humans; Pulmonary Aspergillosis; Triazoles | 2022 |
Invasive mould infections in the ICU setting: complexities and solutions.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; beta-Glucans; Critical Illness; Galactose; Humans; Immunocompromised Host; Intensive Care Units; Invasive Fungal Infections; Lung Diseases, Fungal; Mannans; Mucor; Mucormycosis; Nitriles; Opportunistic Infections; Pyridines; Respiratory System; Triazoles; Voriconazole | 2017 |
Animal Models for Studying Triazole Resistance in Aspergillus fumigatus.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Disease Models, Animal; Drug Resistance, Multiple, Fungal; Echinocandins; Humans; Mice; Microbial Sensitivity Tests; Triazoles | 2017 |
Triazole resistance surveillance in Aspergillus fumigatus.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Drug Resistance, Fungal; Environment; Epidemiological Monitoring; Fungal Proteins; Humans; Mutation; Triazoles | 2018 |
Isavuconazole: A new broad-spectrum azole. Part 2: pharmacokinetics and clinical activity.
Topics: Animals; Antifungal Agents; Aspergillosis; Azoles; Candidemia; Clinical Trials as Topic; Double-Blind Method; Drug Evaluation, Preclinical; Esterases; Humans; Invasive Fungal Infections; Mice; Mucormycosis; Nitriles; Pyridines; Triazoles | 2018 |
Clinical Pharmacokinetics and Pharmacodynamics of Isavuconazole.
Topics: Adult; Animals; Antifungal Agents; Aspergillosis; Drug Interactions; Humans; Invasive Fungal Infections; Mucormycosis; Nitriles; Pyridines; Triazoles | 2018 |
Spotlight on isavuconazole in the treatment of invasive aspergillosis and mucormycosis: design, development, and place in therapy.
Topics: Animals; Antifungal Agents; Aspergillosis; Drug Design; Humans; Mucormycosis; Nitriles; Pyridines; Triazoles | 2018 |
Primary Fungal Prophylaxis in Hematological Malignancy: a Network Meta-Analysis of Randomized Controlled Trials.
Topics: Antifungal Agents; Aspergillosis; Fever; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Invasive Fungal Infections; Network Meta-Analysis; Neutropenia; Opportunistic Infections; Randomized Controlled Trials as Topic; Triazoles | 2018 |
Voriconazole as mono-therapy in orbitofrontal erosive aspergillosis without gross total resection: A case report and review of literature.
Topics: Antifungal Agents; Aspergillosis; Biopsy; Humans; Immunocompetence; Male; Middle Aged; Triazoles; Voriconazole | 2018 |
Systematic review and network meta-analysis of clinical outcomes associated with isavuconazole versus relevant comparators for patients with invasive aspergillosis.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Deoxycholic Acid; Drug Combinations; Humans; Network Meta-Analysis; Nitriles; Pyridines; Randomized Controlled Trials as Topic; Treatment Outcome; Triazoles; Voriconazole | 2018 |
Clinical Pharmacokinetics of Second-Generation Triazoles for the Treatment of Invasive Aspergillosis and Candidiasis.
Topics: Animals; Antifungal Agents; Aspergillosis; Candidiasis; Drug Interactions; Humans; Triazoles; Voriconazole | 2019 |
Emerging threat of triazole-resistant Aspergillus fumigatus.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Drug Resistance, Fungal; Environmental Microbiology; Gene Expression; Global Health; Humans; Mutation; Prevalence; Triazoles | 2019 |
Triazole resistance in Aspergillus fumigatus: recent insights and challenges for patient management.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Disease Management; Drug Resistance, Fungal; Humans; Invasive Fungal Infections; Microbial Sensitivity Tests; Mutation; Polymerase Chain Reaction; Triazoles | 2019 |
Second- versus first-generation azoles for antifungal prophylaxis in hematology patients: a systematic review and meta-analysis.
Topics: Antifungal Agents; Antineoplastic Agents; Aspergillosis; Fungemia; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Immunosuppressive Agents; Multicenter Studies as Topic; Mycoses; Neutropenia; Odds Ratio; Patient Dropouts; Prospective Studies; Randomized Controlled Trials as Topic; Transplantation Conditioning; Treatment Outcome; Triazoles | 2013 |
Aspergillus terreus-related ureteral obstruction in a diabetic patient.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Diabetes Complications; Humans; Lithotripsy; Male; Middle Aged; Pyrimidines; Stents; Tomography, X-Ray Computed; Triazoles; Ureter; Ureteral Obstruction; Voriconazole | 2013 |
Azole resistant Aspergillus fumigatus: an emerging problem.
Topics: Agrochemicals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Drug Resistance, Multiple, Fungal; Environmental Microbiology; Forecasting; Fungal Proteins; Fungicides, Industrial; Global Health; Humans; Microbial Sensitivity Tests; Mutagenesis; Point Mutation; Promoter Regions, Genetic; Tandem Repeat Sequences; Triazoles | 2013 |
Aspergillus vertebral osteomyelitis in immunocompetent subjects: case report and review of the literature.
Topics: Aged; Antifungal Agents; Aspergillosis; Aspergillus; Biopsy; Diabetes Complications; Humans; Male; Osteomyelitis; Pyrimidines; Spondylitis; Triazoles; Voriconazole | 2013 |
Combination antifungal therapy for invasive fungal infections in children and adults.
Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Candida; Candidiasis; Caspofungin; Child; Cryptococcosis; Cryptococcus; Drug Therapy, Combination; Echinocandins; Humans; Lipopeptides; Pyrimidines; Triazoles; Voriconazole | 2013 |
Mold infections in lung transplant recipients.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Bronchiolitis Obliterans; Fungi; Humans; Lung Diseases, Fungal; Lung Transplantation; Neoplasms, Squamous Cell; Pyrimidines; Risk Factors; Triazoles; Voriconazole | 2013 |
Therapeutic drug monitoring of voriconazole and posaconazole for invasive aspergillosis.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Clinical Trials as Topic; Drug Administration Schedule; Drug Dosage Calculations; Drug Monitoring; Drug Resistance, Fungal; Humans; Pyrimidines; Triazoles; Voriconazole | 2013 |
Fungal infections and treatment in cystic fibrosis.
Topics: Antibodies, Fungal; Antifungal Agents; Aspergillosis; Aspergillus; Aspergillus fumigatus; Bronchoalveolar Lavage Fluid; Candida; Candidiasis; Cystic Fibrosis; DNA, Fungal; Female; Humans; Itraconazole; Male; Pyrimidines; Scedosporium; Sputum; Triazoles; Vital Capacity; Voriconazole | 2013 |
Management and diagnostic guidelines for fungal diseases in infectious diseases and clinical microbiology: critical appraisal.
Topics: Antifungal Agents; Aspergillosis; Candidiasis, Invasive; Evidence-Based Medicine; Humans; Mucormycosis; Mycoses; Practice Guidelines as Topic; Pyrimidines; Triazoles; Voriconazole | 2013 |
Fungal infections associated with long-term mechanical circulatory support-diagnosis and management.
Topics: Antifungal Agents; Aspergillosis; Candidiasis; Fluconazole; Heart Failure; Heart-Assist Devices; Humans; Incidence; Mycoses; Pyrimidines; Risk Factors; Time Factors; Triazoles; Voriconazole | 2014 |
[Invasive fungal rhinosinusitis in an apparently immunocompetant patient].
Topics: Aged; Antifungal Agents; Aortic Valve Stenosis; Aspergillosis; Chronic Disease; Female; Humans; Immunocompetence; Incidental Findings; Maxillary Sinusitis; Preoperative Care; Pyrimidines; Recurrence; Rhinitis; Triazoles; Voriconazole | 2013 |
Voriconazole versus amphotericin B or fluconazole in cancer patients with neutropenia.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Fluconazole; Humans; Liposomes; Mycoses; Neoplasms; Neutropenia; Opportunistic Infections; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles; Voriconazole | 2014 |
Breakpoints for antifungal agents: an update from EUCAST focussing on echinocandins against Candida spp. and triazoles against Aspergillus spp.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus; Candida; Candidiasis; Drug Resistance, Fungal; Echinocandins; Humans; Microbial Sensitivity Tests; Triazoles | 2013 |
[Progress in combination therapy for invasive aspergillosis].
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus; Clinical Trials as Topic; Disease Models, Animal; Drug Interactions; Drug Therapy, Combination; Echinocandins; Humans; Immunosuppression Therapy; Survival Rate; Triazoles | 2014 |
Exploring azole antifungal drug resistance in Aspergillus fumigatus with special reference to resistance mechanisms.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Azoles; Cholesterol; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fungal Proteins; Humans; Itraconazole; Microbial Sensitivity Tests; Mutation; Triazoles; Voriconazole | 2014 |
The role of azoles in the management of azole-resistant aspergillosis: from the bench to the bedside.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Dose-Response Relationship, Drug; Drug Monitoring; Drug Resistance, Multiple, Fungal; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Models, Biological; Mutation; Translational Research, Biomedical; Triazoles; Voriconazole | 2014 |
Treatment of Aspergillus terreus infections: a clinical problem not yet resolved.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Echinocandins; Humans; Microbial Sensitivity Tests; Serum; Treatment Outcome; Triazoles | 2014 |
Salvage combination antifungal therapy for acute invasive aspergillosis may improve outcomes: a systematic review and meta-analysis.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Drug Therapy, Combination; Echinocandins; Female; Humans; Male; Middle Aged; Salvage Therapy; Survival Analysis; Treatment Outcome; Triazoles | 2014 |
Survey of antifungal prophylaxis and fungal diagnostic tests employed in malignant haematology and haemopoietic stem cell transplantation (HSCT) in Australia and New Zealand.
Topics: Antifungal Agents; Aspergillosis; Australia; Chemoprevention; Consensus Development Conferences as Topic; Data Collection; Diagnostic Tests, Routine; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; New Zealand; Opportunistic Infections; Practice Guidelines as Topic; Pre-Exposure Prophylaxis; Triazoles | 2014 |
In brief: a new formulation of posaconazole (Noxafil).
Topics: Animals; Antifungal Agents; Aspergillosis; Candidiasis; Chemistry, Pharmaceutical; Humans; Triazoles | 2015 |
Fungi in cystic fibrosis and non-cystic fibrosis bronchiectasis.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillosis, Allergic Bronchopulmonary; Aspergillus fumigatus; Bronchiectasis; Cystic Fibrosis; Humans; Hypersensitivity; Immunoglobulin E; Triazoles | 2015 |
Isavuconazonium: first global approval.
Topics: Animals; Aspergillosis; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Drug Approval; Humans; Mucormycosis; Nitriles; Pyridines; Randomized Controlled Trials as Topic; Triazoles | 2015 |
Pharmacologic and clinical evaluation of posaconazole.
Topics: Animals; Antifungal Agents; Aspergillosis; Candidiasis; Chemistry, Pharmaceutical; Critical Illness; Delayed-Action Preparations; Humans; Mycoses; Triazoles | 2015 |
Isavuconazole: A New Option for the Management of Invasive Fungal Infections.
Topics: Animals; Antifungal Agents; Aspergillosis; Candidemia; Candidiasis; Candidiasis, Invasive; Clinical Trials as Topic; Drug Resistance, Fungal; Humans; Nitriles; Pyridines; Triazoles; Voriconazole | 2015 |
Role of Non-Culture-Based Tests, with an Emphasis on Galactomannan Testing for the Diagnosis of Invasive Aspergillosis.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; beta-Glucans; Bronchoalveolar Lavage Fluid; Galactose; Humans; Mannans; Proteoglycans; Triazoles; Voriconazole | 2015 |
Invasive Aspergillosis: Epidemiology, Clinical Aspects, and Treatment.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Combined Modality Therapy; Drug Therapy, Combination; Echinocandins; Hematopoietic Stem Cell Transplantation; Humans; Lung Transplantation; Magnetic Resonance Imaging; Risk Factors; Tomography, X-Ray Computed; Treatment Outcome; Triazoles; Voriconazole | 2015 |
Emergence of Azole Resistance in Aspergillus.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Azoles; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Echinocandins; Fungal Proteins; Humans; Microbial Sensitivity Tests; Mutation; Triazoles; Voriconazole | 2015 |
Isavuconazole: Pharmacology, Pharmacodynamics, and Current Clinical Experience with a New Triazole Antifungal Agent.
Topics: Antifungal Agents; Aspergillosis; Candidemia; Candidiasis, Invasive; Humans; Mucormycosis; Nitriles; Pyridines; Triazoles | 2015 |
Isavuconazonium sulfate (Cresemba)--a new antifungal.
Topics: Antifungal Agents; Aspergillosis; Drug Interactions; Female; Fungi; Humans; Male; Mucormycosis; Mycoses; Nitriles; Pregnancy; Pyridines; Triazoles | 2016 |
Isavuconazonium sulfate: a new agent for the treatment of invasive aspergillosis and invasive mucormycosis.
Topics: Animals; Antifungal Agents; Aspergillosis; Humans; Invasive Fungal Infections; Mucormycosis; Nitriles; Pyridines; Triazoles | 2016 |
In-host adaptation and acquired triazole resistance in Aspergillus fumigatus: a dilemma for clinical management.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Drug Resistance, Fungal; Genotype; Humans; Microbial Sensitivity Tests; Mutation; Triazoles | 2016 |
Isavuconazole: A Review in Invasive Aspergillosis and Mucormycosis.
Topics: Animals; Antifungal Agents; Aspergillosis; Case-Control Studies; Clinical Trials, Phase III as Topic; Humans; Mucormycosis; Nitriles; Pyridines; Triazoles | 2016 |
Echinocandins: a wealth of choice--how clinically different are they?
Topics: Antifungal Agents; Aspergillosis; Candidiasis; Chemoprevention; Drug Therapy, Combination; Echinocandins; Fungi; Humans; Triazoles | 2008 |
Clinical application of voriconazole concentrations in the treatment of invasive aspergillosis.
Topics: Antifungal Agents; Aspergillosis; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Interactions; Drug Monitoring; Humans; Liver Function Tests; Pyrimidines; Treatment Outcome; Triazoles; Vision Disorders; Voriconazole | 2008 |
Antifungal therapy of Aspergillus invasive otitis externa: efficacy of voriconazole and review.
Topics: Antifungal Agents; Aspergillosis; Humans; Male; Middle Aged; Otitis Externa; Pyrimidines; Radiography; Temporal Bone; Treatment Outcome; Triazoles; Voriconazole | 2009 |
Clinical indications for newer antifungal agents.
Topics: Antifungal Agents; Aspergillosis; Azoles; Candidiasis; Drug Therapy; Echinocandins; Endemic Diseases; Humans; Mycoses; Neutropenia; Triazoles; Zygomycosis | 2009 |
Diagnosis and treatment of aspergillosis in children.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Caspofungin; Child; Echinocandins; Fungal Vaccines; Genomics; Humans; Immunocompromised Host; Lipopeptides; Micafungin; Pyrimidines; Risk Factors; Triazoles; Voriconazole | 2009 |
Aspergillosis.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Combined Modality Therapy; Debridement; Echinocandins; Humans; Immunity, Cellular; Immunity, Innate; Lung Diseases, Fungal; Pyrimidines; Triazoles; Voriconazole | 2009 |
Unilateral ureteral obstruction caused by Aspergillus, subgenus Nidulantes in a patient on steroid therapy: a case report and review of the literature.
Topics: Adrenal Cortex Hormones; Antifungal Agents; Aspergillosis; Aspergillus nidulans; Bezoars; Female; Humans; Immunocompromised Host; Middle Aged; Pulmonary Disease, Chronic Obstructive; Pyrimidines; Triazoles; Ureteral Obstruction; Voriconazole | 2010 |
Primary invasive oral aspergillosis: an updated literature review.
Topics: Acyclovir; Aged; Amphotericin B; Antifungal Agents; Antiviral Agents; Aspergillosis; Fatal Outcome; Humans; Immunocompromised Host; Leukemia, Myeloid, Acute; Male; Mouth Diseases; Paranasal Sinus Diseases; Pyrimidines; Triazoles; Voriconazole | 2010 |
Aspergillus fumigatus joint infection: a review.
Topics: Antifungal Agents; Arthritis, Infectious; Aspergillosis; Aspergillus fumigatus; Caspofungin; Combined Modality Therapy; Drainage; Echinocandins; Female; Humans; Immunocompromised Host; Lipopeptides; Middle Aged; Pyrimidines; Sacroiliac Joint; Treatment Outcome; Triazoles; Voriconazole | 2011 |
Invasive aspergillosis in patients with liver disease.
Topics: Aged; Antifungal Agents; Aspergillosis; Caspofungin; Echinocandins; Fatal Outcome; Humans; Lipopeptides; Liver Diseases; Lung; Male; Middle Aged; Pyrimidines; Risk Factors; Triazoles; Voriconazole | 2011 |
Aspergillus vertebral osteomyelitis in immunocompetent hosts: role of triazole antifungal therapy.
Topics: Adult; Aged; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Female; Humans; Male; Middle Aged; Osteomyelitis; Spondylitis; Treatment Outcome; Triazoles | 2011 |
Newer antifungal agents.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus; Candida; Candidiasis, Invasive; Child; Clinical Trials as Topic; Half-Life; Humans; Lipopeptides; Nitriles; Pyridines; Quinazolines; Thiazoles; Triazoles | 2011 |
[Combination therapy for invasive aspergillosis].
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Caspofungin; Clinical Trials as Topic; Drug Evaluation, Preclinical; Drug Synergism; Drug Therapy, Combination; Echinocandins; Forecasting; Fungemia; Guinea Pigs; Humans; Invasive Pulmonary Aspergillosis; Lipopeptides; Meningitis, Fungal; Micafungin; Mice; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Retrospective Studies; Triazoles | 2011 |
Best practice in treating infants and children with proven, probable or suspected invasive fungal infections.
Topics: Antifungal Agents; Aspergillosis; Candidiasis; Child; Echinocandins; Fever of Unknown Origin; Humans; Infant; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2011 |
Treatment strategies for invasive aspergillosis in neutropenic patients: voriconazole or liposomal amphotericin-B?
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Humans; Neutropenia; Pyrimidines; Triazoles; Voriconazole | 2011 |
Anidulafungin: when and how? The clinician's view.
Topics: Anidulafungin; Antifungal Agents; Aspergillosis; Aspergillus; Candida; Candidiasis; Drug Resistance, Fungal; Drug Synergism; Drug-Related Side Effects and Adverse Reactions; Echinocandins; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2012 |
Posaconazole: when and how? The clinician's view.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus; Candida; Candidiasis, Invasive; Clinical Trials, Phase III as Topic; Cryptococcosis; Cryptococcus neoformans; Drug Administration Schedule; Drug Interactions; Humans; Microbial Sensitivity Tests; Triazoles | 2012 |
Efficacy and safety of current drug therapies for invasive aspergillosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Drug Therapy, Combination; Echinocandins; Humans; Treatment Outcome; Triazoles | 2011 |
Rapid induction of multiple resistance mechanisms in Aspergillus fumigatus during azole therapy: a case study and review of the literature.
Topics: Amino Acid Sequence; Amino Acid Substitution; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Female; Fungal Proteins; Genotype; Humans; Itraconazole; Microbial Sensitivity Tests; Middle Aged; Models, Molecular; Molecular Sequence Data; Mutagenesis, Site-Directed; Mutation Rate; Phenotype; Polymorphism, Single Nucleotide; Sputum; Time Factors; Triazoles | 2012 |
Invasive mycoses: strategies for effective management.
Topics: Adult; Alanine Transaminase; Alkaline Phosphatase; Antifungal Agents; Antineoplastic Agents; Aspartate Aminotransferases; Aspergillosis; Bilirubin; Biomarkers; Drug Monitoring; Echinocandins; Female; Flucytosine; Humans; Immunocompromised Host; Leukemia; Liver; Liver Function Tests; Male; Middle Aged; Mucormycosis; Mycoses; Myelodysplastic Syndromes; Opportunistic Infections; Pneumonia; Risk Factors; Triazoles | 2012 |
[Antifungal therapy update: new drugs and medical uses].
Topics: Anidulafungin; Antifungal Agents; Aspergillosis; Candidiasis; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Early Diagnosis; Echinocandins; Humans; Immunocompromised Host; Lipopeptides; Micafungin; Mycoses; Randomized Controlled Trials as Topic; Salvage Therapy; Treatment Outcome; Triazoles | 2011 |
Antifungal prophylaxis in haematology patients: the role of voriconazole.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Clinical Trials as Topic; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Pyrimidines; Triazoles; Voriconazole | 2012 |
[Azole resistance in Aspergillus fumigatus in the Netherlands--increase due to environmental fungicides?].
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Azoles; Drug Resistance, Fungal; Environmental Microbiology; Fungicides, Industrial; Humans; Itraconazole; Microbial Sensitivity Tests; Netherlands; Pyrimidines; Triazoles; Voriconazole | 2012 |
Treatment of refractory cerebral aspergillosis in a liver transplant recipient with voriconazole: case report and review of the literature.
Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Drug Therapy, Combination; Encephalitis; Humans; Liver Transplantation; Male; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2012 |
Voriconazole in clinical practice.
Topics: 14-alpha Demethylase Inhibitors; Animals; Antifungal Agents; Aspergillosis; Candidiasis, Invasive; Dose-Response Relationship, Drug; Drug Monitoring; Drug Resistance, Fungal; Evidence-Based Medicine; Fungi; Humans; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2012 |
Azole resistance in Aspergillus: global status in Europe and Asia.
Topics: Antifungal Agents; Asia; Aspergillosis; Azoles; Drug Resistance, Fungal; Europe; Humans; Microbial Sensitivity Tests; Triazoles | 2012 |
Antifungal therapy of aspergillosis of the central nervous system and aspergillus endophthalmitis.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus; Combined Modality Therapy; Endophthalmitis; Eye Infections, Fungal; Humans; Neuroaspergillosis; Pyrimidines; Triazoles; Vitrectomy; Voriconazole | 2013 |
Pharmacoeconomic assessment of therapy for invasive aspergillosis.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Clinical Trials as Topic; Cost-Benefit Analysis; Empirical Research; Humans; Length of Stay; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2013 |
Voriconazole: in the treatment of invasive aspergillosis.
Topics: Administration, Oral; Animals; Antifungal Agents; Aspergillosis; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Humans; Injections, Intravenous; Pyrimidines; Triazoles; Voriconazole | 2002 |
Voriconazole: a new triazole antifungal agent.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Candida; Dermatitis; Drug Interactions; Exanthema; Humans; Liver; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2003 |
Systemic mycoses in the immunocompromised host: an update in antifungal therapy.
Topics: Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Aspergillosis; Candidiasis; Deoxycholic Acid; Drug Combinations; Echinocandins; Fungal Proteins; Humans; Immunocompromised Host; Mycoses; Peptides; Peptides, Cyclic; Phosphatidylcholines; Phosphatidylglycerols; Triazoles | 2003 |
[Voriconazole - applications and perspectives].
Topics: Antifungal Agents; Aspergillosis; Candidiasis; Humans; Microbial Sensitivity Tests; Mitosporic Fungi; Pyrimidines; Triazoles; Voriconazole | 2002 |
[Aspergillosis].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; beta-Glucans; Biomarkers; Diagnosis, Differential; Echinocandins; Glucans; Humans; Lipopeptides; Lipoproteins; Micafungin; Peptides, Cyclic; Pyrimidines; Serologic Tests; Triazoles; Voriconazole | 2003 |
Management of Aspergillus osteomyelitis: report of failure of liposomal amphotericin B and response to voriconazole in an immunocompetent host and literature review.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Fungal; Follow-Up Studies; Humans; Immunocompetence; Lumbar Vertebrae; Magnetic Resonance Imaging; Male; Middle Aged; Osteomyelitis; Pyrimidines; Risk Assessment; Severity of Illness Index; Spondylitis; Treatment Failure; Treatment Outcome; Triazoles; Voriconazole | 2003 |
Review of the safety, tolerability, and drug interactions of the new antifungal agents caspofungin and voriconazole.
Topics: Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Clinical Trials as Topic; Drug Interactions; Echinocandins; Humans; Lipopeptides; Peptides; Peptides, Cyclic; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2003 |
Voriconazole.
Topics: Animals; Antifungal Agents; Area Under Curve; Aspergillosis; Candidiasis; Child; Child, Preschool; Female; Fungi; Half-Life; Humans; Intestinal Absorption; Male; Microbial Sensitivity Tests; Pyrimidines; Randomized Controlled Trials as Topic; Scedosporium; Tissue Distribution; Triazoles; Voriconazole; Yeasts | 2003 |
[New antifungal agents: voriconazole and caspofungin].
Topics: Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Child; Drug Interactions; Echinocandins; Humans; Lipopeptides; Peptides; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2003 |
[Experience with voriconazole in invasive aspergillosis].
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Biological Availability; Humans; Immunocompromised Host; Pyrimidines; Triazoles; Voriconazole | 2003 |
CNS-aspergillosis: are there new treatment options?
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Blood-Brain Barrier; Caspofungin; Central Nervous System Fungal Infections; Echinocandins; Female; Flucytosine; Humans; Immunocompromised Host; Itraconazole; Lipopeptides; Male; Peptides; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2003 |
Aspergillus fumigatus septic arthritis complicating intra-articular corticosteroid injection.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Antifungal Agents; Arthritis, Infectious; Aspergillosis; Aspergillus fumigatus; Debridement; Diagnosis, Differential; Humans; Injections, Intra-Articular; Magnetic Resonance Imaging; Male; Pain; Pyrimidines; Shoulder Injuries; Shoulder Joint; Triamcinolone Acetonide; Triazoles; Voriconazole | 2004 |
New options for the treatment of invasive fungal infections.
Topics: Adult; Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Echinocandins; Female; Fungemia; Humans; Immunocompromised Host; Lipopeptides; Male; Middle Aged; Mycetoma; Mycoses; Neoplasms; Opportunistic Infections; Peptides; Peptides, Cyclic; Pyrimidines; Scedosporium; Triazoles; Voriconazole | 2004 |
[Invasive aspergillosis: clinical manifestations and treatment].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillosis, Allergic Bronchopulmonary; Caspofungin; Dermatomycoses; Drug Therapy, Combination; Echinocandins; Humans; Immunocompromised Host; Immunologic Factors; Itraconazole; Lipopeptides; Neuroaspergillosis; Neutropenia; Peptides; Peptides, Cyclic; Pyrimidines; Respiratory Tract Infections; Triazoles; Voriconazole | 2003 |
Aspergillus mediastinitis following orthotopic heart transplantation: case report and review of the literature.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Drug Administration Schedule; Heart Transplantation; Humans; Male; Mediastinitis; Middle Aged; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole | 2004 |
Management of invasive mycoses in hematology patients: current approaches.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Deoxycholic Acid; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Drug Resistance, Fungal; Echinocandins; Fungal Proteins; Hematopoietic Stem Cell Transplantation; Humans; Liposomes; Mycoses; Neoplasms; Neutropenia; Peptides, Cyclic; Randomized Controlled Trials as Topic; Survival Analysis; Triazoles | 2004 |
Use of newer antifungal therapies in clinical practice: what do the data tell us?
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Deoxycholic Acid; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Drug Resistance, Fungal; Echinocandins; Humans; Lipopeptides; Liposomes; Mycoses; Peptides, Cyclic; Phosphatidylcholines; Phosphatidylglycerols; Pyrimidines; Randomized Controlled Trials as Topic; Time Factors; Treatment Outcome; Triazoles; Voriconazole; Zygomycosis | 2004 |
Combination antifungal therapy: where are we now, and where are we going?
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Azoles; Candidiasis; Caspofungin; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Echinocandins; Fluconazole; Humans; In Vitro Techniques; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Peptides, Cyclic; Pyrimidines; Randomized Controlled Trials as Topic; Time Factors; Treatment Outcome; Triazoles; Voriconazole | 2004 |
Systemic aspergillosis with predominant genitourinary manifestations in an immunocompetent man: what we can learn from a disastrous follow-up.
Topics: Abscess; Antifungal Agents; Aspergillosis; Caspofungin; Echinocandins; Humans; Kidney Diseases; Lipopeptides; Lung Diseases, Fungal; Male; Middle Aged; Peptides, Cyclic; Prostatic Diseases; Pyrimidines; Retroperitoneal Space; Triazoles; Voriconazole | 2005 |
A case of Aspergillus mediastinitis after heart transplantation successfully treated with liposomal amphotericin B, caspofungin and voriconazole.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Caspofungin; Echinocandins; Female; Heart Transplantation; Humans; Lipopeptides; Mediastinitis; Middle Aged; Peptides, Cyclic; Pyrimidines; Surgical Wound Infection; Triazoles; Voriconazole | 2005 |
[Update on therapy of invasive mycoses in hematology and oncology].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Deoxycholic Acid; Drug Combinations; Echinocandins; Hematologic Neoplasms; Humans; Itraconazole; Lipopeptides; Liposomes; Mycoses; Organ Transplantation; Peptides, Cyclic; Pyrimidines; Risk Factors; Stem Cell Transplantation; Triazoles; Voriconazole; Zygomycosis | 2005 |
Voriconazole: review of a broad spectrum triazole antifungal agent.
Topics: Administration, Oral; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Cryptococcosis; Cyclic N-Oxides; Disease Models, Animal; Drug Resistance, Fungal; Drug Therapy, Combination; Echinocandins; Fluconazole; Humans; Injections, Intravenous; Lipopeptides; Microbial Sensitivity Tests; Mycoses; Peptides, Cyclic; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles; Voriconazole | 2005 |
Breakthrough disseminated Aspergillus ustus infection in allogeneic hematopoietic stem cell transplant recipients receiving voriconazole or caspofungin prophylaxis.
Topics: Adolescent; Adult; Antifungal Agents; Aspergillosis; Aspergillus; Caspofungin; Chemoprevention; Drug Resistance, Fungal; Echinocandins; Hematopoietic Stem Cell Transplantation; Humans; Lipopeptides; Male; Peptides, Cyclic; Pyrimidines; Transplantation, Homologous; Triazoles; Voriconazole | 2005 |
Combination antifungal therapy for invasive aspergillosis: utilizing new targeting strategies.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Caspofungin; Drug Therapy, Combination; Echinocandins; Humans; Lipopeptides; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2005 |
[Voriconazole-medicalneeds, evidence, potential for the future].
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus; Biological Availability; Candida; Candidiasis; Guinea Pigs; Humans; Pyrimidines; Tissue Distribution; Triazoles; Voriconazole | 2005 |
Voriconazole versus amphotericin B in cancer patients with neutropenia.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Fluconazole; Humans; Liposomes; Mycoses; Neoplasms; Neutropenia; Opportunistic Infections; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles; Voriconazole | 2006 |
Fungal infections in bone marrow transplant recipients.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Bone Marrow Transplantation; Candidiasis; Caspofungin; Drug Administration Schedule; Echinocandins; Humans; Lipopeptides; Peptides, Cyclic; Postoperative Complications; Premedication; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles; Voriconazole | 2006 |
Update on antifungal drug resistance mechanisms of Aspergillus fumigatus.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus; Drug Resistance, Fungal; Echinocandins; Humans; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests; Naphthalenes; Peptides, Cyclic; Terbinafine; Triazoles | 2005 |
Invasive aspergillosis in children with hematologic malignancies.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Aspergillosis; Child; Drug Therapy, Combination; Hematologic Neoplasms; Humans; Triazoles | 2006 |
Treatment of invasive infections due to rare or emerging yeasts and moulds.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Clinical Trials as Topic; Drug Administration Schedule; Drug Resistance, Fungal; Drug Therapy, Combination; Fluconazole; Humans; Immunocompromised Host; Mucormycosis; Practice Guidelines as Topic; Pyrimidines; Triazoles; Voriconazole | 2006 |
Newer triazole antifungal agents: pharmacology, spectrum, clinical efficacy and limitations.
Topics: Animals; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; Drug Administration Schedule; Drug Evaluation, Preclinical; Drug Resistance, Fungal; Drug Therapy, Combination; Humans; Pyrimidines; Randomized Controlled Trials as Topic; Thiazoles; Triazoles; Voriconazole | 2006 |
Invasive aspergillosis with central nervous system dissemination in a presumably immunocompetent, non-neutropenic patient: case report and review.
Topics: Antifungal Agents; Aspergillosis; Brain Diseases; Humans; Immunocompetence; Lung Diseases, Fungal; Magnetic Resonance Imaging; Male; Middle Aged; Pyrimidines; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2006 |
Review of epidemiology, diagnosis, and treatment of invasive mould infections in allogeneic hematopoietic stem cell transplant recipients.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Drug Therapy, Combination; Fusarium; Hematopoietic Stem Cell Transplantation; Humans; Mycoses; Pyrimidines; Scedosporium; Triazoles; Voriconazole | 2006 |
Clinical efficacy of new antifungal agents.
Topics: Antifungal Agents; Aspergillosis; Candidiasis; Clinical Trials as Topic; Diarrhea; Exanthema; Humans; Mycoses; Nausea; Peptides, Cyclic; Triazoles; Vomiting; Zygomycosis | 2006 |
[Efficacies and clinical roles of new antifungal agents].
Topics: Antifungal Agents; Aspergillosis; Caspofungin; Echinocandins; Humans; Lipopeptides; Lipoproteins; Micafungin; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2006 |
Drug evaluation: BAL-8557--a novel broad-spectrum triazole antifungal.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus; Candida; Candidiasis; Clinical Trials, Phase II as Topic; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Humans; Nitriles; Pyridines; Triazoles | 2006 |
Antifungal efficacy and pharmacodynamics of posaconazole in experimental models of invasive fungal infections.
Topics: Animals; Antifungal Agents; Aspergillosis; Candidiasis; Disease Models, Animal; Humans; Mice; Mice, Inbred BALB C; Mice, Inbred ICR; Mycoses; Rabbits; Rats; Treatment Outcome; Triazoles | 2006 |
Second-line treatment in invasive mould infections.
Topics: Antifungal Agents; Aspergillosis; Humans; Mycoses; Salvage Therapy; Treatment Outcome; Triazoles; Zygomycosis | 2006 |
Antifungal therapy in febrile neutropenic patients: review of treatment choices and strategies for aspergillar infection.
Topics: Antifungal Agents; Antineoplastic Agents; Aspergillosis; Fever; Hematologic Neoplasms; Humans; Neutropenia; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2007 |
[Zygomycosis after hematogeneic stem cell transplantation--a current problem?].
Topics: Aspergillosis; Cancer Care Facilities; Cross Infection; Cross-Sectional Studies; Germany; Hematopoietic Stem Cell Transplantation; Humans; Long-Term Care; Opportunistic Infections; Pyrimidines; Risk Factors; Transplantation, Homologous; Triazoles; Voriconazole; Zygomycosis | 2006 |
New agents for the treatment of fungal infections: clinical efficacy and gaps in coverage.
Topics: Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Clinical Trials as Topic; Cryptococcosis; Echinocandins; Fever; Humans; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Neutropenia; Peptides, Cyclic; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2006 |
[Voriconazole as an effective therapy against pulmonary aspergillosis in a man with immunodeficiency virus-infection: a case report].
Topics: Antifungal Agents; Aspergillosis; HIV Infections; Humans; Lung Diseases, Fungal; Male; Middle Aged; Pyrimidines; Triazoles; Voriconazole | 2007 |
Recent advances in antifungal chemotherapy.
Topics: Antifungal Agents; Aspergillosis; Candidiasis; Double-Blind Method; Drug Resistance, Fungal; Drug Therapy, Combination; Humans; Multicenter Studies as Topic; Mycoses; Peptides, Cyclic; Randomized Controlled Trials as Topic; Triazoles | 2007 |
Pulmonary aspergillosis: a clinical update.
Topics: Antifungal Agents; Aspergillosis; Humans; Lung Diseases, Fungal; Prevalence; Risk Factors; Treatment Outcome; Triazoles | 2007 |
[Native valve Aspergillus fumigatus endocarditis with blood culture positive and negative for galactomannan antigen. Case report and literature review].
Topics: Amaurosis Fugax; Aneurysm, Infected; Antifungal Agents; Antigens, Fungal; Aspergillosis; Aspergillus fumigatus; Biomarkers; Caspofungin; Combined Modality Therapy; Echinocandins; Endocarditis; False Negative Reactions; Fatal Outcome; Fungemia; Galactose; Heart Valve Prosthesis Implantation; Humans; Infarction; Kidney; Lipopeptides; Male; Mannans; Mesenteric Arteries; Mesenteric Vascular Occlusion; Middle Aged; Mitral Valve; Peptides, Cyclic; Pulmonary Disease, Chronic Obstructive; Pyrimidines; Renal Artery; Triazoles; Voriconazole | 2007 |
Pharmacodynamic implications for use of antifungal agents.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus; Candida; Candidiasis; Echinocandins; Flucytosine; Humans; Microbial Sensitivity Tests; Polyenes; Triazoles | 2007 |
Breakthrough invasive pulmonary aspergillosis despite empirical voriconazole therapy for febrile neutropenia: case report and review of the literature.
Topics: Acute Disease; Antifungal Agents; Aspergillosis; Drug Resistance, Fungal; Fever; Humans; Leukemia, Myeloid; Lung Diseases, Fungal; Male; Middle Aged; Neutropenia; Pyrimidines; Triazoles; Voriconazole | 2007 |
Changing epidemiology of rare mould infections: implications for therapy.
Topics: Antifungal Agents; Aspergillosis; Drug Resistance, Fungal; Fusarium; Humans; Mycoses; Pyrimidines; Scedosporium; Triazoles; Voriconazole; Zygomycosis | 2007 |
[The role of voriconazole in the treatment of emerging mycoses].
Topics: Antifungal Agents; Aspergillosis; Candidiasis; Communicable Diseases, Emerging; Fusarium; Humans; Mycoses; Opportunistic Infections; Paecilomyces; Pyrimidines; Scedosporium; Triazoles; Voriconazole | 2007 |
[Addressing the "Hot Spots" in the management of invasive aspergillosis].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Caspofungin; Disease Management; Drug Resistance, Multiple, Fungal; Drug Therapy, Combination; Echinocandins; Fungemia; Humans; Immunocompromised Host; Lipopeptides; Treatment Outcome; Triazoles | 2007 |
Posaconazole: an extended-spectrum triazole antifungal agent.
Topics: Administration, Oral; AIDS-Related Opportunistic Infections; Antifungal Agents; Aspergillosis; Candidiasis; Drug Resistance, Fungal; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Mycoses; Tissue Distribution; Triazoles | 2007 |
Bilateral renal aspergillosis in a patient with AIDS: a case report and review of reported cases.
Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Antiretroviral Therapy, Highly Active; Aspergillosis; Aspergillus fumigatus; HIV Infections; Humans; Kidney Diseases; Male; Pyrimidines; Radiography; Tomography Scanners, X-Ray Computed; Triazoles; Voriconazole | 2008 |
Current and future therapeutic options in the management of invasive aspergillosis.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Drug Therapy, Combination; Echinocandins; Fungal Vaccines; Humans; Immunologic Factors; Polyenes; Triazoles | 2008 |
Broad-spectrum antifungal prophylaxis in patients with cancer at high risk for invasive mold infections: counterpoint.
Topics: Antifungal Agents; Antigens, Fungal; Aspergillosis; beta-Glucans; Enzyme-Linked Immunosorbent Assay; Humans; Immunocompromised Host; Mycoses; Neoplasms; Neutropenia; Proteoglycans; Risk Assessment; Tomography, X-Ray Computed; Triazoles | 2008 |
Invasive pulmonary aspergillosis after liver transplantation: rapid and complete response to combined and sequential antifungal therapy.
Topics: Antifungal Agents; Aspergillosis; Caspofungin; Drug Therapy, Combination; Echinocandins; Humans; Immunosuppression Therapy; Lipopeptides; Liver Transplantation; Lung Diseases, Fungal; Male; Middle Aged; Pyrimidines; Radiography, Thoracic; Tomography, Emission-Computed; Triazoles; Voriconazole | 2008 |
Fungicidal versus Fungistatic: what's in a word?
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Candida; Candidiasis; Clinical Trials as Topic; Cryptococcosis; Cryptococcus; Echinocandins; Humans; Meningitis, Cryptococcal; Microbiological Techniques; Polyenes; Triazoles | 2008 |
Posaconazole : a review of its use in the prophylaxis of invasive fungal infections.
Topics: Antifungal Agents; Aspergillosis; Candidiasis; Cost-Benefit Analysis; Drug Interactions; Drug Resistance, Fungal; Humans; In Vitro Techniques; Triazoles | 2008 |
Antifungal prophylaxis in patients with hematologic malignancies: a reappraisal.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Bone Marrow Transplantation; Candidiasis; Clinical Trials as Topic; Disease Susceptibility; Drug Administration Routes; Hematopoietic Cell Growth Factors; Humans; Immunocompromised Host; Leukocyte Transfusion; Mycoses; Neoplasms; Neutropenia; Triazoles | 1995 |
Prevention of invasive fungal infections in patients with neoplastic disease.
Topics: Amphotericin B; Aspergillosis; Candidiasis; Cytokines; Drug Administration Routes; Humans; Imidazoles; Neoplasms; Opportunistic Infections; Polyenes; Triazoles | 1993 |
[Fungal infections in patients undergoing solid organ transplantation].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Celiac Artery; Cytomegalovirus Infections; Female; Heart Transplantation; Humans; Immunocompromised Host; Immunosuppression Therapy; Incidence; Liver Transplantation; Male; Middle Aged; Mucormycosis; Mycoses; Postoperative Complications; Risk Factors; Thrombosis; Time Factors; Transplantation; Triazoles | 1997 |
Novel triazole antifungal agents.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; Humans; Immunocompromised Host; Mycoses; Opportunistic Infections; Triazoles | 2000 |
[Invasive fungal infections. Epidemiology and new therapies].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Drug Resistance, Microbial; Humans; Immunocompromised Host; Incidence; Nystatin; Risk Factors; Triazoles | 2000 |
38 trial(s) available for triazoles and Aspergillosis
| Article | Year |
|---|---|
Efficacy and safety of isavuconazole against deep-seated mycoses: A phase 3, randomized, open-label study in Japan.
Topics: Antifungal Agents; Aspergillosis; Cryptococcosis; Humans; Invasive Fungal Infections; Japan; Mucormycosis; Pulmonary Aspergillosis; Triazoles; Voriconazole | 2023 |
Pharmacokinetic and Exposure Response Analysis of the Double-Blind Randomized Study of Posaconazole and Voriconazole for Treatment of Invasive Aspergillosis.
Topics: Aspergillosis; Double-Blind Method; Humans; Triazoles; Voriconazole | 2023 |
Clinical experience with isavuconazole in healthy volunteers and patients with invasive aspergillosis in China, and the results from an exposure-response analysis.
Topics: Administration, Intravenous; Administration, Oral; Antifungal Agents; Asian People; Aspergillosis; China; Healthy Volunteers; Human Experimentation; Humans; Invasive Fungal Infections; Nitriles; Pyridines; Treatment Outcome; Triazoles | 2021 |
Isavuconazole Treatment of Invasive Fungal Sinusitis: A Post Hoc Analysis of the SECURE and VITAL Trials.
Topics: Antifungal Agents; Aspergillosis; Humans; Invasive Fungal Infections; Mucormycosis; Nitriles; Pyridines; Sinusitis; Triazoles | 2021 |
Exposure-Response Relationships for Isavuconazole in Patients with Invasive Aspergillosis and Other Filamentous Fungi.
Topics: Alanine Transaminase; Antifungal Agents; Aspartate Aminotransferases; Aspergillosis; Dose-Response Relationship, Drug; Drug Monitoring; Humans; Invasive Fungal Infections; Nitriles; Pyridines; Triazoles | 2017 |
Isavuconazole for treatment of invasive fungal diseases caused by more than one fungal species.
Topics: Administration, Intravenous; Adult; Aged; Antifungal Agents; Aspergillosis; Aspergillus; Coinfection; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Invasive Fungal Infections; Male; Middle Aged; Mucorales; Mucormycosis; Nitriles; Pyridines; Treatment Outcome; Triazoles | 2018 |
Outcomes by MIC Values for Patients Treated with Isavuconazole or Voriconazole for Invasive Aspergillosis in the Phase 3 SECURE and VITAL Trials.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Humans; Invasive Fungal Infections; Microbial Sensitivity Tests; Nitriles; Pyridines; Triazoles; Voriconazole | 2019 |
Variability and exposure-response relationships of isavuconazole plasma concentrations in the Phase 3 SECURE trial of patients with invasive mould diseases.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Drug Monitoring; Female; Humans; Invasive Fungal Infections; Male; Nitriles; Pyridines; Treatment Outcome; Triazoles | 2019 |
Steady-state pharmacokinetics of oral voriconazole and its primary metabolite, N-oxide voriconazole, pre- and post-autologous peripheral stem cell transplantation.
Topics: Aged; Antifungal Agents; Aspergillosis; Cyclic N-Oxides; Female; Humans; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Pyrimidines; Triazoles; Voriconazole | 2013 |
Identification of factors influencing the pharmacokinetics of voriconazole and the optimization of dosage regimens based on Monte Carlo simulation in patients with invasive fungal infections.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Candidiasis, Invasive; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Monte Carlo Method; Prospective Studies; Pyrimidines; Triazoles; Voriconazole | 2014 |
Voriconazole or amphotericin B as primary therapy yields distinct early serum galactomannan trends related to outcomes in invasive aspergillosis.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Biomarkers; Female; Fungal Polysaccharides; Galactose; Hematologic Neoplasms; Humans; Male; Mannans; Pyrimidines; Survival Analysis; Treatment Outcome; Triazoles; Voriconazole | 2014 |
Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial.
Topics: Administration, Oral; Adult; Aged; Antifungal Agents; Aspergillosis; Double-Blind Method; Drug Administration Schedule; Female; Humans; Injections, Intravenous; Male; Middle Aged; Mycoses; Nitriles; Pyridines; Treatment Outcome; Triazoles; Voriconazole | 2016 |
Hospital resource use of patients receiving isavuconazole vs voriconazole for invasive mold infections in the phase III SECURE trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Body Mass Index; Double-Blind Method; Female; Glomerular Filtration Rate; Hospital Charges; Humans; Kaplan-Meier Estimate; Length of Stay; Male; Middle Aged; Mycoses; Nitriles; Pyridines; Triazoles; Voriconazole; Young Adult | 2016 |
Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis.
Topics: Administration, Intravenous; Adult; Animals; Antifungal Agents; Aspergillosis; Female; Fungi; Humans; Male; Middle Aged; Mucormycosis; Nitriles; Pyridines; Treatment Outcome; Triazoles | 2016 |
Population Pharmacokinetics of Isavuconazole from Phase 1 and Phase 3 (SECURE) Trials in Adults and Target Attainment in Patients with Invasive Infections Due to Aspergillus and Other Filamentous Fungi.
Topics: Antifungal Agents; Area Under Curve; Aspergillosis; Aspergillus; Fungi; Humans; Microbial Sensitivity Tests; Monte Carlo Method; Nitriles; Probability; Pyridines; Triazoles | 2016 |
Cost-Effectiveness Analysis of Isavuconazole vs. Voriconazole as First-Line Treatment for Invasive Aspergillosis.
Topics: Antifungal Agents; Aspergillosis; Cost-Benefit Analysis; Fees, Pharmaceutical; Female; Hospitalization; Humans; Male; Models, Econometric; Nitriles; Pyridines; Triazoles; Voriconazole | 2017 |
Impact of Mucositis on Absorption and Systemic Drug Exposure of Isavuconazole.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Aspergillosis; Biological Availability; Female; Humans; Invasive Fungal Infections; Male; Middle Aged; Mucormycosis; Mucositis; Nitriles; Pyridines; Treatment Outcome; Triazoles; Young Adult | 2017 |
Posaconazole as salvage treatment of invasive fungal infections in patients with underlying renal impairment.
Topics: Adult; Antifungal Agents; Aspergillosis; Female; Humans; Male; Middle Aged; Renal Insufficiency; Salvage Therapy; Treatment Outcome; Triazoles | 2008 |
Pharmacokinetics of oral voriconazole in patients with cystic fibrosis.
Topics: Administration, Oral; Adult; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cystic Fibrosis; Female; Humans; Male; Pyrimidines; Triazoles; Voriconazole | 2011 |
Voriconazole-related severe adverse events: clinical application of therapeutic drug monitoring in Korean patients.
Topics: Adult; Alleles; Antifungal Agents; Aryl Hydrocarbon Hydroxylases; Aspergillosis; Aspergillus; Cytochrome P-450 CYP2C19; Drug Monitoring; Female; Genotype; Hematologic Neoplasms; Humans; Immunocompromised Host; Infusions, Intravenous; Male; Middle Aged; Prospective Studies; Pyrimidines; Republic of Korea; Risk Factors; Triazoles; Voriconazole; Young Adult | 2011 |
The effect of therapeutic drug monitoring on safety and efficacy of voriconazole in invasive fungal infections: a randomized controlled trial.
Topics: Adult; Aged; Antifungal Agents; Aryl Hydrocarbon Hydroxylases; Aspergillosis; Chi-Square Distribution; Cytochrome P-450 CYP2C19; Drug Monitoring; Female; Humans; Male; Middle Aged; Prospective Studies; Pyrimidines; Single-Blind Method; Treatment Outcome; Triazoles; Voriconazole | 2012 |
Phase II study on voriconazole for treatment of Chinese patients with malignant hematological disorders and invasive aspergillosis.
Topics: Administration, Oral; Antifungal Agents; Aspergillosis; Female; Follow-Up Studies; Hematologic Neoplasms; Humans; Male; Middle Aged; Prognosis; Pyrimidines; Triazoles; Voriconazole | 2012 |
Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Aspergillosis; Female; Hematologic Diseases; Humans; Infusions, Intravenous; Male; Middle Aged; Pyrimidines; Survival Rate; Triazoles; Voriconazole | 2002 |
Improving the outcome of invasive aspergillosis: new diagnostic tools and new therapeutic strategies.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Humans; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2002 |
Voriconazole treatment for less-common, emerging, or refractory fungal infections.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Candidiasis; Child; Humans; Middle Aged; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2003 |
Voriconazole for invasive bone aspergillosis: a worldwide experience of 20 cases.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Aspergillosis; Child, Preschool; Humans; Middle Aged; Osteitis; Osteomyelitis; Pyrimidines; Salvage Therapy; Spondylitis; Triazoles; Voriconazole | 2005 |
Strategy of following voriconazole versus amphotericin B therapy with other licensed antifungal therapy for primary treatment of invasive aspergillosis: impact of other therapies on outcome.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Deoxycholic Acid; Drug Combinations; Humans; Itraconazole; Pyrimidines; Salvage Therapy; Treatment Outcome; Triazoles; Voriconazole | 2005 |
Combination of voriconazole and caspofungin as primary therapy for invasive aspergillosis in solid organ transplant recipients: a prospective, multicenter, observational study.
Topics: Adult; Aged; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Caspofungin; Drug Therapy, Combination; Echinocandins; Female; Humans; Lipopeptides; Male; Middle Aged; Organ Transplantation; Peptides, Cyclic; Pyrimidines; Renal Insufficiency; Treatment Outcome; Triazoles; Voriconazole | 2006 |
Voriconazole treatment for subacute invasive and chronic pulmonary aspergillosis.
Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Chronic Disease; Drug Administration Schedule; Female; Humans; Itraconazole; Lung Diseases, Fungal; Male; Middle Aged; Pyrimidines; Salvage Therapy; Treatment Failure; Treatment Outcome; Triazoles; Voriconazole | 2006 |
Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: an externally controlled trial.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Humans; Logistic Models; Salvage Therapy; Treatment Outcome; Triazoles | 2007 |
Posaconazole plasma concentrations in juvenile patients with invasive fungal infection.
Topics: Adolescent; Adult; Antifungal Agents; Aspergillosis; Body Surface Area; Body Weight; Child; Female; Humans; Male; Mycoses; Treatment Outcome; Triazoles | 2007 |
Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Aspergillosis; Double-Blind Method; Female; Fluconazole; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Mycoses; Opportunistic Infections; Risk Factors; Triazoles | 2007 |
Resource use and cost of treatment with voriconazole or conventional amphotericin B for invasive aspergillosis.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Drug Costs; Humans; Lung Diseases, Fungal; Pyrimidines; Triazoles; Voriconazole | 2007 |
Novel antifungal agents as salvage therapy for invasive aspergillosis in patients with hematologic malignancies: posaconazole compared with high-dose lipid formulations of amphotericin B alone or in combination with caspofungin.
Topics: Adult; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Caspofungin; Combined Modality Therapy; Drug Combinations; Drug Therapy, Combination; Echinocandins; Female; Fungemia; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Itraconazole; Lipopeptides; Male; Middle Aged; Neutropenia; Phosphatidylcholines; Phosphatidylglycerols; Pyrimidines; Salvage Therapy; Treatment Outcome; Triazoles; Voriconazole | 2008 |
Changes in causes of death over time after treatment for invasive aspergillosis.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Cause of Death; Graft vs Host Disease; Humans; Neoplasms; Pyrimidines; Survival Rate; Time Factors; Triazoles; Voriconazole | 2008 |
Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Antifungal Agents; Aspergillosis; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Prospective Studies; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2002 |
Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in children.
Topics: Adolescent; Antifungal Agents; Aspergillosis; Child; Child, Preschool; Drug Administration Schedule; Female; Granulomatous Disease, Chronic; Hematologic Neoplasms; Humans; Infant; Male; Mycoses; Pyrimidines; Treatment Failure; Triazoles; Voriconazole | 2002 |
[Clinical study of fluconazole on deep-seated fungal infections].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Candidiasis; Child; Clinical Trials as Topic; Cryptococcosis; Drug Tolerance; Female; Fluconazole; Humans; Japan; Male; Middle Aged; Multicenter Studies as Topic; Mycoses; Triazoles | 1989 |
594 other study(ies) available for triazoles and Aspergillosis
| Article | Year |
|---|---|
Broad-spectrum azoles and flucloxacillin: a dangerous match.
Topics: Aged; Anti-Bacterial Agents; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Azoles; Drug Interactions; Drug Therapy, Combination; Female; Floxacillin; Humans; Male; Middle Aged; Nitriles; Pyridines; Staphylococcal Infections; Staphylococcus aureus; Triazoles; Voriconazole | 2022 |
Stable prevalence of triazole-resistance in Aspergillus fumigatus complex clinical isolates in a Belgian tertiary care center from 2016 to 2020.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Belgium; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fungal Proteins; Humans; Microbial Sensitivity Tests; Prevalence; Tertiary Care Centers; Triazoles | 2021 |
Economic evaluation of isavuconazole for suspected invasive pulmonary aspergillosis in Canada.
Topics: Antifungal Agents; Aspergillosis; Canada; Cost-Benefit Analysis; Humans; Invasive Pulmonary Aspergillosis; Nitriles; Pyridines; Triazoles; Voriconazole | 2022 |
Implementation of a clinical decision rule for selecting empiric treatment for invasive aspergillosis in a setting with high triazole resistance.
Topics: Animals; Antifungal Agents; Aspergillosis; Clinical Decision Rules; Invasive Fungal Infections; Triazoles; Voriconazole | 2021 |
Systemic antifungal therapy with isavuconazonium sulfate or other agents in adults with invasive mucormycosis or invasive aspergillosis (non-fumigatus): A multicentre, non-interventional registry study.
Topics: Adult; Antifungal Agents; Aspergillosis; Humans; Invasive Fungal Infections; Mucormycosis; Nitriles; Pyridines; Registries; Triazoles | 2022 |
Efficacy and safety of Isavuconazole for the treatment of invasive
Topics: Antifungal Agents; Aspergillosis; COVID-19 Drug Treatment; Delayed Diagnosis; Humans; Nitriles; Pyridines; Triazoles | 2022 |
Safety and Effectiveness of Isavuconazole Treatment for Fungal Infections in Solid Organ Transplant Recipients (ISASOT Study).
Topics: Aged; Antifungal Agents; Aspergillosis; Aspergillus; Female; Humans; Male; Middle Aged; Mycoses; Nitriles; Organ Transplantation; Pyridines; Transplant Recipients; Triazoles | 2022 |
Interaction between posaconazole and flucloxacillin in a lung transplant patient: decrease in plasma exposure of posaconazole and possible undertreatment of invasive aspergillosis: case report.
Topics: Antifungal Agents; Aspergillosis; Floxacillin; Humans; Lung Transplantation; Male; Middle Aged; Triazoles | 2022 |
Longitudinal multimodal imaging-compatible mouse model of triazole-sensitive and -resistant invasive pulmonary aspergillosis.
Topics: Animals; Aspergillosis; Aspergillus fumigatus; Female; Humans; Invasive Pulmonary Aspergillosis; Male; Mice; Multimodal Imaging; Triazoles | 2022 |
Decreased isavuconazole trough concentrations in the treatment of invasive aspergillosis in an adult patient receiving extracorporeal membrane oxygenation support.
Topics: Adult; Aspergillosis; Extracorporeal Membrane Oxygenation; Humans; Invasive Fungal Infections; Male; Middle Aged; Nitriles; Pyridines; Respiratory Insufficiency; Triazoles | 2022 |
Triazole Priming as an Adaptive Response and Gateway to Resistance in Aspergillus fumigatus.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Azoles; Drug Resistance, Fungal; Fungal Proteins; Humans; Microbial Sensitivity Tests; Triazoles | 2022 |
Antagonism of the Azoles to Olorofim and Cross-Resistance Are Governed by Linked Transcriptional Networks in Aspergillus fumigatus.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Azoles; Drug Resistance, Fungal; Ergosterol; Fungal Proteins; Gene Regulatory Networks; Humans; Microbial Sensitivity Tests; Pyrimidines; Transcription Factors; Triazoles | 2022 |
Isavuconazole for the Treatment of Invasive Mold Disease in Solid Organ Transplant Recipients: A Multicenter Study on Efficacy and Safety in Real-life Clinical Practice.
Topics: Adult; Antifungal Agents; Aspergillosis; Fungi; Humans; Invasive Fungal Infections; Mucormycosis; Nitriles; Organ Transplantation; Retrospective Studies; Tacrolimus; Transplant Recipients; Triazoles | 2023 |
Health economic analysis of patients treated with isavuconazole in a German comprehensive cancer centre.
Topics: Antifungal Agents; Aspergillosis; Humans; Invasive Fungal Infections; Neoplasms; Nitriles; Triazoles | 2023 |
Clinical Impact of Polymerase Chain Reaction-Based Aspergillus and Azole Resistance Detection in Invasive Aspergillosis: A Prospective Multicenter Study.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Aspergillus fumigatus; Azoles; Drug Resistance, Fungal; Humans; Invasive Fungal Infections; Invasive Pulmonary Aspergillosis; Prospective Studies; Real-Time Polymerase Chain Reaction; Triazoles | 2023 |
Context of instauration and evolution under isavuconazole, a 2-year prospective real-life study.
Topics: Animals; Antifungal Agents; Aspergillosis; Invasive Fungal Infections; Mucormycosis; Prospective Studies; Triazoles | 2023 |
Succinylation modification provides new insights for the treatment of immunocompromised individuals with drug-resistant
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Humans; Itraconazole; Lysine; Mice; Triazoles | 2023 |
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Drug Resistance, Fungal; Fungal Proteins; Humans; Microbial Sensitivity Tests; Triazoles | 2023 |
Post-hoc analysis of the safety and efficacy of isavuconazole in older patients with invasive fungal disease from the VITAL and SECURE studies.
Topics: Aged; Antifungal Agents; Aspergillosis; Humans; Invasive Fungal Infections; Nitriles; Prospective Studies; Triazoles; Voriconazole | 2023 |
Isavuconazole Diffusion in Infected Human Brain.
Topics: Adult; Aspergillosis; Aspergillus fumigatus; Brain; Cerebrospinal Fluid; Female; Granulomatous Disease, Chronic; Humans; Magnetic Resonance Imaging; Nitriles; Pyridines; Triazoles; Young Adult | 2019 |
Extended-Interval Dosing of Rezafungin against Azole-Resistant Aspergillus fumigatus.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Azoles; Drug Resistance, Fungal; Echinocandins; Fungal Proteins; Kidney; Male; Mice; Real-Time Polymerase Chain Reaction; Triazoles | 2019 |
Influence of Sustained Low-Efficiency Dialysis Treatment on Isavuconazole Plasma Levels in Critically Ill Patients.
Topics: Adult; Antifungal Agents; Aspergillosis; Aspergillus; Critical Illness; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Nitriles; Pyridines; Triazoles | 2019 |
The fading boundaries between patient and environmental routes of triazole resistance selection in Aspergillus fumigatus.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Drug Resistance, Fungal; Environment; Fungal Proteins; Humans; Mutation; Selection, Genetic; Triazoles | 2019 |
Genomic perspective of triazole resistance in clinical and environmental Aspergillus fumigatus isolates without cyp51A mutations.
Topics: Amino Acid Substitution; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Environmental Microbiology; Fungal Proteins; Genome, Fungal; Genomics; Membrane Transport Proteins; Mutation; Polymorphism, Single Nucleotide; Sequence Deletion; Triazoles; Whole Genome Sequencing | 2019 |
Successful Treatment of Severe Aspergillosis with Isavuconazole Therapy after Allogeneic Stem Cell Transplantation.
Topics: Adult; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; DNA, Fungal; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Male; Nitriles; Pyridines; Thorax; Transplantation, Homologous; Triazoles | 2019 |
Use of triazoles for the treatment of invasive aspergillosis: A three-year cohort analysis.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Cohort Studies; Female; Humans; Invasive Fungal Infections; Male; Middle Aged; Nitriles; Pyridines; Treatment Outcome; Triazoles; Voriconazole | 2020 |
High-dose posaconazole for azole-resistant aspergillosis and other difficult-to-treat mould infections.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Aspergillosis; Azoles; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Drug Resistance, Fungal; Fungal Proteins; Humans; Likelihood Functions; Middle Aged; Mutation; Probability; Retrospective Studies; Surveys and Questionnaires; Triazoles | 2020 |
Galactomannan Is a Biomarker of Fosmanogepix (APX001) Efficacy in Treating Experimental Invasive Pulmonary Aspergillosis.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Biomarkers; Galactose; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Lung; Male; Mannans; Mice; Microbial Sensitivity Tests; Triazoles | 2019 |
Evaluation of posaconazole antifungal prophylaxis in reducing the incidence of invasive aspergillosis in patients with acute myeloid leukemia.
Topics: Adult; Aerosols; Air Filters; Air Microbiology; Air Pollution, Indoor; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Aspergillus; Combined Modality Therapy; Environmental Exposure; Febrile Neutropenia; Female; Filtration; France; Hematopoietic Stem Cell Transplantation; Hospital Design and Construction; Hospitals, Teaching; Humans; Incidence; Invasive Fungal Infections; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Male; Middle Aged; Prospective Studies; Retrospective Studies; Spores, Fungal; Triazoles | 2020 |
Successful Treatment of Invasive Fungal Infection Due to Highly Resistant Aspergillus calidoustus in an Allogeneic Hematopoietic Cell Transplant Recipient.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Azoles; Drug Resistance, Fungal; Female; Hematopoietic Stem Cell Transplantation; Humans; Invasive Fungal Infections; Microbial Sensitivity Tests; Middle Aged; Nitriles; Primary Myelofibrosis; Pyridines; Triazoles | 2020 |
[Cryptic Aspergillus species - a case report of chronic cavitary pulmonary Aspergillus lentulus infection in a heart transplant recipient].
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Heart Transplantation; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Transplant Recipients; Triazoles; Voriconazole | 2019 |
In vitro activity of isavuconazole versus opportunistic filamentous fungal pathogens from the SENTRY Antifungal Surveillance Program, 2017-2018.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Aspergillus fumigatus; Drug Resistance, Fungal; Fungi; Humans; Microbial Sensitivity Tests; Nitriles; Public Health Surveillance; Pyridines; Triazoles; Voriconazole | 2020 |
Ibrutinib related cerebral aspergillosis successfully treated with isavuconazole: a case report.
Topics: Adenine; Antifungal Agents; Aspergillosis; Humans; Nitriles; Piperidines; Pyridines; Triazoles | 2020 |
Antifungal Activity of a Novel Triazole, Efinaconazole and Nine Comparators against 354 Molecularly Identified Aspergillus Isolates.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Microbial Sensitivity Tests; Triazoles | 2020 |
Intravenous isavuconazole can be administered 5 days-a-week. A possibility suggested by a real-life observation.
Topics: Administration, Intravenous; Antifungal Agents; Aspergillosis; Child; Drug Monitoring; Humans; Male; Nitriles; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Pyridines; Triazoles | 2020 |
Screening for triazole resistance in clinically significant Aspergillus species; report from Pakistan.
Topics: Aspergillosis; Aspergillosis, Allergic Bronchopulmonary; Aspergillus; Cross-Sectional Studies; Drug Resistance, Bacterial; Female; Humans; Invasive Pulmonary Aspergillosis; Male; Microbial Sensitivity Tests; Pakistan; Prospective Studies; Triazoles | 2020 |
High prevalence of triazole-resistant Aspergillus fumigatus sensu stricto in an Argentinean cohort of patients with cystic fibrosis.
Topics: Adolescent; Adult; Antifungal Agents; Argentina; Aspergillosis; Aspergillus fumigatus; Child; Cystic Fibrosis; Drug Resistance, Fungal; Humans; Microbial Sensitivity Tests; Middle Aged; Mutation; Prevalence; Retrospective Studies; Sequence Analysis, DNA; Sputum; Triazoles; Young Adult | 2020 |
Duration of posaconazole therapy for Aspergillus fumigatus osteomyelitis dictated by serial monitoring of 1,3-beta-D glucan.
Topics: Adult; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Baltimore; beta-Glucans; Humans; Male; Osteomyelitis; Treatment Outcome; Triazoles | 2020 |
Evaluating posaconazole dosing regimens of the different formulations against Aspergillus spp. in adults: a pharmacokinetic/pharmacodynamic analysis using Monte Carlo simulation.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Delayed-Action Preparations; Humans; Invasive Fungal Infections; Microbial Sensitivity Tests; Triazoles | 2020 |
The cost-effectiveness of isavuconazole compared to voriconazole, the standard of care in the treatment of patients with invasive mould diseases, prior to differential pathogen diagnosis in Spain.
Topics: Antifungal Agents; Aspergillosis; Clinical Laboratory Techniques; Cost-Benefit Analysis; Diagnosis, Differential; Fungi; Hospitalists; Humans; Mucormycosis; Nitriles; Pyridines; Spain; Standard of Care; Triazoles; Voriconazole | 2021 |
Antifungal susceptibility profile and molecular identification of Cyp51C mutations in clinical and environmental isolates of Aspergillus flavus from Argentina.
Topics: Amphotericin B; Antifungal Agents; Argentina; Aspergillosis; Aspergillus flavus; Cytochrome P450 Family 51; Drug Resistance, Fungal; Environmental Microbiology; Environmental Monitoring; Genes, Fungal; Humans; Itraconazole; Microbial Sensitivity Tests; Mutation; Triazoles; Voriconazole | 2021 |
Invasive aspergillosis in solid organ transplant patients: diagnosis, prophylaxis, treatment, and assessment of response.
Topics: Aspergillosis; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Invasive Fungal Infections; Organ Transplantation; Patient Outcome Assessment; Practice Guidelines as Topic; Transplant Recipients; Triazoles | 2021 |
Disposition of posaconazole after single oral administration in large falcons (Falco spp): Effect of meal and dosage and a non-compartmental model to predict effective dosage.
Topics: Administration, Oral; Animals; Antifungal Agents; Aspergillosis; Aspergillus; Bird Diseases; Dose-Response Relationship, Drug; Drug Resistance, Fungal; Falconiformes; Female; Male; Triazoles; Voriconazole | 2021 |
Clinical utility of antifungal susceptibility testing in patients with fungal rhinosinusitis.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Azoles; Humans; Itraconazole; Microbial Sensitivity Tests; Mucormycosis; Mycoses; Sinusitis; Triazoles; Voriconazole | 2021 |
Topics: Aged; Antifungal Agents; Aspergillosis; Brain; Female; Humans; Immunocompromised Host; Lung Diseases, Fungal; Triazoles; Voriconazole | 2017 |
Detection of Polish clinical Aspergillus fumigatus isolates resistant to triazoles.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cities; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fungal Proteins; Genotype; Humans; Mutation, Missense; Poland; Triazoles | 2018 |
New pharmacological opportunities for the treatment of invasive mould diseases.
Topics: Amphotericin B; Anidulafungin; Antibiotic Prophylaxis; Antifungal Agents; Aspergillosis; Drug Therapy, Combination; Echinocandins; Humans; Invasive Fungal Infections; Mucormycosis; Nitriles; Pyridines; Triazoles; Voriconazole | 2017 |
Intercountry Transfer of Triazole-Resistant Aspergillus fumigatus on Plant Bulbs.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Environmental Microbiology; Humans; Netherlands; Plant Roots; Triazoles | 2017 |
Clinical effectiveness of early posaconazole suspension pre-emptive therapy in lung transplant recipients: The Alfred's experience.
Topics: Adult; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cohort Studies; Drug Monitoring; Female; Humans; Lung Transplantation; Male; Middle Aged; Retrospective Studies; Suspensions; Transplant Recipients; Treatment Outcome; Triazoles; Voriconazole | 2017 |
Changes in In Vitro Susceptibility Patterns of Aspergillus to Triazoles and Correlation With Aspergillosis Outcome in a Tertiary Care Cancer Center, 1999-2015.
Topics: Adult; Antifungal Agents; Aspergillosis; Aspergillus; Aspergillus fumigatus; Cohort Studies; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Ergosterol; Female; Fungal Proteins; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Invasive Pulmonary Aspergillosis; Male; Microbial Sensitivity Tests; Polymorphism, Genetic; Prospective Studies; Tertiary Healthcare; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2017 |
Susceptibility Testing of Common and Uncommon Aspergillus Species against Posaconazole and Other Mold-Active Antifungal Azoles Using the Sensititre Method.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Drug Resistance, Fungal; Itraconazole; Microbial Sensitivity Tests; Sterol 14-Demethylase; Triazoles; Voriconazole | 2017 |
Treatment of refractory sino-nasal aspergillosis with posaconazole and terbinafine in 10 dogs.
Topics: Animals; Antifungal Agents; Aspergillosis; Dog Diseases; Dogs; Naphthalenes; Prospective Studies; Terbinafine; Treatment Outcome; Triazoles | 2017 |
The Aspergillus fumigatus farnesyltransferase β-subunit, RamA, mediates growth, virulence, and antifungal susceptibility.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Farnesyltranstransferase; Fungal Proteins; Gene Expression Regulation, Fungal; Humans; Hyphae; Male; Mice; Triazoles; Virulence | 2017 |
Evidence of unique genetic diversity in Aspergillus fumigatus isolates from Cameroon.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cameroon; Genetic Variation; Genotype; Geography; Humans; Itraconazole; Microbial Sensitivity Tests; Microsatellite Repeats; Phylogeny; Soil Microbiology; Triazoles; Voriconazole | 2017 |
Evaluation of Posaconazole Serum Concentrations from Delayed-Release Tablets in Patients at High Risk for Fungal Infections.
Topics: Adult; Aged; Antifungal Agents; Aspergillosis; Aspergillus; Candida; Female; Fusarium; Humans; Invasive Fungal Infections; Male; Middle Aged; Mucorales; Mucositis; Retrospective Studies; Triazoles | 2017 |
Assessment of carvacrol for control of avian aspergillosis in intratracheally challenged chickens in comparison to voriconazole with a reference on economic impact.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Chickens; Cymenes; Eugenol; Microbial Sensitivity Tests; Monoterpenes; Poultry Diseases; Real-Time Polymerase Chain Reaction; Spores, Fungal; Thymol; Triazoles; Voriconazole | 2017 |
Diversity of clinical isolates of Aspergillus terreus in antifungal susceptibilities, genotypes and virulence in Galleria mellonella model: Comparison between respiratory and ear isolates.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus; Drug Resistance, Fungal; Ear; Genotype; Hospitals, University; Humans; Itraconazole; Lepidoptera; Microsatellite Repeats; Respiratory System; Triazoles; Voriconazole | 2017 |
Isavuconazole susceptibility of clinical Aspergillus fumigatus isolates and feasibility of isavuconazole dose escalation to treat isolates with elevated MICs.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fungal Proteins; Humans; Itraconazole; Microbial Sensitivity Tests; Nitriles; Pyridines; Triazoles; Voriconazole | 2018 |
Urinary tract aspergillosis in a patient with chronic kidney disease.
Topics: Antifungal Agents; Aspergillosis; Combined Modality Therapy; Diagnosis, Differential; Humans; Immunocompromised Host; Male; Middle Aged; Renal Insufficiency, Chronic; Triazoles; Urinary Tract Infections | 2017 |
Posaconazole liquid vs tablet formulation in lung transplant recipients.
Topics: Administration, Oral; Adult; Aged; Antifungal Agents; Aspergillosis; Delayed-Action Preparations; Drug Monitoring; Female; Humans; Invasive Fungal Infections; Longitudinal Studies; Lung Transplantation; Male; Middle Aged; Retrospective Studies; Suspensions; Tablets; Transplant Recipients; Triazoles; Young Adult | 2018 |
Azole-resistant and -susceptible Aspergillus fumigatus isolates show comparable fitness and azole treatment outcome in immunocompetent mice.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Azoles; Disease Models, Animal; Drug Resistance, Fungal; Female; Humans; Itraconazole; Lymphocyte Count; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Mutation; Spleen; Treatment Outcome; Triazoles; Virulence | 2018 |
The challenges of treating aspergillus abdominal aneurysm after hematopoietic cell transplant: Rapid voriconazole metabolizer.
Topics: Aneurysm, Infected; Antifungal Agents; Aspergillosis; Cytochrome P-450 CYP2C19; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Triazoles; Voriconazole | 2019 |
Comparative evaluation of different gradient diffusion tests for detection of azole resistance in Aspergillus fumigatus.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Azoles; Disk Diffusion Antimicrobial Tests; Drug Resistance, Fungal; Itraconazole; Microbial Sensitivity Tests; Nitriles; Pyridines; Reproducibility of Results; Triazoles; Voriconazole | 2018 |
Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline.
Topics: Antibodies, Fungal; Antifungal Agents; Aspergillosis; Aspergillus; Biopsy; Bronchoalveolar Lavage; Disease Management; Early Diagnosis; Flucytosine; Galactose; Humans; Immunocompromised Host; Immunologic Tests; Invasive Pulmonary Aspergillosis; Itraconazole; Leukemia, Myeloid, Acute; Magnetic Resonance Imaging; Mannans; Microbial Sensitivity Tests; Myelodysplastic Syndromes; Nitriles; Pyridines; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2018 |
Direct in vitro comparison of the prodrug isavuconazonium sulfate with the isavuconazole active compound against Aspergillus spp. and 2 rare moulds.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Humans; Mycoses; Nitriles; Prodrugs; Pyridines; Scedosporium; Triazoles | 2018 |
Economic impact of treating invasive mold disease with isavuconazole compared with liposomal amphotericin B in the UK.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Costs and Cost Analysis; Drug Costs; Health Care Costs; Humans; Models, Economic; Mucormycosis; Nitriles; Pyridines; Treatment Outcome; Triazoles; United Kingdom | 2018 |
High prevalence of triazole resistance in clinical Aspergillus fumigatus isolates in a specialist cardiothoracic centre.
Topics: Adolescent; Adult; Age Distribution; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Child; Cystic Fibrosis; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Female; Fungal Proteins; Hospitals; Humans; London; Male; Microbial Sensitivity Tests; Middle Aged; Polymorphism, Genetic; Prevalence; Prospective Studies; Real-Time Polymerase Chain Reaction; Triazoles; Young Adult | 2018 |
Onychomycosis caused by Aspergillus subramanianii.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Antifungal Agents; Aspergillosis; Aspergillus; Female; Foot Dermatoses; Humans; Hyphae; Japan; Microscopy; Onychomycosis; Terbinafine; Triazoles; Young Adult | 2018 |
Diagnosis and Treatment of Invasive Aspergillus fumigatus Wound Infection Following Subtotal Colectomy for Perforated Toxic Megacolon in an Immunosuppressed Patient.
Topics: Adult; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Colectomy; Debridement; Female; Humans; Immunocompromised Host; Megacolon, Toxic; Postoperative Complications; Surgical Wound Infection; Treatment Outcome; Triazoles; Voriconazole | 2018 |
Sequence analysis of isolates of Aspergillus from patients with chronic and allergic aspergillosis reveals a spectrum of cryptic species.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus flavus; Aspergillus fumigatus; Aspergillus nidulans; Genes, Fungal; Genetic Loci; Humans; Microbial Sensitivity Tests; Retrospective Studies; Sequence Analysis, DNA; Sputum; Triazoles | 2018 |
Isavuconazole: Case Report and Pharmacokinetic Considerations.
Topics: Administration, Oral; Antifungal Agents; Aspergillosis; Aspergillus flavus; Bronchoalveolar Lavage Fluid; Chemical and Drug Induced Liver Injury; Chromatography, High Pressure Liquid; Drug Monitoring; Female; Half-Life; Humans; Immunocompromised Host; Nitriles; Pyridines; Tandem Mass Spectrometry; Triazoles; Voriconazole; Young Adult | 2018 |
The pharmacokinetic challenge of treating invasive aspergillosis complicating severe influenzae assisted by extracorporeal membrane oxygenation.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Bronchopulmonary Sequestration; Extracorporeal Membrane Oxygenation; Humans; Influenza, Human; Invasive Fungal Infections; Male; Middle Aged; Nitriles; Pyridines; Triazoles; Voriconazole | 2018 |
Therapeutic drug concentrations of isavuconazole following the administration of isavuconazonium sulfate capsules via gastro-jejunum tube: A case report.
Topics: Aged; Antifungal Agents; Aspergillosis; Capsules; Drug Monitoring; Enteral Nutrition; Humans; Immunocompromised Host; Invasive Fungal Infections; Jejunum; Lung Transplantation; Male; Nitriles; Pyridines; Triazoles | 2019 |
Novel Point Mutations in
Topics: Amino Acid Sequence; Antifungal Agents; Aspergillosis; Aspergillus; Base Sequence; Binding Sites; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fungal Proteins; Gene Expression; Humans; Itraconazole; Microbial Sensitivity Tests; Molecular Docking Simulation; Molecular Dynamics Simulation; Nails; Point Mutation; Protein Binding; Protein Conformation, alpha-Helical; Protein Conformation, beta-Strand; Protein Interaction Domains and Motifs; Sequence Alignment; Sputum; Structural Homology, Protein; Triazoles | 2019 |
Cost-effectiveness analysis of isavuconazole versus voriconazole for the treatment of patients with possible invasive aspergillosis in Sweden.
Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Case-Control Studies; Cost-Benefit Analysis; Decision Trees; Female; Humans; Invasive Fungal Infections; Mucormycosis; Nitriles; Pyridines; Quality-Adjusted Life Years; Sweden; Triazoles; Voriconazole | 2019 |
A Rare Case of Pulmonary Coinfection by Lichtheimia ramosa and Aspergillus fumigatus in a Patient With Delayed Graft Function After Renal Transplantation.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Coinfection; Delayed Graft Function; Humans; Immunocompromised Host; Kidney Transplantation; Male; Mucorales; Mucormycosis; Respiratory Tract Infections; Triazoles | 2019 |
Triazole Antifungal Susceptibility Patterns among
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Drug Resistance, Fungal; Humans; Microbial Sensitivity Tests; Quebec; Triazoles | 2019 |
Mutations in
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Drug Resistance, Fungal; Humans; Hydroxymethylglutaryl CoA Reductases; Mutant Proteins; Triazoles | 2019 |
Tissue Distribution and Penetration of Isavuconazole at the Site of Infection in Experimental Invasive Aspergillosis in Mice with Underlying Chronic Granulomatous Disease.
Topics: Administration, Oral; Animals; Antifungal Agents; Aspergillosis; Chromatography, Liquid; Disease Models, Animal; Granulomatous Disease, Chronic; Invasive Fungal Infections; Male; Mice; Nitriles; Prodrugs; Pyridines; Tandem Mass Spectrometry; Tissue Distribution; Triazoles | 2019 |
Aerosolization of Second-generation Triazoles: In Vitro Evaluation and Application in Therapy of Invasive Airway Aspergillosis.
Topics: Administration, Inhalation; Adult; Aerosols; Antifungal Agents; Aspergillosis; Bronchoscopy; Feasibility Studies; Female; Humans; Invasive Fungal Infections; Lung Transplantation; Respiratory Tract Infections; Triazoles; Voriconazole | 2019 |
EUCAST technical note on voriconazole and Aspergillus spp.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2013 |
Voriconazole induced bradycardia.
Topics: Antifungal Agents; Aspergillosis; Bradycardia; Child; Child, Preschool; Female; Humans; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Time Factors; Triazoles; Voriconazole | 2013 |
Risk-adjusted relationship between voriconazole utilization and non-melanoma skin cancer among lung and heart/lung transplant patients.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Aspergillosis; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Female; Heart Transplantation; Humans; Incidence; Lung Transplantation; Male; Middle Aged; Proportional Hazards Models; Pyrimidines; Risk Factors; Skin Neoplasms; Triazoles; Voriconazole; Young Adult | 2013 |
Molecular identification and antifungal susceptibility profile of Aspergillus flavus isolates recovered from clinical specimens in Kuwait.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus flavus; Genes, Fungal; Humans; Kuwait; Microbial Sensitivity Tests; Phylogeny; Pyrimidines; Statistics, Nonparametric; Triazoles; Voriconazole | 2013 |
Treatment of invasive fungal infections in high risk hematological patients. The outcome with liposomal amphotericin B is not negatively affected by prior administration of mold-active azoles.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Candidiasis, Invasive; Child; Child, Preschool; Combined Modality Therapy; Cross Infection; Drug Evaluation; Female; Fungemia; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Infant; Male; Middle Aged; Myelodysplastic Syndromes; Neutropenia; Postoperative Complications; Retrospective Studies; Risk; Transplantation, Homologous; Treatment Outcome; Triazoles; Young Adult | 2013 |
Severe skin toxicity in pediatric oncology patients treated with voriconazole and concomitant methotrexate.
Topics: Adolescent; Antibiotic Prophylaxis; Antifungal Agents; Antimetabolites, Antineoplastic; Aspergillosis; Cheilitis; Child; Child, Preschool; Dermatitis, Photoallergic; Drug Therapy, Combination; Female; Hematologic Neoplasms; Humans; Infant; Infant, Newborn; Leukemia, Megakaryoblastic, Acute; Male; Methotrexate; Pyrimidines; Skin; Treatment Outcome; Triazoles; Voriconazole | 2013 |
Assessment of efficacy of antifungals against Aspergillus fumigatus: value of real-time bioluminescence imaging.
Topics: Amphotericin B; Anidulafungin; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Echinocandins; Luminescent Measurements; Male; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2013 |
Potential factors for inadequate voriconazole plasma concentrations in intensive care unit patients and patients with hematological malignancies.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Body Mass Index; Cohort Studies; Drug Monitoring; Female; Hematologic Neoplasms; Humans; Intensive Care Units; Male; Middle Aged; Prospective Studies; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2013 |
Exacerbation of myasthenia gravis with voriconazole.
Topics: Antifungal Agents; Aspergillosis; Blepharoptosis; Computer Simulation; Disease Progression; Female; Humans; Middle Aged; Myasthenia Gravis; Ophthalmoplegia; Pyrimidines; Triazoles; Voriconazole | 2013 |
Aspergillosis due to voriconazole highly resistant Aspergillus fumigatus and recovery of genetically related resistant isolates from domiciles.
Topics: Aged; Air Microbiology; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Child; Drug Resistance, Fungal; Female; Genes, Fungal; Genotype; Hospitals; Humans; Male; Middle Aged; Molecular Typing; Mycological Typing Techniques; Netherlands; Pyrimidines; Residence Characteristics; Selection, Genetic; Sequence Analysis, DNA; Surveys and Questionnaires; Treatment Failure; Triazoles; Voriconazole; Young Adult | 2013 |
Voriconazole resistance in Aspergillus fumigatus: should we be concerned?
Topics: Air Microbiology; Aspergillosis; Aspergillus fumigatus; Drug Resistance, Fungal; Female; Humans; Male; Molecular Typing; Pyrimidines; Residence Characteristics; Triazoles; Voriconazole | 2013 |
cyp51A-Based mechanisms of Aspergillus fumigatus azole drug resistance present in clinical samples from Germany.
Topics: Alleles; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fungal Proteins; Germany; Humans; Itraconazole; Microbial Sensitivity Tests; Mutation; Prevalence; Pyrimidines; Triazoles; Voriconazole | 2013 |
Multicenter study of isavuconazole MIC distributions and epidemiological cutoff values for Aspergillus spp. for the CLSI M38-A2 broth microdilution method.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fungal Proteins; Genes, Fungal; Geography; Humans; Microbial Sensitivity Tests; Mutation; Nitriles; Pyridines; Pyrimidines; Reference Values; Triazoles; Voriconazole | 2013 |
In vitro activities of isavuconazole and comparator antifungal agents tested against a global collection of opportunistic yeasts and molds.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Candida; Candidiasis; Humans; Microbial Sensitivity Tests; Nitriles; Opportunistic Infections; Pyridines; Triazoles | 2013 |
Posaconazole concentrations after allogeneic hematopoietic stem cell transplantation.
Topics: Adult; Aged; Antifungal Agents; Aspergillosis; Female; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Mycoses; Retrospective Studies; Triazoles; Young Adult | 2013 |
Dried blood spot analysis suitable for therapeutic drug monitoring of voriconazole, fluconazole, and posaconazole.
Topics: Adult; Aged; Antifungal Agents; Aspergillosis; Dried Blood Spot Testing; Drug Monitoring; Fluconazole; Humans; Middle Aged; Mucormycosis; Mycoses; Triazoles; Young Adult | 2013 |
Successful treatment of acute thyroiditis due to Aspergillus spp. in the context of disseminated invasive aspergillosis in a kidney transplant patient.
Topics: Acute Disease; Antifungal Agents; Aspergillosis; Female; Humans; Kidney Transplantation; Middle Aged; Postoperative Complications; Pyrimidines; Remission Induction; Thyroiditis; Triazoles; Voriconazole | 2013 |
Aspergillosis sinusitis with cranio-orbital spread in an apparently immunocompetent patient.
Topics: Aged; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Blindness; Brain; Combined Modality Therapy; Debridement; Humans; Immunocompromised Host; Magnetic Resonance Imaging; Male; Neurosurgical Procedures; Ophthalmoplegia; Orbit; Pyrimidines; Sinusitis; Triazoles; Voriconazole | 2013 |
Determination of isavuconazole susceptibility of Aspergillus and Candida species by the EUCAST method.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Candida; Candidiasis, Invasive; Drug Dosage Calculations; Drug Resistance, Fungal; Europe; Humans; Microbial Sensitivity Tests; Mutation; Nitriles; Pyridines; Triazoles | 2013 |
Acute chiasmal abscess resulting from perineural extension of invasive sino-orbital aspergillosis in an immunocompetent patient.
Topics: Abscess; Antifungal Agents; Aspergillosis; Cranial Sinuses; Debridement; Humans; Immunocompetence; Immunohistochemistry; Itraconazole; Magnetic Resonance Imaging; Male; Middle Aged; Neuroimaging; Optic Chiasm; Optic Nerve; Orbital Diseases; Pyrimidines; Triazoles; Visual Fields; Voriconazole | 2014 |
Iatrogenic Cushing's syndrome induced by posaconazole.
Topics: Androstadienes; Antifungal Agents; Aspergillosis; Bronchi; Bronchodilator Agents; Common Variable Immunodeficiency; Cushing Syndrome; Female; Fluticasone; Humans; Iatrogenic Disease; Itraconazole; Middle Aged; Triazoles | 2013 |
Invasive Aspergillus niger complex infections in a Belgian tertiary care hospital.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Aspergillus niger; Belgium; Female; Humans; Incidence; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Typing; Mycological Typing Techniques; Retrospective Studies; Tertiary Care Centers; Triazoles; Voriconazole | 2014 |
Predictors of invasive fungal infection in pediatric allogeneic hematopoietic SCT recipients.
Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Child; Child, Preschool; Echinocandins; Female; Fusariosis; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Infant; Lipopeptides; Logistic Models; Male; Mycoses; Neutrophils; Prospective Studies; Pyrimidines; Retrospective Studies; Risk; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2014 |
Ulcerative tracheobronchitis due to Aspergillus.
Topics: Adult; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Asthma; Biopsy; Bronchitis; Bronchoscopy; Critical Care; Humans; Incidental Findings; Male; Pyrimidines; Respiration, Artificial; Respiratory Mucosa; Tracheitis; Tracheostomy; Treatment Failure; Treatment Outcome; Triazoles; Ulcer; Voriconazole | 2013 |
Aspergillus tubingenesis endophthalmitis after cataract surgery with implantation of preloaded intraocular lens.
Topics: Aged, 80 and over; Antifungal Agents; Aspergillosis; Aspergillus; Device Removal; Drug Therapy, Combination; Echinocandins; Endophthalmitis; Eye Infections, Fungal; Humans; Intravitreal Injections; Lens Implantation, Intraocular; Lipopeptides; Male; Micafungin; Phacoemulsification; Postoperative Complications; Pyrimidines; Triazoles; Visual Acuity; Vitrectomy; Voriconazole | 2014 |
Antifungal prophylaxis following allogeneic haematopoietic stem cell transplantation: what is the role of voriconazole?
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Pyrimidines; Triazoles | 2014 |
Refractory invasive aspergillosis controlled with posaconazole and pulmonary surgery in a patient with chronic granulomatous disease: case report.
Topics: Antifungal Agents; Aspergillosis; Child, Preschool; Diagnosis, Differential; Follow-Up Studies; Granulomatous Disease, Chronic; Humans; Immunocompromised Host; Male; Pneumonectomy; Tomography, X-Ray Computed; Triazoles | 2014 |
Utilizing hardware culture in a case of atypical keratitis.
Topics: Antifungal Agents; Aspergillosis; Aspergillus flavus; Contact Lenses, Hydrophilic; Corneal Ulcer; Drug Therapy, Combination; Equipment Contamination; Eye Infections, Fungal; Humans; Male; Mycological Typing Techniques; Natamycin; Pyrimidines; Triazoles; Voriconazole; Young Adult | 2014 |
Chronic granulomatous invasive fungal sinusitis: an evolving approach to management.
Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Chronic Disease; Granuloma; Humans; Male; Pyrimidines; Sinusitis; Triazoles; Voriconazole | 2014 |
Aspergillus spondylodiscitis in an immunocompetent patient following spinal anesthesia.
Topics: Adult; Anesthesia, Spinal; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cesarean Section; Debridement; Discitis; Female; Humans; Immunocompetence; Pregnancy; Puerperal Infection; Pyrimidines; Triazoles; Voriconazole | 2014 |
Factors influencing posaconazole plasmatic concentrations in patients presenting with acute myeloid leukemia.
Topics: Adult; Aged; Antifungal Agents; Aspergillosis; Drug Monitoring; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Retrospective Studies; Triazoles; Young Adult | 2014 |
Azole-resistant Aspergillus fumigatus in the environment of northern Italy, May 2011 to June 2012.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Humans; Italy; Itraconazole; Microbial Sensitivity Tests; Mutation; Polymerase Chain Reaction; Sentinel Surveillance; Soil Microbiology; Triazoles | 2014 |
Posaconazole responsive cerebral aspergillosis in an immunocompetent adult.
Topics: Aged; Antifungal Agents; Aspergillosis; Brain; Encephalitis; Humans; Magnetic Resonance Imaging; Male; Suction; Treatment Outcome; Triazoles; Voriconazole | 2014 |
Cryptic and rare Aspergillus species in Brazil: prevalence in clinical samples and in vitro susceptibility to triazoles.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Brazil; Calmodulin; Cluster Analysis; DNA, Fungal; DNA, Ribosomal Spacer; Humans; Itraconazole; Microbial Sensitivity Tests; Molecular Sequence Data; Phylogeny; Prevalence; Sequence Analysis, DNA; Triazoles; Tubulin; Voriconazole | 2014 |
EUCAST testing of Isavuconazole susceptibility in Aspergillus: comparison of results for Inoculum standardization using Conidium counting versus optical density.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Drug Resistance, Fungal; Microbial Sensitivity Tests; Nitriles; Pyridines; Spectrophotometry; Spores, Fungal; Triazoles | 2014 |
In vitro combination of isavuconazole with micafungin or amphotericin B deoxycholate against medically important molds.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Cunninghamella; Deoxycholic Acid; Drug Combinations; Drug Interactions; Echinocandins; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Mucormycosis; Nitriles; Pyridines; Triazoles | 2014 |
Serum galactomannan-based early detection of invasive aspergillosis in hematology patients receiving effective antimold prophylaxis.
Topics: Antifungal Agents; Antigens, Fungal; Aspergillosis; Galactose; Humans; Mannans; Triazoles | 2014 |
Comparative pharmacodynamics of posaconazole in neutropenic murine models of invasive pulmonary aspergillosis and mucormycosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Area Under Curve; Aspergillosis; Aspergillus fumigatus; Benzoates; Caspofungin; Deferasirox; Disease Models, Animal; Drug Therapy, Combination; Echinocandins; Female; Invasive Pulmonary Aspergillosis; Lipopeptides; Lung; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Mucormycosis; Neutropenia; Rhizopus; Treatment Outcome; Triazoles | 2014 |
Efficacy of oleylphosphocholine (OlPC) in vitro and in a mouse model of invasive aspergillosis.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus; Aspergillus fumigatus; Azoles; Disease Models, Animal; Mice; Microbial Sensitivity Tests; Phosphorylcholine; Pyrimidines; Triazoles; Voriconazole | 2015 |
Invasive cardiac aspergillosis presenting as complete heart block in a patient with acute lymphoblastic leukaemia.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Cardiomyopathies; Electrocardiography; Heart Block; Humans; Male; Middle Aged; Opportunistic Infections; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Triazoles | 2015 |
Pharmacodynamics of isavuconazole in an Aspergillus fumigatus mouse infection model.
Topics: Animals; Aspergillosis; Aspergillus fumigatus; Female; Mice; Nitriles; Pyridines; Triazoles | 2015 |
Multi-triazole-resistant Aspergillus fumigatus infections in Australia.
Topics: Adult; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Australia; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Female; Fungal Proteins; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Mutation, Missense; Retrospective Studies; Triazoles; Voriconazole | 2015 |
Genetic Analysis Using an Isogenic Mating Pair of Aspergillus fumigatus Identifies Azole Resistance Genes and Lack of MAT Locus's Role in Virulence.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Azoles; Crosses, Genetic; Drug Resistance, Multiple, Fungal; Fungal Proteins; Genes, Mating Type, Fungal; Genetic Loci; Hydroxymethylglutaryl CoA Reductases; Itraconazole; Larva; Mice, Inbred BALB C; Microbial Sensitivity Tests; Mixed Function Oxygenases; Moths; Mutation; Sterol 14-Demethylase; Survival Analysis; Triazoles; Virulence; Voriconazole | 2015 |
First determination of azole resistance in Aspergillus fumigatus strains carrying the TR34/L98H mutations in Turkey.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; DNA Mutational Analysis; Drug Resistance, Fungal; Female; Fungal Proteins; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Mutation; Promoter Regions, Genetic; Triazoles; Turkey; Voriconazole; Young Adult | 2015 |
Incidence and risk factors of post-engraftment invasive fungal disease in adult allogeneic hematopoietic stem cell transplant recipients receiving oral azoles prophylaxis.
Topics: Administration, Oral; Adult; Aged; Allografts; Amphotericin B; Antifungal Agents; Aspergillosis; Caspofungin; Cause of Death; Drug Therapy, Combination; Echinocandins; Female; Fungemia; Granulocyte Colony-Stimulating Factor; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Incidence; Lipopeptides; Male; Medication Adherence; Middle Aged; Mycoses; Neutropenia; Patient Compliance; Premedication; Retrospective Studies; Risk Assessment; Risk Factors; Survival Analysis; Transplantation Conditioning; Treatment Failure; Triazoles; Young Adult | 2015 |
In vivo efficacy of voriconazole and posaconazole therapy in a novel invertebrate model of Aspergillus fumigatus infection.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Disease Models, Animal; Larva; Lepidoptera; Microbial Sensitivity Tests; Survival Analysis; Triazoles; Voriconazole | 2015 |
Azole resistance in canine and feline isolates of Aspergillus fumigatus.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cat Diseases; Cats; Cytochrome P-450 Enzyme System; Dog Diseases; Dogs; Drug Resistance, Fungal; Fungal Proteins; Itraconazole; Microbial Sensitivity Tests; Mutation; Triazoles; Voriconazole | 2015 |
In Vivo Synergy of Amphotericin B plus Posaconazole in Murine Aspergillosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Drug Administration Schedule; Drug Resistance, Fungal; Drug Synergism; Gene Expression; Isoenzymes; Kidney; Lung; Male; Mice; Microbial Sensitivity Tests; Sterol 14-Demethylase; Survival Analysis; Triazoles | 2016 |
Aspergillus Mediastinitis after Orthotopic Heart Transplantation: A Case Report.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Combined Modality Therapy; Debridement; Drainage; Drug Administration Schedule; Drug Therapy, Combination; Female; Heart Transplantation; Humans; Mediastinitis; Middle Aged; Reoperation; Surgical Flaps; Surgical Wound Infection; Time Factors; Treatment Outcome; Triazoles; Voriconazole | 2015 |
Single-tube PCR coupled with mini-sequencing assay for the detection of cyp51A and cyp51B polymorphisms in Aspergillus fumigatus.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fungal Proteins; Genotyping Techniques; Humans; Microbial Sensitivity Tests; Multiplex Polymerase Chain Reaction; Polymorphism, Genetic; Portugal; Sequence Analysis, DNA; Triazoles | 2015 |
Quantitative Analysis of Single-Nucleotide Polymorphism for Rapid Detection of TR34/L98H- and TR46/Y121F/T289A-Positive Aspergillus fumigatus Isolates Obtained from Patients in Iran from 2010 to 2014.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; DNA, Fungal; Drug Resistance, Fungal; Fungal Proteins; Gene Expression; Humans; Iran; Itraconazole; Microbial Sensitivity Tests; Microsatellite Repeats; Mycological Typing Techniques; Polymorphism, Single Nucleotide; Promoter Regions, Genetic; Retrospective Studies; Sequence Analysis, DNA; Triazoles; Voriconazole | 2016 |
In Vitro Activity of ASP2397 against Aspergillus Isolates with or without Acquired Azole Resistance Mechanisms.
Topics: Amino Acid Substitution; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Aspergillus fumigatus; Azoles; Coordination Complexes; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fungal Proteins; Gene Expression; Humans; Itraconazole; Microbial Sensitivity Tests; Mutation; Peptides, Cyclic; Triazoles; Voriconazole | 2016 |
Azole Resistance in Aspergillus fumigatus Clinical Isolates from an Italian Culture Collection.
Topics: Amino Acid Substitution; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Bacterial Typing Techniques; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Epidemiological Monitoring; Fungal Proteins; Gene Expression; Genotype; Humans; Italy; Itraconazole; Microbial Sensitivity Tests; Microsatellite Repeats; Mutation; Promoter Regions, Genetic; Triazoles; Voriconazole | 2016 |
Molecular Characterization of a Voriconazole-Resistant, Posaconazole-Susceptible Aspergillus fumigatus Isolate in a Lung Transplant Recipient in the United States.
Topics: Aged; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Cytomegalovirus Infections; Drug Resistance, Fungal; Fungal Proteins; Humans; Lung Transplantation; Male; Microbial Sensitivity Tests; Transplant Recipients; Triazoles; United States; Voriconazole | 2016 |
Time-Kill Kinetics and In Vitro Antifungal Susceptibility of Non-fumigatus Aspergillus Species Isolated from Patients with Ocular Mycoses.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Aspergillosis; Aspergillus; Caspofungin; Echinocandins; Eye; Eye Infections, Fungal; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Triazoles; Voriconazole | 2016 |
In Vitro Activities of Five Antifungal Drugs Against Opportunistic Agents of Aspergillus Nigri Complex.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Caspofungin; Echinocandins; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Triazoles; Voriconazole | 2016 |
Disseminated fusariosis by Fusarium proliferatum in a patient with aplastic anaemia receiving primary posaconazole prophylaxis - case report and review of the literature.
Topics: Anemia, Aplastic; Antifungal Agents; Aspergillosis; Aspergillus flavus; Coinfection; Fatal Outcome; Fusariosis; Fusarium; Humans; Immunocompromised Host; Male; Opportunistic Infections; Triazoles; Young Adult | 2016 |
Diversity and origins of Indian multi-triazole resistant strains of Aspergillus fumigatus.
Topics: Aspergillosis; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; DNA Fingerprinting; DNA, Fungal; Drug Resistance, Multiple, Fungal; Environmental Microbiology; Fungal Proteins; Genes, Mating Type, Fungal; Genetic Variation; Genotype; Humans; India; Microbial Sensitivity Tests; Microsatellite Repeats; Multilocus Sequence Typing; Mycological Typing Techniques; Triazoles | 2016 |
In vitro activities of five antifungal agents against 199 clinical and environmental isolates of Aspergillus flavus, an opportunistic fungal pathogen.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus flavus; Caspofungin; Dose-Response Relationship, Drug; Drug Resistance, Fungal; Echinocandins; Environmental Microbiology; Humans; Iran; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Opportunistic Infections; Triazoles; Voriconazole | 2016 |
High Intracellular Concentrations of Posaconazole Do Not Impact on Functional Capacities of Human Polymorphonuclear Neutrophils and Monocyte-Derived Macrophages In Vitro.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cell Movement; Cells, Cultured; Humans; Macrophages; Neutrophils; Reactive Oxygen Species; Spores, Fungal; Triazoles | 2016 |
Isavuconazole Population Pharmacokinetic Analysis Using Nonparametric Estimation in Patients with Invasive Fungal Disease (Results from the VITAL Study).
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Candida; Female; Humans; Linear Models; Male; Microbial Sensitivity Tests; Mucormycosis; Nitriles; Pyridines; Triazoles | 2016 |
Identification of novel antifungal lead compounds through pharmacophore modeling, virtual screening, molecular docking, antimicrobial evaluation, and gastrointestinal permeation studies.
Topics: 14-alpha Demethylase Inhibitors; Antifungal Agents; Aspergillosis; Aspergillus niger; Candida; Candidiasis; Gastrointestinal Tract; Humans; Ligands; Microbial Sensitivity Tests; Models, Molecular; Molecular Docking Simulation; Permeability; Triazoles | 2017 |
Ungual aspergillosis successfully treated with topical efinaconazole.
Topics: Administration, Topical; Aged; Antifungal Agents; Aspergillosis; Female; Humans; Onychomycosis; Triazoles | 2017 |
Aspergillus fumigatus carrying TR34/L98H resistance allele causing complicated suppurative otitis media in Tanzania: Call for improved diagnosis of fungi in sub-Saharan Africa.
Topics: Adolescent; Adult; Alleles; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Drug Resistance, Fungal; Female; Genes, Fungal; Humans; Itraconazole; Microbial Sensitivity Tests; Otitis Media, Suppurative; Tanzania; Triazoles; Voriconazole; Young Adult | 2016 |
Synergistic effect of anidulafungin combined with posaconazole in experimental aspergillosis.
Topics: Anidulafungin; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Echinocandins; Kidney; Male; Mice; Survival Analysis; Triazoles | 2017 |
Synergistic Effects of Tetrandrine with Posaconazole Against Aspergillus fumigatus.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Benzylisoquinolines; Candidiasis; Drug Resistance, Fungal; Drug Synergism; Female; Humans; Itraconazole; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Triazoles; Voriconazole | 2017 |
[A suspected case of voriconazole-induced lung injury].
Topics: Aged; Antifungal Agents; Aspergillosis; Humans; Lung Diseases; Lung Diseases, Fungal; Male; Pyrimidines; Triazoles; Voriconazole | 2008 |
Osteomyelitis of the rib caused by Aspergillus flavus following cardiac surgery.
Topics: Abscess; Aged; Antifungal Agents; Aspergillosis; Aspergillus flavus; Humans; Male; Osteomyelitis; Pyrimidines; Ribs; Surgical Wound Infection; Thoracic Surgery; Triazoles; Voriconazole | 2009 |
Does pre-exposure of Aspergillus fumigatus to voriconazole or posaconazole in vitro affect its virulence and the in vivo activity of subsequent posaconazole or voriconazole, respectively? A study in a fly model of aspergillosis.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Drosophila melanogaster; Drosophila Proteins; Pyrimidines; Survival Analysis; Toll-Like Receptors; Triazoles; Virulence; Voriconazole | 2008 |
In vitro survey of triazole cross-resistance among more than 700 clinical isolates of Aspergillus species.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Drug Resistance, Fungal; Humans; Microbial Sensitivity Tests; Statistics as Topic; Triazoles | 2008 |
Fatal Aspergillus fumigatus and Candida glabrata infections with posaconazole prophylaxis after stem cell transplantation.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Candida glabrata; Candidiasis; Chemoprevention; Fatal Outcome; Humans; Male; Middle Aged; Stem Cell Transplantation; Triazoles | 2008 |
Voriconazole treatment of invasive aspergillosis: real-world versus health-economic model results.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Belgium; Cost-Benefit Analysis; Female; Health Care Costs; Humans; Immunocompromised Host; Male; Middle Aged; Models, Economic; Prospective Studies; Pyrimidines; Triazoles; Voriconazole | 2008 |
Treatment of aspergillosis.
Topics: Antifungal Agents; Aspergillosis; Fluconazole; Humans; Itraconazole; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Neutropenia; Triazoles | 2008 |
Clinical isolates of Aspergillus species remain fully susceptible to voriconazole in the post-voriconazole era.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Pyrimidines; Spain; Time Factors; Treatment Outcome; Triazoles; Voriconazole | 2008 |
Angio-oedema as an unusual tolerable side effect of voriconazole therapy.
Topics: Adult; Angioedema; Antifungal Agents; Aspergillosis; Female; Histamine H1 Antagonists; Humans; Infusions, Intravenous; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2008 |
Designing voriconazole treatment for racing pigeons: balancing between hepatic enzyme auto induction and toxicity.
Topics: Administration, Inhalation; Administration, Oral; Animals; Antifungal Agents; Aspergillosis; Bird Diseases; Chromatography, High Pressure Liquid; Columbidae; Female; Injections, Intravenous; Liver; Lung; Male; Plasma; Pyrimidines; Triazoles; Voriconazole | 2009 |
First case of breakthrough pulmonary Aspergillus niveus infection in a patient after allogeneic hematopoietic stem cell transplantation.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Bronchoalveolar Lavage Fluid; Drug Resistance, Fungal; Fanconi Anemia; Fatal Outcome; Female; Hematopoietic Stem Cell Transplantation; Humans; Lung Diseases, Fungal; Pyrimidines; Transplantation, Homologous; Triazoles; Voriconazole; Young Adult | 2008 |
Posaconazole in intensive care patients I: invasive fungal infections in surgical intensive care and case presentation.
Topics: Aged; Antifungal Agents; Aspergillosis; Candidiasis; Critical Care; Cross Infection; Humans; Middle Aged; Mycoses; Postoperative Complications; Triazoles | 2008 |
Breakthrough invasive fungal infection in an immunocompromised host while on posaconazole prophylaxis: an omission in patient counseling and follow-up.
Topics: Antibiotic Prophylaxis; Antifungal Agents; Antineoplastic Agents; Aspergillosis; Candidiasis; Female; Humans; Immunosuppression Therapy; Leukemia, Myeloid, Acute; Middle Aged; Mucormycosis; Paranasal Sinus Diseases; Patient Compliance; Patient Education as Topic; Triazoles | 2008 |
Molecular characterisation of cyp51A and cyp51B genes coding for P450 14alpha-lanosterol demethylases A (CYP51Ap) and B (CYP51Bp) from voriconazole-resistant laboratory isolates of Aspergillus flavus.
Topics: Amino Acid Sequence; Antifungal Agents; Aspergillosis; Aspergillus flavus; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; DNA, Fungal; Drug Resistance, Fungal; Fungal Proteins; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Pyrimidines; Triazoles; Voriconazole | 2008 |
Pharmacokinetic interaction between everolimus and antifungal triazoles in a liver transplant patient.
Topics: Aged; Antifungal Agents; Aspergillosis; Drug Interactions; Everolimus; Fatal Outcome; Fluconazole; Humans; Immunosuppressive Agents; Liver Transplantation; Male; Pyrimidines; Sirolimus; Triazoles; Voriconazole | 2008 |
Posaconazole as salvage therapy in patients with invasive fungal infections after solid organ transplant.
Topics: Adult; Aged; Antifungal Agents; Aspergillosis; Candidiasis; Female; Humans; Immunosuppressive Agents; Incidence; Male; Middle Aged; Mycoses; Organ Transplantation; Postoperative Complications; Retrospective Studies; Safety; Treatment Outcome; Triazoles | 2008 |
[Chronic necrotizing aspergillosis].
Topics: Antifungal Agents; Aspergillosis; Bronchoalveolar Lavage; Chronic Disease; Cough; Female; Fever; Humans; Lung Diseases, Fungal; Middle Aged; Necrosis; Pyrimidines; Triazoles; Voriconazole | 2008 |
Successful treatment of primary cutaneous Aspergillus ustus infection with surgical debridement and a combination of voriconazole and terbinafine.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Debridement; Drug Resistance, Fungal; Drug Therapy, Combination; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Naphthalenes; Pyrimidines; Soft Tissue Infections; Terbinafine; Triazoles; Voriconazole | 2008 |
Pulmonary aspergillosis in hematologic malignancies: lights and shadows.
Topics: Antifungal Agents; Aspergillosis; Hematologic Neoplasms; Humans; Lung Diseases; Pyrimidines; Sensitivity and Specificity; Triazoles; Voriconazole | 2008 |
Outcome and medical costs of patients with invasive aspergillosis and acute myelogenous leukemia-myelodysplastic syndrome treated with intensive chemotherapy: an observational study.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Aspergillosis; Drug Therapy; Female; Health Care Costs; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2008 |
Emergence of azole resistance in Aspergillus fumigatus and spread of a single resistance mechanism.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Azoles; Drug Resistance, Multiple, Fungal; Humans; Itraconazole; Pyrimidines; Triazoles; Voriconazole | 2008 |
Adverse drug events complicate antifungal therapy for pulmonary aspergilloma.
Topics: Aged; Antifungal Agents; Aspergillosis; Drug Interactions; Follow-Up Studies; Hallucinations; Heart Failure; Humans; Itraconazole; Liver Function Tests; Lung Diseases, Fungal; Male; Pyrimidines; Triazoles; Voriconazole | 2008 |
Aspergillus mastoiditis, presenting with unexplained progressive otalgia, in an immunocompetent (older) patient.
Topics: Aged, 80 and over; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Diagnosis, Differential; Drug Therapy, Combination; Earache; Humans; Immunocompetence; Male; Mastoid; Mastoiditis; Miconazole; Postoperative Care; Pyrimidines; Tomography, X-Ray Computed; Triazoles; Tympanic Membrane Perforation; Voriconazole | 2009 |
Therapeutic drug monitoring of voriconazole in a child with invasive aspergillosis requiring extracorporeal membrane oxygenation.
Topics: Antifungal Agents; Aspergillosis; Child, Preschool; Drug Monitoring; Extracorporeal Membrane Oxygenation; Humans; Male; Pyrimidines; Triazoles; Voriconazole | 2008 |
[Clinical features of chronic necrotizing pulmonary aspergillosis treated with voriconazole in patients with chronic respiratory disease].
Topics: Adult; Aged; Aged, 80 and over; Aspergillosis; Chronic Disease; Female; Humans; Lung Diseases, Fungal; Male; Middle Aged; Pyrimidines; Respiratory Tract Diseases; Treatment Outcome; Triazoles; Voriconazole | 2008 |
[Case of orbital apex syndrome caused by invasive aspergillosis successfully treated during the diagnostic procedure by the use of voriconazole].
Topics: Aged; Antifungal Agents; Aspergillosis; Female; Humans; Ocular Motility Disorders; Orbital Diseases; Pyrimidines; Syndrome; Treatment Outcome; Triazoles; Vision Disorders; Voriconazole | 2008 |
Multiple-azole-resistant Aspergillus fumigatus osteomyelitis in a patient with chronic granulomatous disease successfully treated with long-term oral posaconazole and surgery.
Topics: Administration, Oral; Adolescent; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Azoles; Drug Resistance, Fungal; Foot Bones; Granulomatous Disease, Chronic; Humans; Male; Osteomyelitis; Radiography; Treatment Outcome; Triazoles | 2009 |
Successful treatment of invasive sphenoidal, pulmonary and intracerebral aspergillosis after multivisceral transplantation.
Topics: Adult; Amphotericin B; Aspergillosis; Cerebrum; Female; Flucytosine; Humans; Immunocompromised Host; Intestines; Kidney Transplantation; Lung Diseases, Fungal; Neuroaspergillosis; Pyrimidines; Sphenoid Sinus; Triazoles; Voriconazole | 2009 |
Comparative in vitro activities of posaconazole, voriconazole, itraconazole, and amphotericin B against Aspergillus and Rhizopus, and synergy testing for Rhizopus.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Drug Synergism; Humans; Itraconazole; Microbial Sensitivity Tests; Mucormycosis; Pyrimidines; Rhizopus; Triazoles; Voriconazole | 2008 |
Cerebral aspergillosis.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Brain; Brain Abscess; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Mood Disorders; Myelodysplastic Syndromes; Personality; Pyrimidines; Stem Cell Transplantation; Transplantation, Homologous; Triazoles; Voriconazole | 2009 |
Limited penetration of posaconazole into cerebrospinal fluid in an allogeneic stem cell recipient with invasive pulmonary aspergillosis.
Topics: Acute Disease; Antifungal Agents; Aspergillosis; Central Nervous System Fungal Infections; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid; Lung Diseases, Fungal; Male; Triazoles; Young Adult | 2009 |
Aspergillus osteomyelitis: review of 12 cases identified by the Prospective Antifungal Therapy Alliance registry.
Topics: Adult; Aged; Antifungal Agents; Aspergillosis; Aspergillus; Aspergillus fumigatus; Female; Humans; Male; Middle Aged; Osteomyelitis; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2009 |
Avian Aspergillus fumigatus strains resistant to both itraconazole and voriconazole.
Topics: Amphotericin B; Animals; Animals, Domestic; Animals, Wild; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Bird Diseases; Drug Resistance, Fungal; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2009 |
Voriconazole pharmacokinetic variability in cystic fibrosis lung transplant patients.
Topics: Adolescent; Adult; Antifungal Agents; Aspergillosis; Aspergillus; Cystic Fibrosis; Drug Administration Schedule; Drug Interactions; Drug Monitoring; Female; Humans; Immunosuppressive Agents; Lung Transplantation; Male; Mycoses; Pyrimidines; Scedosporium; Tacrolimus; Triazoles; Voriconazole; Young Adult | 2009 |
[Cerebral aspergillosis in an HIV-infected patient: unsuccessful outcome despite combined antifungal therapy. ].
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Brain Abscess; Caspofungin; Deoxycholic Acid; Drug Combinations; Drug Therapy, Combination; Echinocandins; Fatal Outcome; Humans; Leukoencephalopathy, Progressive Multifocal; Lipopeptides; Male; Middle Aged; Pulmonary Aspergillosis; Pyrimidines; Triazoles; Voriconazole | 2009 |
The effects of caspofungin and voriconazole in an experimental fungal infection of the ear due to Aspergillus.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Caspofungin; Cyclophosphamide; Disease Models, Animal; Echinocandins; Immunocompromised Host; Immunosuppressive Agents; Lipopeptides; Otitis Media; Pyrimidines; Rabbits; Triamcinolone Acetonide; Triazoles; Voriconazole | 2009 |
[Two cases of mycoses associated with hematologic disease].
Topics: Aged; Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Cunninghamella; Fatal Outcome; Humans; Liposomes; Male; Mucormycosis; Myelodysplastic Syndromes; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2008 |
[Case of pulmonary mycoses associated with malignant lymphoma during chemotherapy].
Topics: Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Humans; Immunocompromised Host; Lung Diseases, Fungal; Lymphoma; Male; Middle Aged; Muscle Neoplasms; Prednisolone; Psoas Muscles; Pyrimidines; Treatment Outcome; Triazoles; Vincristine; Voriconazole | 2008 |
Safe management of tacrolimus together with posaconazole in lung transplant patients with cystic fibrosis.
Topics: Adult; Antifungal Agents; Aspergillosis; Candidiasis; Cystic Fibrosis; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Drug Monitoring; Drug-Related Side Effects and Adverse Reactions; Enzyme Inhibitors; Female; Graft Rejection; Humans; Immunosuppressive Agents; Itraconazole; Lung Transplantation; Male; Microbial Sensitivity Tests; Mycoses; Prescriptions; Pyrimidines; Tacrolimus; Triazoles; Voriconazole | 2009 |
Possible environmental origin of resistance of Aspergillus fumigatus to medical triazoles.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cluster Analysis; Cross Infection; DNA Fingerprinting; DNA, Fungal; Drug Resistance, Fungal; Environmental Microbiology; Genotype; Humans; Microbial Sensitivity Tests; Microsatellite Repeats; Molecular Epidemiology; Mycological Typing Techniques; Triazoles | 2009 |
Comparative pharmacodynamic interaction analysis of triple combinations of caspofungin and voriconazole or ravuconazole with subinhibitory concentrations of amphotericin B against Aspergillus spp.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Drug Synergism; Echinocandins; Humans; Microbial Sensitivity Tests; Triazoles | 2010 |
Aspergillus vertebral osteomyelitis and epidural abscess.
Topics: Administration, Oral; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Diagnosis, Differential; Epidural Abscess; Fatal Outcome; Humans; Infusions, Intravenous; Laminectomy; Magnetic Resonance Imaging; Male; Middle Aged; Osteomyelitis; Pneumonectomy; Postoperative Complications; Pulmonary Aspergillosis; Pyrimidines; Spinal Cord Compression; Spondylitis; Thoracic Vertebrae; Triazoles; Voriconazole | 2009 |
Isolated cerebral aspergilloma in a young immunocompetent patient.
Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Brain Edema; Female; Humans; Muscle Weakness; Pyrimidines; Seizures; Treatment Outcome; Triazoles; Voriconazole | 2009 |
Successful management of postpneumonectomy Aspergillus pleural empyema by combined surgical and anti-fungal treatment with voriconazole and caspofungin.
Topics: Adult; Antifungal Agents; Aspergillosis; Caspofungin; Drug Therapy, Combination; Echinocandins; Empyema, Pleural; Female; Humans; Lipopeptides; Male; Middle Aged; Pneumonectomy; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2010 |
Management of metabolic cytochrome P450 3A4 drug-drug interaction between everolimus and azole antifungals in a renal transplant patient.
Topics: Antifungal Agents; Aspergillosis; Cytochrome P-450 CYP3A; Drug Interactions; Drug Monitoring; Everolimus; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Pyrimidines; Sirolimus; Triazoles; Voriconazole | 2009 |
Splenic hyalohyphomycosis, molecularly and immunologically consistent with invasive aspergillosis, in a patient with acute lymphoblastic leukemia.
Topics: Acute Disease; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Aspergillus; Caspofungin; Combined Modality Therapy; Echinocandins; Humans; Hyphae; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Leukemia, B-Cell; Lipopeptides; Male; Middle Aged; Neutropenia; Spleen; Splenectomy; Splenic Diseases; Triazoles | 2010 |
Efficacy of voriconazole in Japanese quail (Coturnix japonica) experimentally infected with Aspergillus fumigatus.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Coturnix; Disease Models, Animal; Female; Histocytochemistry; Lung; Male; Microbial Sensitivity Tests; Pyrimidines; Statistics, Nonparametric; Triazoles; Voriconazole | 2010 |
New treatment for invasive fungal sinusitis: three cases of chronic invasive fungal sinusitis treated with surgery and voriconazole.
Topics: Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Male; Maxillary Sinusitis; Pyrimidines; Sphenoid Sinusitis; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2010 |
Designing a treatment protocol with voriconazole to eliminate Aspergillus fumigatus from experimentally inoculated pigeons.
Topics: Administration, Inhalation; Administration, Oral; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Bird Diseases; Columbidae; Invasive Pulmonary Aspergillosis; Liver; Pyrimidines; Triazoles; Voriconazole | 2009 |
Cutaneous aspergillosis in a lung transplant recipient.
Topics: Adult; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Dermatomycoses; Female; Humans; Lung Transplantation; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2009 |
Frequency and evolution of Azole resistance in Aspergillus fumigatus associated with treatment failure.
Topics: Amino Acid Substitution; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Azoles; Cytochrome P-450 Enzyme System; Disease Progression; Drug Resistance, Fungal; Evolution, Molecular; Fungal Proteins; Humans; Itraconazole; Pyrimidines; Treatment Failure; Triazoles; Voriconazole | 2009 |
Fungal keratitis with intracameral extension following penetrating keratoplasty.
Topics: Administration, Oral; Administration, Topical; Anterior Chamber; Antifungal Agents; Aspergillosis; Corneal Stroma; Debridement; Drug Administration Schedule; Graft Rejection; Humans; Injections; Keratitis; Keratoconus; Keratoplasty, Penetrating; Male; Middle Aged; Postoperative Care; Prednisolone; Pyrimidines; Triazoles; Visual Acuity; Voriconazole | 2009 |
Atypical Aspergillus flavus isolates associated with chronic azole therapy.
Topics: Antifungal Agents; Aspergillosis; Aspergillus flavus; Azoles; Female; Humans; Itraconazole; Middle Aged; Pyrimidines; Sinusitis; Triazoles; Voriconazole | 2009 |
Wild-type MIC distribution and epidemiological cutoff values for Aspergillus fumigatus and three triazoles as determined by the Clinical and Laboratory Standards Institute broth microdilution methods.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Drug Resistance, Fungal; Microbial Sensitivity Tests; Triazoles | 2009 |
Central nervous system Aspergillus infection after epidural analgesia: diagnosis, therapeutic challenges, and literature review.
Topics: Adult; Analgesia, Epidural; Antifungal Agents; Aspergillosis; Aspergillus; Central Nervous System Infections; Female; Humans; Pyrimidines; Triazoles; Voriconazole | 2009 |
Endogenous Aspergillus endophthalmitis occurring after liver transplantation: a case report.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Antifungal Agents; Aspergillosis; Aspergillus; Endophthalmitis; Eye Enucleation; Humans; Liver Cirrhosis; Liver Transplantation; Male; Polymerase Chain Reaction; Pyrimidines; Triazoles; Vancomycin; Voriconazole; Young Adult | 2009 |
Scedosporium apiospermum: an emerging opportunistic pathogen that must be distinguished from Aspergillus and other hyalohyphomycetes.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Diagnosis, Differential; Humans; Immunocompromised Host; Lung Transplantation; Male; Middle Aged; Mycetoma; Opportunistic Infections; Pyrimidines; Scedosporium; Skin Diseases; Triazoles; Voriconazole | 2009 |
Voriconazole is safe and effective as prophylaxis for early and late fungal infections following allogeneic hematopoietic stem cell transplantation.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Aspergillosis; Candidiasis; Chemoprevention; Female; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Male; Middle Aged; Mycoses; Pyrimidines; Time Factors; Transplantation, Homologous; Triazoles; Voriconazole; Young Adult | 2010 |
[Effects of voriconazole and vascular lesions in invasion of aspergillosis into the central nerve system].
Topics: Aged, 80 and over; Antifungal Agents; Aspergillosis; Cerebral Infarction; Drug Resistance, Fungal; Fatal Outcome; Female; Humans; Male; Middle Aged; Neuroaspergillosis; Pyrimidines; Sphenoid Sinusitis; Triazoles; Voriconazole | 2009 |
Invasive aspergillosis in patients with acute myeloid leukemia: a SEIFEM-2008 registry study.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Caspofungin; Echinocandins; Female; Humans; Leukemia, Myeloid, Acute; Lipopeptides; Male; Middle Aged; Prospective Studies; Pyrimidines; Registries; Survival Rate; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2010 |
Pseudomembranous Aspergillus tracheobronchitis in a heart transplant recipient.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Bronchitis; Bronchoscopy; Female; Heart Transplantation; Humans; Invasive Pulmonary Aspergillosis; Middle Aged; Pyrimidines; Tracheitis; Triazoles; Voriconazole | 2010 |
Vertebral osteomyelitis due to Aspergillus fumigatus in a patient with chronic granulomatous disease successfully treated with antifungal agents and interferon-gamma.
Topics: Adolescent; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Caspofungin; Cervical Vertebrae; Drainage; Echinocandins; Granulomatous Disease, Chronic; Humans; Interferon-gamma; Itraconazole; Lipopeptides; Male; Osteomyelitis; Pyrimidines; Saudi Arabia; Thoracic Vertebrae; Treatment Outcome; Triazoles; Voriconazole | 2010 |
Management of obstructive renal failure caused by bilateral renal aspergilloma in an immunocompetent newborn.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus flavus; Bladder Exstrophy; Humans; Infant, Newborn; Male; Nephrostomy, Percutaneous; Pyrimidines; Renal Insufficiency; Treatment Outcome; Triazoles; Ureterostomy; Voriconazole | 2010 |
Efficacy of posaconazole against three clinical Aspergillus fumigatus isolates with mutations in the cyp51A gene.
Topics: Administration, Oral; Animals; Antifungal Agents; Area Under Curve; Aspergillosis; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Disease Models, Animal; Drug Administration Schedule; Female; Fungal Proteins; Mice; Microbial Sensitivity Tests; Mutation; Triazoles | 2010 |
Azole resistance in Aspergillus fumigatus: a side-effect of environmental fungicide use?
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Drug Resistance, Multiple, Fungal; Europe; Fungal Proteins; Fungicides, Industrial; Humans; Microbial Sensitivity Tests; Mutation; Soil Microbiology; Triazoles | 2009 |
Voriconazole pharmacokinetics in liver transplant recipients.
Topics: Adult; Aged; Antifungal Agents; Area Under Curve; Aspergillosis; Female; Genotype; Humans; Liver Transplantation; Male; Middle Aged; Prospective Studies; Pyrimidines; Triazoles; Voriconazole | 2010 |
Drug interactions and adverse events associated with antimycotic drugs used for invasive aspergillosis in hematopoietic SCT.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Caspofungin; Drug Interactions; Drug-Related Side Effects and Adverse Reactions; Echinocandins; Hematopoietic Stem Cell Transplantation; Humans; Lipopeptides; Prevalence; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole | 2010 |
[Cerebral aspergilloma in an immunocompetent patient: radiological and histopathological findings].
Topics: Antifungal Agents; Aspergillosis; Brain; Central Nervous System Fungal Infections; Humans; Immunohistochemistry; Magnetic Resonance Imaging; Male; Pyrimidines; Triazoles; Voriconazole; Young Adult | 2009 |
Successful treatment of ascending aortic graft and valve endocarditis after debulking splenectomy for invasive aspergillosis and mucor.
Topics: Aneurysm; Antifungal Agents; Aortic Aneurysm, Thoracic; Arterial Occlusive Diseases; Aspergillosis; Blood Vessel Prosthesis; Endocarditis; Femoral Artery; Heart Valve Prosthesis; Humans; Male; Middle Aged; Mucormycosis; Popliteal Artery; Prosthesis-Related Infections; Splenectomy; Triazoles | 2009 |
Voriconazole-associated myositis.
Topics: Acute Disease; Adult; Antifungal Agents; Aspergillosis; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Myositis; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole | 2009 |
Oral voriconazole for invasive fungal skull base infection.
Topics: Adult; Antifungal Agents; Aspergillosis; Biopsy; Diagnosis, Differential; Exophthalmos; Female; Humans; Magnetic Resonance Imaging; Pyrimidines; Radiography; Skull Base; Triazoles; Voriconazole | 2010 |
The effects of antifungal agents to conidial and hyphal forms of Aspergillus fumigatus.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Caspofungin; Echinocandins; Humans; Hyphae; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Microbial Viability; Pyrimidines; Spores, Fungal; Tetrazolium Salts; Triazoles; Voriconazole | 2010 |
Cutaneous model of invasive aspergillosis.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Catalase; Cyclophosphamide; Dermatomycoses; Disease Models, Animal; Female; Galactose; Hyphae; Immunocompromised Host; Immunosuppressive Agents; Mannans; Mice; Mice, Inbred BALB C; Mice, Nude; Mutagenesis; Skin; Spores; Triazoles; Virulence; Virulence Factors | 2010 |
Novel mixed-format real-time PCR assay to detect mutations conferring resistance to triazoles in Aspergillus fumigatus and prevalence of multi-triazole resistance among clinical isolates in the Netherlands.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; DNA Primers; Drug Resistance, Multiple, Fungal; Humans; Microbial Sensitivity Tests; Mutation; Netherlands; Polymerase Chain Reaction; Prevalence; Sensitivity and Specificity; Triazoles | 2010 |
Recalcitrant fungal tunnel infection treated with intrastromal injection of voriconazole.
Topics: Administration, Topical; Antifungal Agents; Aspergillosis; Aspergillus flavus; Cataract Extraction; Corneal Stroma; Eye Infections, Fungal; Female; Follow-Up Studies; Humans; Injections, Intraocular; Middle Aged; Phacoemulsification; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2010 |
AfMkk2 is required for cell wall integrity signaling, adhesion, and full virulence of the human pathogen Aspergillus fumigatus.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cell Adhesion; Cell Wall; Disease Models, Animal; Glass; Humans; Hydrogen-Ion Concentration; Mice; Mitogen-Activated Protein Kinase Kinases; Plastics; Pyrimidines; Signal Transduction; Survival Analysis; Temperature; Triazoles; Virulence; Virulence Factors; Voriconazole | 2010 |
[Primary cutaneous aspergillosis in an immunocompetent farmworker].
Topics: Adult; Agricultural Workers' Diseases; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Biopsy; Dermatomycoses; Dermis; Facial Dermatoses; Humans; Immunocompetence; Male; Neutrophils; Periodic Acid-Schiff Reaction; Pyrimidines; Triazoles; Voriconazole | 2010 |
A case series of unilateral orbital aspergillosis in three cats and treatment with voriconazole.
Topics: Animals; Antifungal Agents; Aspergillosis; Cat Diseases; Cats; Eye Diseases; Pyrimidines; Triazoles; Voriconazole | 2010 |
Design, synthesis and antifungal activity of the novel water-soluble prodrug of antifungal triazole CS-758.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Candida albicans; Candidiasis; Humans; Mice; Microsomes, Liver; Mycoses; Prodrugs; Rats; Solubility; Triazoles | 2010 |
Increasing the dose of voriconazole compensates for enzyme induction by phenytoin.
Topics: Administration, Oral; Adult; Anticonvulsants; Antifungal Agents; Aspergillosis; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Drug Interactions; Female; Humans; Phenytoin; Pyrimidines; Triazoles; Voriconazole | 2010 |
Wild-type MIC distributions and epidemiological cutoff values for the triazoles and six Aspergillus spp. for the CLSI broth microdilution method (M38-A2 document).
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Europe; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; United States; Voriconazole | 2010 |
Aspergillus endocarditis 2003-2009.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Child; Child, Preschool; Endocarditis; Humans; Immunocompromised Host; Infant; Male; Middle Aged; Pyrimidines; Retrospective Studies; Surgical Procedures, Operative; Triazoles; Voriconazole; Young Adult | 2011 |
Clinical characteristics and therapeutic analysis of invasive fungal infection in chronic severe hepatitis patients.
Topics: Adult; Aged; Antifungal Agents; Aspergillosis; Candidiasis; Hepatitis, Chronic; Humans; Middle Aged; Mycoses; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole; Young Adult | 2010 |
Adherence to international guidelines for the treatment of invasive aspergillosis in acute myeloid leukaemia: feasibility and utility (SEIFEM-2008B study).
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Caspofungin; Echinocandins; Guideline Adherence; Humans; Leukemia, Myeloid, Acute; Lipopeptides; Pyrimidines; Survival Analysis; Treatment Outcome; Triazoles; Voriconazole | 2010 |
European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3--2009 update.
Topics: Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Echinocandins; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Leukemia; Lipopeptides; Micafungin; Mycoses; Neutropenia; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole | 2011 |
Azole antifungal resistance in Aspergillus fumigatus: 2008 and 2009.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Azoles; Cytochrome P-450 Enzyme System; DNA, Fungal; Drug Resistance, Fungal; Fungal Proteins; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Sequence Analysis, DNA; Triazoles; Voriconazole | 2010 |
Impact of cyp51A mutations on the pharmacokinetic and pharmacodynamic properties of voriconazole in a murine model of disseminated aspergillosis.
Topics: Administration, Oral; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Female; Fungal Proteins; Mice; Microbial Sensitivity Tests; Mutation; Pyrimidines; Triazoles; Voriconazole | 2010 |
Catheter-associated aspergillosis of the chest wall following allogeneic hematopoietic stem cell transplantation.
Topics: Antifungal Agents; Aspergillosis; Caspofungin; Catheters; Child, Preschool; Echinocandins; Hematopoietic Stem Cell Transplantation; Humans; Lipopeptides; Male; Pyrimidines; Thoracic Wall; Transplantation, Homologous; Triazoles; Voriconazole | 2011 |
Aspergillus thyroiditis in a renal transplant recipient mimicking subacute thyroiditis.
Topics: Antifungal Agents; Aspergillosis; Caspofungin; Echinocandins; Humans; Kidney Transplantation; Lipopeptides; Pyrimidines; Thyroid Gland; Thyroiditis; Triazoles; Voriconazole | 2011 |
Comparative survival and cost of antifungal therapy: posaconazole versus standard antifungals in the treatment of refractory invasive aspergillosis.
Topics: Algorithms; Antifungal Agents; Aspergillosis; Cause of Death; Cost-Benefit Analysis; Disease Progression; Drug Costs; Drug Resistance, Fungal; Humans; Matched-Pair Analysis; Survival Analysis; Triazoles; United States | 2010 |
[Anti-infectious activity of intravitreal injectable voriconazole microspheres on experimental rabbit fungal endophthalmitis of Aspergillus fumigatus].
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Delayed-Action Preparations; Endophthalmitis; Eye; Female; Intravitreal Injections; Lactic Acid; Male; Microspheres; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Pyrimidines; Rabbits; Random Allocation; Triazoles; Voriconazole | 2010 |
Successful treatment of disseminated mixed invasive fungal infection after hematopoietic stem cell transplantation for severe aplastic anemia.
Topics: Anemia, Aplastic; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Child; Combined Modality Therapy; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Immunosuppressive Agents; Male; Mucormycosis; Rhizopus; Triazoles | 2012 |
Effect of cytochrome P450 2C19 genotype on voriconazole exposure in cystic fibrosis lung transplant patients.
Topics: Adolescent; Adult; Antifungal Agents; Aryl Hydrocarbon Hydroxylases; Aspergillosis; Cystic Fibrosis; Cytochrome P-450 CYP2C19; Dose-Response Relationship, Drug; Female; Genotype; Humans; Lung Transplantation; Male; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole; Young Adult | 2011 |
Human tissue distribution of voriconazole.
Topics: Adult; Aged; Aspergillosis; Autopsy; Brain; Female; Humans; Kidney; Liver; Lung; Male; Middle Aged; Myocardium; Pyrimidines; Spleen; Tissue Distribution; Triazoles; Voriconazole; Young Adult | 2011 |
Fatal dysrhythmia following initiation of lansoprazole during a long-term course of voriconazole.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Antifungal Agents; Aspergillosis; Drug Interactions; Fatal Outcome; Humans; Lansoprazole; Male; Pyrimidines; Tachycardia, Ventricular; Triazoles; Voriconazole | 2011 |
In vitro activity and in vivo efficacy of posaconazole in treatment of murine infections by different isolates of the Aspergillus terreus complex.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus; Disease Models, Animal; Dose-Response Relationship, Drug; Humans; Male; Mice; Microbial Sensitivity Tests; Species Specificity; Treatment Outcome; Triazoles | 2011 |
Use of epidemiological cutoff values to examine 9-year trends in susceptibility of Aspergillus species to the triazoles.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Drug Resistance, Fungal; Humans; Microbial Sensitivity Tests; Triazoles | 2011 |
Caspofungin plus posaconazole as salvage therapy of invasive fungal infections in immunocompromised patients.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Aspergillosis; Caspofungin; Drug Therapy, Combination; Echinocandins; Female; Humans; Immunocompromised Host; Lipopeptides; Male; Middle Aged; Retrospective Studies; Salvage Therapy; Triazoles; Young Adult | 2011 |
Low prevalence of resistance to azoles in Aspergillus fumigatus in a French cohort of patients treated for haematological malignancies.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Azoles; Cohort Studies; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Female; France; Fungal Proteins; Hematologic Neoplasms; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Mutation; Pyrimidines; Triazoles; Tubulin; Voriconazole | 2011 |
Clinical features and outcomes of four patients with invasive fungal sinusitis.
Topics: Aged; Antifungal Agents; Aspergillosis; Biopsy; Blindness; Brain Infarction; Candidiasis; Cavernous Sinus; Combined Modality Therapy; Debridement; Early Diagnosis; Echinocandins; Fatal Outcome; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Lipopeptides; Magnetic Resonance Imaging; Male; Maxillary Sinusitis; Micafungin; Middle Aged; Orbit Evisceration; Orbital Diseases; Postoperative Complications; Pyrimidines; Sphenoid Sinusitis; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2011 |
Aspergillus infection of supramid orbital implant and hyperostosis of orbital bone: report of a unique case.
Topics: Adult; Aspergillosis; Aspergillus; Combined Modality Therapy; Device Removal; Follow-Up Studies; Humans; Hyperostosis; Male; Nylons; Orbital Fractures; Orbital Implants; Prosthesis-Related Infections; Pyrimidines; Radiography; Risk Assessment; Treatment Outcome; Triazoles; Voriconazole | 2010 |
Interaction of oxycodone and voriconazole-a case series of patients with cancer pain supports the findings of randomised controlled studies with healthy subjects.
Topics: Analgesics, Opioid; Antifungal Agents; Aspergillosis; Burkitt Lymphoma; Chronic Pain; Female; Humans; Male; Oxycodone; Pyrimidines; Triazoles; Voriconazole | 2011 |
Effects of voriconazole co-administration on oxycodone-induced adverse events: a case in the retrospective survey.
Topics: Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Antifungal Agents; Aspergillosis; Burkitt Lymphoma; Chronic Pain; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Enzyme Inhibitors; Female; Humans; Male; Middle Aged; Mycoses; Oxycodone; Pyrimidines; Receptors, Opioid, mu; Retrospective Studies; Triazoles; Voriconazole | 2011 |
Drug interactions between voriconazole, darunavir/ritonavir and etravirine in an HIV-infected patient with Aspergillus pneumonia.
Topics: Anti-Retroviral Agents; Aspergillosis; Aspergillus; Drug Interactions; Female; HIV Infections; HIV-1; Humans; Male; Nitriles; Pneumonia, Aspiration; Pyridazines; Pyrimidines; Ritonavir; Triazoles; Voriconazole | 2011 |
Risk factors for invasive aspergillosis in acute myeloid leukemia patients prophylactically treated with posaconazole.
Topics: Adult; Aged; Antifungal Agents; Aspergillosis; Case-Control Studies; Chemoprevention; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Risk Factors; Triazoles | 2011 |
Azole resistance of Aspergillus fumigatus biofilms is partly associated with efflux pump activity.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Azoles; Biofilms; Drug Resistance, Fungal; Fungal Proteins; Male; Mice; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2011 |
Aspergillus fumigatus strains with mutations in the cyp51A gene do not always show phenotypic resistance to itraconazole, voriconazole, or posaconazole.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fungal Proteins; Humans; Itraconazole; Mutation; Pyrimidines; Triazoles; Voriconazole | 2011 |
Anti-infectious activity of intravitreal injectable voriconazole microspheres on experimental rabbit fungal endophthalmitis caused by Aspergillus fumigatus.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Delayed-Action Preparations; Endophthalmitis; Eye; Humans; Intravitreal Injections; Microspheres; Pyrimidines; Rabbits; Triazoles; Voriconazole | 2011 |
Successful management of invasive aspergillosis with voriconazole and amphoteracin B therapy in a patient with acute mycloid leukemia (AML-M2).
Topics: Amphotericin B; Antifungal Agents; Antineoplastic Agents; Aspergillosis; Child; Fever; Humans; Leukemia, Myeloid, Acute; Male; Neutropenia; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2010 |
A vascular graft infection by aspergillus treated without graft removal.
Topics: Abscess; Adult; Anti-Bacterial Agents; Antifungal Agents; Aortic Aneurysm, Abdominal; Aspergillosis; Aspergillus fumigatus; Blood Vessel Prosthesis; Combined Modality Therapy; Coronary Sinus; Coronary Vessels; Debridement; Drug Therapy, Combination; Fever; Heart Valve Prosthesis; Humans; Male; Postoperative Complications; Povidone-Iodine; Prosthesis-Related Infections; Pyrimidines; Replantation; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2011 |
Evaluation of intrastromal voriconazole injection in recalcitrant deep fungal keratitis: case series.
Topics: Administration, Ophthalmic; Adult; Aged; Antifungal Agents; Aspergillosis; Corneal Ulcer; Eye Infections, Fungal; Female; Fusariosis; Humans; Injections, Intralesional; Keratitis; Keratoplasty, Penetrating; Male; Middle Aged; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2011 |
Failure of posaconazole therapy in a renal transplant patient with invasive aspergillosis due to Aspergillus fumigatus with attenuated susceptibility to posaconazole.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Female; Humans; Kidney Transplantation; Middle Aged; Triazoles | 2011 |
The efficacy of voriconazole in the treatment of 192 fungal central nervous system infections: a retrospective analysis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Aspergillus; Central Nervous System Fungal Infections; Child; Child, Preschool; Female; Humans; Infant; Male; Middle Aged; Pyrimidines; Retrospective Studies; Scedosporium; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2011 |
In vitro susceptibility of 188 clinical and environmental isolates of Aspergillus flavus for the new triazole isavuconazole and seven other antifungal drugs.
Topics: Antifungal Agents; Aspergillosis; Aspergillus flavus; Environmental Microbiology; Humans; India; Microbial Sensitivity Tests; Netherlands; Nitriles; Pyridines; Triazoles | 2011 |
A prospective survey of Aspergillus spp. in respiratory tract samples: prevalence, clinical impact and antifungal susceptibility.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Child; Child, Preschool; Denmark; Drug Resistance, Fungal; Female; Hospitals; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Prevalence; Prospective Studies; Pyrimidines; Respiratory System; Respiratory Tract Infections; Treatment Outcome; Triazoles; Voriconazole | 2011 |
Intravitreally implantable voriconazole delivery system for experimental fungal endophthalmitis.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Disease Models, Animal; Drug Delivery Systems; Drug Implants; Endophthalmitis; Eye Infections, Fungal; Female; Lactic Acid; Male; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Pyrimidines; Rabbits; Triazoles; Vitreous Body; Voriconazole | 2011 |
Invasive Myceliophthora thermophila infection mimicking invasive aspergillosis in a neutropenic patient: a new cause of cross-reactivity with the Aspergillus galactomannan serum antigen assay.
Topics: Antifungal Agents; Antigens, Fungal; Aspergillosis; Aspergillus; Base Sequence; Cross Reactions; Diagnosis, Differential; Galactose; Hematologic Neoplasms; Humans; Male; Mannans; Middle Aged; Molecular Sequence Data; Mycoses; Neutropenia; Pyrimidines; Sensitivity and Specificity; Sordariales; Spores, Fungal; Triazoles; Voriconazole | 2011 |
Isolated cutaneous aspergillosis in an acute lymphoblastic leukemia patient after allogeneic stem cell transplantation.
Topics: Adult; Antifungal Agents; Aspergillosis; Dermatomycoses; Humans; Immunocompromised Host; Immunosuppressive Agents; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Stem Cell Transplantation; Treatment Outcome; Triazoles; Voriconazole | 2011 |
Invasive aspergillosis of orbit in immunocompetent patients: treatment and outcome.
Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Child; Child, Preschool; Drug Therapy, Combination; Eye Infections, Fungal; Female; Humans; Infant; Itraconazole; Magnetic Resonance Imaging; Male; Middle Aged; Orbital Diseases; Paranasal Sinus Diseases; Pyrimidines; Retrospective Studies; Tomography, X-Ray Computed; Triazoles; Voriconazole; Young Adult | 2011 |
Voriconazole-associated severe hyponatremia.
Topics: Aged; Antifungal Agents; Aspergillosis; Drug Monitoring; Female; Humans; Hyponatremia; Male; Middle Aged; Pyrimidines; Serum; Triazoles; Voriconazole | 2012 |
Peripheral neuropathy in patients on long-term triazole antifungal therapy.
Topics: Adult; Aged; Antifungal Agents; Aspergillosis; Chronic Disease; Cohort Studies; Female; Humans; Itraconazole; Long-Term Care; Male; Middle Aged; Peripheral Nervous System Diseases; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole; Young Adult | 2011 |
Pigmented fruiting bodies and birefringent crystals in a surgical wound: A clue to Aspergillus niger infection.
Topics: Aged; Antifungal Agents; Aspergillosis; Aspergillus niger; Crystallization; Debridement; Fruiting Bodies, Fungal; Humans; Male; Opportunistic Infections; Pyrimidines; Surgical Wound Infection; Treatment Outcome; Triazoles; Voriconazole | 2011 |
Intravitreal voriconazole for the treatment of Aspergillus chorioretinitis.
Topics: Adult; Antifungal Agents; Aspergillosis; Chorioretinitis; Diagnosis, Differential; Eye Infections, Fungal; Follow-Up Studies; Humans; Intravitreal Injections; Male; Microscopy, Acoustic; Pyrimidines; Triazoles; Visual Acuity; Voriconazole | 2011 |
Polyhexamethylene biguanide and calcineurin inhibitors as novel antifungal treatments for Aspergillus keratitis.
Topics: Amphotericin B; Animals; Aspergillosis; Aspergillus fumigatus; Biguanides; Calcineurin Inhibitors; Corneal Ulcer; Cyclosporine; Disinfectants; Drug Synergism; Eye Infections, Fungal; Immunosuppressive Agents; Male; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Prospective Studies; Pyrimidines; Tacrolimus; Triazoles; Voriconazole | 2011 |
Genetic re-identification and antifungal susceptibility testing of Aspergillus section Nigri strains of the BCCM/IHEM collection.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Biological Specimen Banks; DNA, Fungal; Humans; Itraconazole; Microbial Sensitivity Tests; Mycological Typing Techniques; Phylogeny; Polymerase Chain Reaction; Pyrimidines; Triazoles; Voriconazole | 2012 |
In vitro activity of isavuconazole against 208 Aspergillus flavus isolates in comparison with 7 other antifungal agents: assessment according to the methodology of the European Committee on Antimicrobial Susceptibility Testing.
Topics: Antifungal Agents; Aspergillosis; Aspergillus flavus; Humans; India; Microbial Sensitivity Tests; Netherlands; Nitriles; Pyridines; Triazoles | 2011 |
An observational efficacy and safety analysis of the treatment of acute invasive aspergillosis using voriconazole.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Middle Aged; Prospective Studies; Pyrimidines; Survival Analysis; Time Factors; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2012 |
In vitro acquisition of secondary azole resistance in Aspergillus fumigatus isolates after prolonged exposure to itraconazole: presence of heteroresistant populations.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Codon; Culture Media; Cytochrome P-450 Enzyme System; DNA Mutational Analysis; Drug Resistance, Fungal; Fungal Proteins; Humans; Itraconazole; Microbial Sensitivity Tests; Mutation; Mycological Typing Techniques; Pyrimidines; Time Factors; Triazoles; Voriconazole | 2012 |
SREBP-dependent triazole susceptibility in Aspergillus fumigatus is mediated through direct transcriptional regulation of erg11A (cyp51A).
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Ergosterol; Fluconazole; Fungal Proteins; Gene Expression Regulation, Fungal; Genetic Complementation Test; Genotype; Humans; Microbial Sensitivity Tests; Organisms, Genetically Modified; Pyrimidines; Real-Time Polymerase Chain Reaction; Sterol Regulatory Element Binding Proteins; Transcription, Genetic; Triazoles; Voriconazole | 2012 |
Antifungal susceptibilities of Aspergillus fumigatus clinical isolates obtained in Nagasaki, Japan.
Topics: Amino Acid Substitution; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Echinocandins; Female; Fungal Proteins; Humans; Itraconazole; Japan; Lipopeptides; Male; Micafungin; Microbial Sensitivity Tests; Mutation; Pyrimidines; Sequence Analysis, DNA; Triazoles; Voriconazole | 2012 |
[Pulmonary aspergillosis and HIV infection: about two cases].
Topics: Adult; Antifungal Agents; Aspergillosis; Bronchoalveolar Lavage; HIV Infections; Humans; Lung Diseases, Fungal; Male; Middle Aged; Prognosis; Pulmonary Aspergillosis; Pyrimidines; Radiography; Risk Factors; Triazoles; Voriconazole | 2012 |
Population pharmacokinetics of voriconazole in adults.
Topics: Administration, Oral; Adult; Aged; Antifungal Agents; Area Under Curve; Aspergillosis; Aspergillus; Bayes Theorem; Case-Control Studies; Chromatography, High Pressure Liquid; Humans; Injections, Intravenous; Logistic Models; Male; Middle Aged; Monte Carlo Method; Pyrimidines; Triazoles; Voriconazole | 2012 |
Pharmacodynamic effects of simulated standard doses of antifungal drugs against Aspergillus species in a new in vitro pharmacokinetic/pharmacodynamic model.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Aspergillus flavus; Aspergillus fumigatus; Caspofungin; Diffusion Chambers, Culture; Echinocandins; Galactose; Humans; Lipopeptides; Mannans; Microbial Sensitivity Tests; Pulsatile Flow; Pyrimidines; Species Specificity; Spores, Fungal; Triazoles; Voriconazole | 2012 |
Evidence for genetic differentiation and variable recombination rates among Dutch populations of the opportunistic human pathogen Aspergillus fumigatus.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Drug Resistance, Fungal; Evolution, Molecular; Genetic Drift; Genetic Variation; Genotype; Humans; Linkage Disequilibrium; Microbial Sensitivity Tests; Mycological Typing Techniques; Netherlands; Phylogeography; Recombination, Genetic; Triazoles | 2012 |
[Invasive aspergillosis: new tools for a targeted medical management].
Topics: Adult; Aged; Antifungal Agents; Antigens, Fungal; Aspergillosis; beta-Glucans; Clinical Trials as Topic; Comorbidity; Disease Management; Female; France; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Male; Middle Aged; Prospective Studies; Pyrimidines; Risk Factors; Survival Rate; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2011 |
Combined therapy of voriconazole and anidulafungin in murine infections by Aspergillus flavus.
Topics: Anidulafungin; Animals; Antifungal Agents; Aspergillosis; Aspergillus flavus; Drug Therapy, Combination; Echinocandins; Humans; Male; Mice; Pyrimidines; Triazoles; Voriconazole | 2012 |
A case of bronchial aspergillosis caused by Aspergillus udagawae and its mycological features.
Topics: Aged, 80 and over; Animals; Aspergillosis; Aspergillus; Bronchial Diseases; Bronchoscopy; Diabetes Mellitus; Female; Humans; Hydrogen Peroxide; Immunocompromised Host; Lung; Mice; Pyrimidines; Triazoles; Voriconazole | 2012 |
Outbreak of invasive aspergillosis after major heart surgery caused by spores in the air of the intensive care unit.
Topics: Aged, 80 and over; Air Microbiology; Antifungal Agents; Aspergillosis; Aspergillus; Cardiac Surgical Procedures; Caspofungin; Coronary Care Units; Disease Outbreaks; Echinocandins; Female; Humans; Incidence; Lipopeptides; Male; Middle Aged; Pyrimidines; Spores, Fungal; Triazoles; Voriconazole | 2012 |
How does antifungal pharmacology differ for mucormycosis versus aspergillosis?
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Cell Membrane; Cell Wall; Drug Resistance, Multiple, Fungal; Ergosterol; Gene Duplication; Genome, Fungal; Genomic Instability; Humans; Itraconazole; Microbial Sensitivity Tests; Mucormycosis; Pyrimidines; Rhizopus; Species Specificity; Triazoles; Virulence Factors; Voriconazole | 2012 |
The T788G mutation in the cyp51C gene confers voriconazole resistance in Aspergillus flavus causing aspergillosis.
Topics: Adolescent; Agrobacterium tumefaciens; Amino Acid Substitution; Antifungal Agents; Aspergillosis; Aspergillus flavus; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Female; Fungal Proteins; Gene Transfer Techniques; Humans; Lung; Microbial Sensitivity Tests; Mutagenesis, Site-Directed; Mutation; Plasmids; Pyrimidines; Sequence Analysis, DNA; Triazoles; Voriconazole | 2012 |
Epidemiological cutoff values for azoles and Aspergillus fumigatus based on a novel mathematical approach incorporating cyp51A sequence analysis.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fungal Proteins; Humans; Itraconazole; Longitudinal Studies; Mathematical Computing; Microbial Sensitivity Tests; Models, Statistical; Mutation; Netherlands; Promoter Regions, Genetic; Pyrimidines; Sequence Analysis, DNA; Tandem Repeat Sequences; Triazoles; Voriconazole | 2012 |
[Vertebral aspergillosis in a cirrhotic patient: an uncommon cause of spondylitis].
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Biomarkers; Cross Infection; Fatal Outcome; Galactose; Haemophilus influenzae; Hepatitis C, Chronic; Humans; Immunocompromised Host; Liver Cirrhosis; Low Back Pain; Lumbar Vertebrae; Male; Mannans; Middle Aged; Multiple Organ Failure; Opportunistic Infections; Pulmonary Disease, Chronic Obstructive; Pyrimidines; Spondylitis; Triazoles; Voriconazole | 2012 |
High frequency of voriconazole-related phototoxicity in cystic fibrosis patients.
Topics: Adolescent; Adult; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Child; Child, Preschool; Cystic Fibrosis; Dermatitis, Phototoxic; Female; Humans; Male; Pyrimidines; Severity of Illness Index; Triazoles; Voriconazole; Young Adult | 2012 |
Intracameral and topical voriconazole for fungal corneal endoexudates.
Topics: Administration, Topical; Adult; Aged; Anterior Chamber; Antifungal Agents; Aspergillosis; Corneal Stroma; Corneal Ulcer; Exudates and Transudates; Eye Infections, Fungal; Humans; Injections, Intraocular; Male; Middle Aged; Pyrimidines; Triazoles; Visual Acuity; Voriconazole; Young Adult | 2012 |
Monitoring trough voriconazole plasma concentrations in haematological patients: real life multicentre experience.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Aryl Hydrocarbon Hydroxylases; Aspergillosis; Cytochrome P-450 CYP2C19; Dose-Response Relationship, Drug; Drug Monitoring; Female; Hematologic Diseases; Humans; Male; Middle Aged; Polymorphism, Single Nucleotide; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2012 |
Drug interactions between voriconazole, darunavir/ritonavir and etravirine in an HIV-infected patient with Aspergillus pneumonia.
Topics: Aspergillosis; Female; HIV Infections; Humans; Male; Pneumonia, Aspiration; Pyridazines; Pyrimidines; Ritonavir; Triazoles | 2012 |
Poststernotomy aspergillosis: successful treatment with voriconazole, surgical debridement and vacuum-assisted closure therapy.
Topics: Antifungal Agents; Aspergillosis; Debridement; Humans; Male; Middle Aged; Negative-Pressure Wound Therapy; Pyrimidines; Sternotomy; Treatment Outcome; Triazoles; Voriconazole | 2012 |
Recurrent fungal iris granuloma in a 10-year-old child.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Child; Drug Therapy, Combination; Eye Infections, Fungal; Female; Fluconazole; Granuloma; Humans; Iris Diseases; Pyrimidines; Recurrence; Treatment Outcome; Triazoles; Voriconazole | 2012 |
Posaconazole plasma concentrations and invasive mould infections in patients with haematological malignancies.
Topics: Adult; Antifungal Agents; Aspergillosis; Chemoprevention; Drug Monitoring; Female; Hematologic Neoplasms; Humans; Male; Middle Aged; Mycoses; Risk Factors; Triazoles; Young Adult | 2012 |
Emergency hemicolectomy for intestinal primary aspergillosis in acute myeloid leukemia.
Topics: Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Colectomy; Emergencies; Enterocolitis, Necrotizing; Female; Humans; Ileostomy; Immunocompromised Host; Leukemia, Myeloid, Acute; Middle Aged; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2012 |
High prevalence of triazole resistance in Aspergillus fumigatus, especially mediated by TR/L98H, in a French cohort of patients with cystic fibrosis.
Topics: Adolescent; Adult; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Child; Child, Preschool; Cystic Fibrosis; Drug Resistance, Fungal; France; Humans; In Vitro Techniques; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Prevalence; Pyrimidines; Retrospective Studies; Sequence Analysis, DNA; Triazoles; Tubulin; Voriconazole; Young Adult | 2012 |
Pseudomembranous necrotizing tracheobronchial aspergillosis: an analysis of 16 cases.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Aspergillosis; Bronchoscopy; Caspofungin; Echinocandins; Female; Humans; Itraconazole; Lipopeptides; Lung Diseases, Fungal; Male; Middle Aged; Pyrimidines; Triazoles; Voriconazole | 2012 |
Pharmacodynamics of itraconazole against Aspergillus fumigatus in an in vitro model of the human alveolus: perspectives on the treatment of triazole-resistant infection and utility of airway administration.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cells, Cultured; Drug Administration Routes; Drug Resistance, Fungal; Flucytosine; Galactose; Humans; Itraconazole; Lung Diseases, Fungal; Mannans; Microbial Sensitivity Tests; Pulmonary Alveoli; Triazoles | 2012 |
Aspergillus endocarditis in a native valve without prior cardiac surgery.
Topics: Aged; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Combined Modality Therapy; Endocarditis; Humans; Male; Pyrimidines; Triazoles; Ultrasonography; Voriconazole | 2012 |
Antifungal therapy and length of hospitalization in transplant patients with invasive aspergillosis.
Topics: Adult; Aged; Antifungal Agents; Aspergillosis; Aspergillus; Caspofungin; Cohort Studies; Demography; Drug Therapy, Combination; Echinocandins; Female; Hematopoietic Stem Cell Transplantation; Humans; Infection Control; Length of Stay; Lipopeptides; Lung; Male; Middle Aged; Pyrimidines; Severity of Illness Index; Time Factors; Triazoles; Voriconazole | 2013 |
Azole preexposure affects the Aspergillus fumigatus population in patients.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fungal Proteins; Genotype; Humans; Itraconazole; Microbial Sensitivity Tests; Multigene Family; Polymorphism, Single Nucleotide; Pyrimidines; Triazoles; Voriconazole | 2012 |
Voriconazole-induced pancreatitis in a patient of acute myeloid leukemia and invasive aspergillosis.
Topics: Adolescent; Antifungal Agents; Aspergillosis; Dose-Response Relationship, Drug; Female; Humans; Leukemia, Myeloid, Acute; Pancreatitis; Pyrimidines; Triazoles; Voriconazole | 2012 |
A retrospective analysis of voriconazole pharmacokinetics in Japanese pediatric and adolescent patients.
Topics: Administration, Intravenous; Administration, Oral; Adolescent; Antifungal Agents; Aspergillosis; Candidemia; Child; Child, Preschool; Female; Humans; Infant; Infant, Newborn; Japan; Male; Mycoses; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole | 2013 |
Multiple fungal brain abscesses in a child with acute lymphoblastic leukemia.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus niger; Brain Abscess; Child, Preschool; Female; Humans; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Triazoles; Voriconazole | 2012 |
Clinical images: voriconazole-induced periostitis deformans.
Topics: Antifungal Agents; Aspergillosis; Female; Humans; Middle Aged; Periostitis; Pyrimidines; Triazoles; Voriconazole | 2012 |
Frequency of fungal isolation and antifungal susceptibility pattern of the fungal isolates from nasal polyps of chronic rhinosinusitis patients at a tertiary care centre in north India.
Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Chronic Disease; Female; Fungi; Humans; Immunoglobulin E; Incidence; India; Itraconazole; Male; Middle Aged; Mucins; Mycoses; Nasal Polyps; Pyrimidines; Retrospective Studies; Rhinitis, Allergic, Perennial; Sinusitis; Tertiary Healthcare; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2013 |
A targeted peritransplant antifungal strategy for the prevention of invasive fungal disease after lung transplantation: a sequential cohort analysis.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Cohort Studies; Echinocandins; Female; Humans; Lipopeptides; Lung Transplantation; Male; Micafungin; Middle Aged; Mycoses; Risk; Time Factors; Triazoles | 2012 |
Use of prophylactic voriconazole for three months after lung transplantation does not reduce infection with Aspergillus: a retrospective study of 147 patients.
Topics: Adult; Antibiotic Prophylaxis; Antifungal Agents; Aspergillosis; Chi-Square Distribution; Female; Humans; Incidence; Kaplan-Meier Estimate; Lung Transplantation; Male; Middle Aged; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole | 2012 |
Emergence of Aspergillus calidoustus infection in the era of posttransplantation azole prophylaxis.
Topics: Adult; Aged; Antifungal Agents; Aspergillosis; Aspergillus; Female; Humans; Lung Transplantation; Male; Microbial Sensitivity Tests; Middle Aged; Pyrimidines; Retrospective Studies; Risk Factors; Triazoles; Voriconazole | 2012 |
VFEND® (voriconazole)-associated hypoglycaemia without identified drug interaction.
Topics: Antifungal Agents; Aspergillosis; Enterocolitis; Glucose; Humans; Hyperinsulinism; Hypoglycemia; Infusions, Intravenous; Male; Middle Aged; Pyrimidines; Severity of Illness Index; Syncope; Treatment Outcome; Triazoles; Voriconazole | 2013 |
Aspergillus tanneri sp. nov., a new pathogen that causes invasive disease refractory to antifungal therapy.
Topics: Adolescent; Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus; Cluster Analysis; DNA, Fungal; Drug Resistance, Fungal; Fungal Proteins; Granulomatous Disease, Chronic; Humans; Itraconazole; Lung; Male; Mice; Microbial Sensitivity Tests; Microscopy; Molecular Sequence Data; Phylogeny; Pyrimidines; Sequence Analysis, DNA; Tomography, X-Ray Computed; Treatment Failure; Triazoles; Voriconazole; Young Adult | 2012 |
Are epidemiologic cut-off values predictors of the in vivo efficacy of azoles in experimental aspergillosis?
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus flavus; Aspergillus niger; Disease Models, Animal; Male; Mice; Microbial Sensitivity Tests; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2012 |
Voriconazole-induced photosensitivity: photobiological assessment of a case series of 12 patients.
Topics: Adult; Antibodies, Antinuclear; Antifungal Agents; Aspergillosis; Drug Eruptions; Female; Humans; Light; Male; Middle Aged; Patch Tests; Photosensitivity Disorders; Pyrimidines; Sunlight; Triazoles; Voriconazole | 2013 |
Importance of voriconazole therapeutic drug monitoring in pediatric cancer patients with invasive aspergillosis.
Topics: Adolescent; Age Factors; Antifungal Agents; Aspergillosis; Child; Child, Preschool; Drug Monitoring; Female; Humans; Infant; Male; Pyrimidines; Triazoles; Voriconazole | 2013 |
Utilization of omeprazole to augment subtherapeutic voriconazole concentrations for treatment of Aspergillus infections.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Brain; Drug Administration Routes; Drug Administration Schedule; Drug Monitoring; Drug Synergism; Humans; Magnetic Resonance Imaging; Male; Omeprazole; Pyrimidines; Triazoles; Voriconazole; Young Adult | 2012 |
Natamycin and voriconazole in Fusarium and Aspergillus keratitis: subgroup analysis of a randomised controlled trial.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Eye Infections, Fungal; Fusariosis; Fusarium; Humans; Keratitis; Natamycin; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles; Voriconazole | 2012 |
Better hospital nutrition needed to prevent and treat Aspergillus infections.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Caspofungin; Echinocandins; Female; Humans; Lipopeptides; Male; Pyrimidines; Triazoles; Voriconazole | 2013 |
Azole-resistant invasive aspergillosis in a patient with acute myeloid leukaemia in Germany.
Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Azoles; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fever; Fungal Proteins; Germany; Humans; Leukemia, Myeloid, Acute; Male; Microbial Sensitivity Tests; Mutation; Polymerase Chain Reaction; Pyrimidines; Sequence Analysis; Treatment Outcome; Triazoles; Voriconazole | 2012 |
Voriconazole hepatotoxicity in severe liver dysfunction.
Topics: Adult; Aged; Amphotericin B; Analysis of Variance; Antifungal Agents; Aspergillosis; Chemical and Drug Induced Liver Injury; Cohort Studies; Female; Humans; Liver; Liver Function Tests; Male; Middle Aged; Observation; Pyrimidines; Triazoles; Voriconazole | 2013 |
Relapsing cerebral aspergilloma associated with pregnancy.
Topics: Adult; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Brain; Central Nervous System Fungal Infections; Female; Humans; Infant, Newborn; Magnetic Resonance Imaging; Pregnancy; Pregnancy Complications, Infectious; Pyrimidines; Recurrence; Seizures; Triazoles; Voriconazole | 2013 |
Pharmacokinetic effect of voriconazole on cyclosporine in the treatment of aspergillosis after renal transplantation.
Topics: Adult; Antiviral Agents; Aspergillosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cyclosporine; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Pyrimidines; Triazoles; Voriconazole | 2012 |
Invasive aspergillosis in patients with hematological malignancies in the Czech and Slovak republics: Fungal InfectioN Database (FIND) analysis, 2005-2009.
Topics: Acute Disease; Adolescent; Adult; Aged; Antifungal Agents; Aspergillosis; Bronchoalveolar Lavage Fluid; Child; Child, Preschool; Czech Republic; Databases, Factual; Echinocandins; Female; Galactose; Humans; Leukemia; Lung Diseases, Fungal; Male; Mannans; Middle Aged; Neutrophils; Pyrimidines; Retrospective Studies; Slovakia; Triazoles; Voriconazole; Young Adult | 2013 |
Triazole fungicides and the selection of resistance to medical triazoles in the opportunistic mould Aspergillus fumigatus.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Drug Resistance, Fungal; Fungicides, Industrial; Humans; Microbial Sensitivity Tests; Triazoles | 2013 |
Highly variable plasma concentrations of voriconazole in pediatric hematopoietic stem cell transplantation patients.
Topics: Adolescent; Analysis of Variance; Antifungal Agents; Aspergillosis; Aspergillus; Child; Child, Preschool; Drug Administration Schedule; Drug Dosage Calculations; Drug Monitoring; Female; Hematopoietic Stem Cell Transplantation; Humans; Infant; Male; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2013 |
Pharmacodynamics of anidulafungin against clinical Aspergillus fumigatus isolates in a nonneutropenic murine model of disseminated aspergillosis.
Topics: Anidulafungin; Animals; Antifungal Agents; Area Under Curve; Aspergillosis; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Echinocandins; Female; Fungal Proteins; Humans; Mice; Mutation; Neutrophils; Promoter Regions, Genetic; Pyrimidines; Survival Analysis; Treatment Outcome; Triazoles; Voriconazole | 2013 |
Efficacy and pharmacodynamics of voriconazole combined with anidulafungin in azole-resistant invasive aspergillosis.
Topics: Anidulafungin; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Disease Models, Animal; Drug Resistance, Fungal; Drug Synergism; Drug Therapy, Combination; Echinocandins; Female; Mice; Pyrimidines; Survival Analysis; Treatment Outcome; Triazoles; Voriconazole | 2013 |
Case report of exposure to voriconazole in the second and third trimesters of pregnancy.
Topics: Adult; Aspergillosis; Aspergillus flavus; Female; Humans; Pregnancy; Pregnancy Trimester, Third; Pyrimidines; Triazoles; Voriconazole | 2013 |
Posaconazole after previous antifungal therapy with voriconazole for therapy of invasive aspergillus disease, a retrospective analysis.
Topics: Adolescent; Adult; Aged; Alanine Transaminase; Antifungal Agents; Aspartate Aminotransferases; Aspergillosis; Drug Evaluation; Female; gamma-Glutamyltransferase; Humans; Liver; Male; Middle Aged; Pyrimidines; Retrospective Studies; Time Factors; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2013 |
Pharmacogenetics and beyond: variability of voriconazole plasma levels in a patient with primary immunodeficiency.
Topics: Adult; Aryl Hydrocarbon Hydroxylases; Aspergillosis; Cytochrome P-450 CYP2C19; Genetic Association Studies; Granulomatous Disease, Chronic; Humans; Male; Pharmacogenetics; Pyrimidines; Triazoles; Voriconazole | 2012 |
What paths are open for tackling increasing azole resistance in Aspergillus in the clinic?
Topics: Aspergillosis; Aspergillus; Drug Resistance, Fungal; Humans; Triazoles | 2012 |
Evaluation of the in vitro activity of voriconazole as predictive of in vivo outcome in a murine Aspergillus fumigatus infection model.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Brain; Drug Resistance, Fungal; Galactose; Immunocompromised Host; Kidney; Male; Mannans; Mice; Microbial Sensitivity Tests; Predictive Value of Tests; Pyrimidines; Triazoles; Voriconazole | 2013 |
MIC values of voriconazole are predictive of treatment results in murine infections by Aspergillus terreus species complex.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus; Drug Resistance, Fungal; Galactose; Male; Mannans; Mice; Microbial Sensitivity Tests; Prognosis; Pyrimidines; Survival Analysis; Triazoles; Voriconazole | 2013 |
Effects of a defective endoplasmic reticulum-associated degradation pathway on the stress response, virulence, and antifungal drug susceptibility of the mold pathogen Aspergillus fumigatus.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cytosol; Drug Resistance, Fungal; Endoplasmic Reticulum; Endoplasmic Reticulum Stress; Endoplasmic Reticulum-Associated Degradation; Fungal Proteins; Gene Deletion; Gene Expression Regulation, Fungal; Mice; Proteasome Endopeptidase Complex; Protein Folding; Pyrimidines; Survival Analysis; Triazoles; Ubiquitin-Protein Ligases; Virulence; Voriconazole | 2013 |
Selection of the antifungal agent decides prognosis of invasive aspergillosis: case report of a successful outcome with voriconazole.
Topics: Aged, 80 and over; Antifungal Agents; Aspergillosis; Humans; Male; Orbital Diseases; Prognosis; Pyrimidines; Sinusitis; Treatment Outcome; Triazoles; Voriconazole | 2014 |
Pharmacokinetics of intravenous voriconazole in obese patients: implications of CYP2C19 homozygous poor metabolizer genotype.
Topics: Adolescent; Antifungal Agents; Area Under Curve; Aryl Hydrocarbon Hydroxylases; Aspergillosis; Body Weight; Cytochrome P-450 CYP2C19; Dose-Response Relationship, Drug; Drug Administration Schedule; Genotype; Humans; Injections, Intravenous; Male; Obesity; Pyrimidines; Triazoles; Voriconazole | 2013 |
Effect of medium composition on static and cidal activity of amphotericin B, itraconazole, voriconazole, posaconazole and terbinafine against Aspergillus fumigatus: a multicenter study.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Culture Media; France; Humans; Itraconazole; Laboratories; Microbial Sensitivity Tests; Naphthalenes; Observer Variation; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2002 |
Efficacy of caspofungin alone and in combination with voriconazole in a Guinea pig model of invasive aspergillosis.
Topics: Amphotericin B; Animals; Anti-Bacterial Agents; Antifungal Agents; Aspergillosis; Caspofungin; Drug Therapy, Combination; Echinocandins; Guinea Pigs; Lipopeptides; Male; Organ Culture Techniques; Peptides; Peptides, Cyclic; Pyrimidines; Survival Analysis; Triazoles; Voriconazole | 2002 |
Voriconazole.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Fusarium; Humans; Injections, Intravenous; Mycoses; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles; Voriconazole | 2002 |
In vitro interaction of caspofungin acetate with voriconazole against clinical isolates of Aspergillus spp.
Topics: Anti-Bacterial Agents; Antifungal Agents; Aspergillosis; Aspergillus; Caspofungin; Drug Interactions; Echinocandins; Humans; Lipopeptides; Microbial Sensitivity Tests; Peptides; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2002 |
An unusual case of pulmonary invasive aspergillosis and aspergilloma cured with voriconazole in a patient with cystic fibrosis.
Topics: Adult; Antifungal Agents; Aspergillosis; Cystic Fibrosis; Female; Humans; Lung Diseases, Fungal; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2002 |
The safety of voriconazole.
Topics: Antifungal Agents; Aspergillosis; Humans; Immunocompromised Host; Liver Function Tests; Pyrimidines; Triazoles; Voriconazole | 2002 |
Voriconazole in the management of invasive aspergillosis in two patients with acute myeloid leukemia undergoing stem cell transplantation.
Topics: Adult; Amphotericin B; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Bone Marrow Transplantation; Combined Modality Therapy; Cytarabine; Daunorubicin; Deoxycholic Acid; Drug Combinations; Drug Resistance, Fungal; Etoposide; Fatal Outcome; Humans; Immunocompromised Host; Itraconazole; Leukemia, Megakaryoblastic, Acute; Leukemia, Myelomonocytic, Acute; Liposomes; Lung Diseases, Fungal; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Pyrimidines; Recurrence; Remission Induction; Salvage Therapy; Transplantation Conditioning; Transplantation, Autologous; Transplantation, Homologous; Triazoles; Voriconazole | 2002 |
Design, synthesis and antifungal activity of a novel water soluble prodrug of antifungal triazole.
Topics: Animals; Antifungal Agents; Aspergillosis; Biotransformation; Candidiasis; Chemical Phenomena; Chemistry, Physical; Drug Design; Half-Life; Haplorhini; Humans; Hydrogen-Ion Concentration; In Vitro Techniques; Models, Molecular; Molecular Conformation; Prodrugs; Rats; Solubility; Solvents; Triazoles; Water | 2003 |
Voriconazole versus amphotericin B for invasive aspergillosis.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Humans; Patient Dropouts; Pyrimidines; Triazoles; Voriconazole | 2002 |
Voriconazole versus amphotericin B for invasive aspergillosis.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Humans; Liposomes; Pyrimidines; Triazoles; Voriconazole | 2002 |
In vitro activity of voriconazole, itraconazole, caspofungin, anidulafungin (VER002, LY303366) and amphotericin B against aspergillus spp.
Topics: Amphotericin B; Anidulafungin; Anti-Bacterial Agents; Antifungal Agents; Aspergillosis; Aspergillus; Caspofungin; Echinocandins; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Peptides; Peptides, Cyclic; Pyrimidines; Time Factors; Triazoles; Voriconazole | 2003 |
Voriconazole treatment of fungal scleritis and epibulbar abscess resulting from scleral buckle infection.
Topics: Abscess; Aged; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Eye Infections, Fungal; Female; Humans; Orbital Diseases; Pyrimidines; Scleral Buckling; Scleritis; Surgical Wound Infection; Triazoles; Voriconazole | 2003 |
Voriconazole inhibits fungal growth without impairing antigen presentation or T-cell activation.
Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Antigen Presentation; Aspergillosis; Aspergillus fumigatus; Caspofungin; Dendritic Cells; Echinocandins; Lipopeptides; Lymphocyte Activation; Mice; Mice, Inbred C57BL; Mice, Transgenic; Peptides; Peptides, Cyclic; Pyrimidines; Specific Pathogen-Free Organisms; T-Lymphocytes; Triazoles; Voriconazole | 2003 |
Combination therapy in treatment of experimental pulmonary aspergillosis: synergistic interaction between an antifungal triazole and an echinocandin.
Topics: Animals; Aspergillosis; Aspergillus fumigatus; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Echinocandins; Female; Lipopeptides; Lipoproteins; Lung; Lung Diseases, Fungal; Micafungin; Organ Size; Peptides, Cyclic; Rabbits; Thiazoles; Triazoles | 2003 |
Voriconazole in the treatment of invasive mold infections in transplant recipients.
Topics: Adult; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Female; Fungi; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mycoses; Organ Transplantation; Pyrimidines; Scedosporium; Triazoles; Voriconazole | 2003 |
[Update on voriconazole].
Topics: Adult; Age Factors; AIDS-Related Opportunistic Infections; Antifungal Agents; Aspergillosis; Candidiasis; Child; Humans; Mycoses; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles; Voriconazole | 2003 |
Voriconazole treatment of presumptive disseminated Aspergillus infection in a child with acute leukemia.
Topics: Acute Disease; Adolescent; Amphotericin B; Antifungal Agents; Aspergillosis; Combined Modality Therapy; Debridement; Drug Therapy, Combination; Female; Hepatitis; Humans; Leukemia; Lung Diseases, Fungal; Opportunistic Infections; Osteomyelitis; Pyrimidines; Remission Induction; Sacroiliac Joint; Splenic Diseases; Triazoles; Voriconazole | 2003 |
Voriconazole for invasive aspergillosis in oncohematological patients: a single-center pediatric experience.
Topics: Adolescent; Amphotericin B; Anemia, Aplastic; Anemia, Refractory; Antifungal Agents; Antineoplastic Agents; Aspergillosis; Bone Marrow Transplantation; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Hematologic Neoplasms; Humans; Leukemia, Myelomonocytic, Acute; Male; Neutropenia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Time Factors; Treatment Outcome; Triazoles; Voriconazole | 2003 |
In vitro activities of three licensed antifungal agents against spanish clinical isolates of Aspergillus spp.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Retrospective Studies; Spain; Triazoles; Voriconazole | 2003 |
High-risk AML complicated by pulmonary aspergillosis: successful treatment with nonmyeloablative stem cell transplantation and long-term administration of voriconazole.
Topics: Adult; Antifungal Agents; Aspergillosis; Female; Humans; Leukemia, Myeloid, Acute; Lung Diseases, Fungal; Myeloablative Agonists; Pyrimidines; Radiography, Thoracic; Stem Cell Transplantation; Tomography, X-Ray Computed; Transplantation Conditioning; Triazoles; Voriconazole | 2004 |
Successful treatment of pulmonary invasive aspergillosis with voriconazole in patients who failed conventional therapy.
Topics: Adult; Aged; Antifungal Agents; Aspergillosis; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Fungal; Follow-Up Studies; Fungemia; Humans; Lung Diseases, Fungal; Male; Microbial Sensitivity Tests; Middle Aged; Pyrimidines; Sampling Studies; Severity of Illness Index; Tomography, X-Ray Computed; Treatment Outcome; Triazoles; Voriconazole | 2003 |
Pulmonary aspergillosis in a patient with chronic granulomatous disease: confirmation by polymerase chain reaction and serological tests, and successful treatment with voriconazole.
Topics: Adult; Antifungal Agents; Aspergillosis; Dose-Response Relationship, Drug; Drug Administration Schedule; Fungemia; Granulomatous Disease, Chronic; Humans; Lung Diseases, Fungal; Male; Polymerase Chain Reaction; Pyrimidines; Sensitivity and Specificity; Serologic Tests; Treatment Outcome; Triazoles; Voriconazole | 2003 |
Comparison of Etest with modified broth microdilution method for testing susceptibility of Aspergillus spp. to voriconazole.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Aspergillus flavus; Aspergillus fumigatus; Aspergillus niger; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2003 |
Triple antifungal therapy for the treatment of invasive aspergillosis in a neutropenic pediatric patient.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Caspofungin; Child; Drug Combinations; Drug Therapy, Combination; Echinocandins; Female; Humans; Leukemia, Myeloid, Acute; Lipopeptides; Neutropenia; Peptides; Peptides, Cyclic; Phosphatidylcholines; Phosphatidylglycerols; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2003 |
Rapid improvement of disseminated aspergillosis with caspofungin/voriconazole combination in an adult leukemic patient.
Topics: Antifungal Agents; Aspergillosis; Caspofungin; Drug Therapy, Combination; Echinocandins; Humans; Leukemia, Myelomonocytic, Acute; Lipopeptides; Male; Middle Aged; Peptides; Peptides, Cyclic; Pyrimidines; Radiography; Treatment Outcome; Triazoles; Voriconazole | 2004 |
Case report: Invasive aspergillosis successfully treated with voriconazole without recurrence during subsequent bone marrow transplantation.
Topics: Adolescent; Antifungal Agents; Aspergillosis; Bone Marrow Transplantation; Dose-Response Relationship, Drug; Drug Administration Schedule; Follow-Up Studies; Fungemia; Humans; Immunocompromised Host; Infusions, Intravenous; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Risk Assessment; Treatment Outcome; Triazoles; Voriconazole | 2003 |
Salvage therapy with voriconazole for invasive fungal infections in patients failing or intolerant to standard antifungal therapy.
Topics: Adult; Aged; Antifungal Agents; Aspergillosis; Bone Marrow Transplantation; Child; Drug Resistance, Fungal; Female; Hematologic Neoplasms; Humans; Immunocompromised Host; Middle Aged; Mycoses; Neoplasms; Pyrimidines; Salvage Therapy; Transplantation; Treatment Failure; Triazoles; Voriconazole | 2003 |
Invasive aspergillosis: current and future challenges in diagnosis and therapy.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Clinical Trials as Topic; Humans; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2004 |
Novel effect of voriconazole on conidiation of Aspergillus species.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Humans; Pyrimidines; Spores, Fungal; Triazoles; Voriconazole | 2004 |
Successful treatment of invasive aspergillosis with oral voriconazole following intravenous liposomal amphotericin in a child with acute lymphoblastic leukemia.
Topics: Administration, Oral; Amphotericin B; Antifungal Agents; Aspergillosis; Child; Humans; Infusions, Intravenous; Liposomes; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Tomography, X-Ray Computed; Treatment Outcome; Triazoles; Voriconazole | 2004 |
[symbol: see text]Caspofungin and [symbol: see text]voriconazole for fungal infections.
Topics: Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Echinocandins; Humans; Lipopeptides; Mycoses; Peptides; Peptides, Cyclic; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles; Voriconazole | 2004 |
Activity of posaconazole combined with amphotericin B against Aspergillus flavus infection in mice: comparative studies in two laboratories.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus flavus; Colony Count, Microbial; Lung; Mice; Survival Analysis; Triazoles | 2004 |
Pleural diffusion of voriconazole in a patient with Aspergillus fumigatus empyema thoracis.
Topics: Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Diffusion; Empyema, Pleural; Humans; Male; Pleura; Pyrimidines; Triazoles; Voriconazole | 2004 |
Breakthrough zygomycosis after voriconazole treatment in recipients of hematopoietic stem-cell transplants.
Topics: Adult; Antifungal Agents; Aspergillosis; Drug Resistance, Fungal; Female; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid; Male; Middle Aged; Mycoses; Pyrimidines; Triazoles; Voriconazole; Zygomycosis | 2004 |
Aspergillus fumigatus empyema, arthritis, and calcaneal osteomyelitis in a lung transplant patient successfully treated with posaconazole.
Topics: Antifungal Agents; Arthritis, Infectious; Aspergillosis; Aspergillus fumigatus; Empyema; Humans; Lung Transplantation; Male; Middle Aged; Pulmonary Disease, Chronic Obstructive; Time Factors; Treatment Outcome; Triazoles | 2004 |
Secondary antifungal prophylaxis with voriconazole to adhere to scheduled treatment in leukemic patients and stem cell transplant recipients.
Topics: Adolescent; Adult; Antifungal Agents; Aspergillosis; Aspergillus; Candida; Candidiasis; Female; Graft vs Host Disease; Humans; Leukemia; Male; Middle Aged; Prognosis; Prospective Studies; Pyrimidines; Recurrence; Risk; Stem Cell Transplantation; Transplantation, Homologous; Triazoles; Voriconazole | 2004 |
Voriconazole for the treatment of disseminated nodular cutaneous aspergillosis in a patient affected by acute myeloid leukemia.
Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus flavus; Dermatomycoses; Female; Humans; Leukemia, Myeloid, Acute; Pyrimidines; Triazoles; Voriconazole | 2004 |
Successful treatment of concomitant pulmonary zygomycosis and aspergillosis with a combination of amphotericin B lipid complex, caspofungin, and voriconazole in a patient on immunosuppression for chronic graft-versus-host disease.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Caspofungin; Chronic Disease; Drug Therapy, Combination; Echinocandins; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Lipopeptides; Lung; Middle Aged; Peptides, Cyclic; Pyrimidines; Tomography, X-Ray Computed; Transplantation, Homologous; Treatment Outcome; Triazoles; Voriconazole; Zygomycosis | 2004 |
Histological examination of an eye with endogenous Aspergillus endophthalmitis treated with oral voriconazole: a case report.
Topics: Administration, Oral; Antifungal Agents; Aspergillosis; Endophthalmitis; Eye Enucleation; Eye Infections, Fungal; Fungemia; Humans; Male; Middle Aged; Pyrimidines; Triazoles; Voriconazole | 2004 |
Voriconazole: new preparation. Invasive aspergillosis: benefits to be confirmed.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Drug Interactions; Fusarium; Humans; Immunocompromised Host; Mycetoma; Mycoses; Pyrimidines; Scedosporium; Treatment Outcome; Triazoles | 2004 |
[Fulminant invasive fungal sinusitis in immunosuppressed hosts -- pathognomic presentation in MRI].
Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Ethmoid Sinusitis; Humans; Immunocompromised Host; Magnetic Resonance Imaging; Male; Mucor; Mucormycosis; Triazoles | 2004 |
Images in cardiovascular medicine. Left ventricular mass after treatment with chemotherapic drugs.
Topics: Acute Disease; Adult; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Aspergillosis, Allergic Bronchopulmonary; Aspergillus; Combined Modality Therapy; Echocardiography; Heart Septum; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Leukemia, Myeloid; Male; Myelodysplastic Syndromes; Pyrimidines; Triazoles; Ventricular Outflow Obstruction; Voriconazole | 2004 |
Safety and efficacy of caspofungin and liposomal amphotericin B, followed by voriconazole in young patients affected by refractory invasive mycosis.
Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus flavus; Aspergillus fumigatus; Caspofungin; Child; Drug Synergism; Drug Therapy, Combination; Echinocandins; Female; Geotrichosis; Hodgkin Disease; Humans; Leukemia, Myeloid, Acute; Lipopeptides; Liposomes; Male; Mycoses; Myelodysplastic Syndromes; Peptides; Peptides, Cyclic; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Survival Rate; Treatment Outcome; Triazoles; Voriconazole | 2004 |
Successful elimination of an invasive Aspergillus nidulans lung infection by voriconazole after failure of a combination of caspofungin and liposomal amphotericin B in a boy with chronic granulomatous disease.
Topics: Adolescent; Amphotericin B; Aspergillosis; Aspergillus nidulans; Caspofungin; Drug Therapy, Combination; Echinocandins; Follow-Up Studies; Granulomatous Disease, Chronic; Humans; Lipopeptides; Lung Diseases, Fungal; Male; Opportunistic Infections; Peptides; Peptides, Cyclic; Pyrimidines; Risk Assessment; Salvage Therapy; Treatment Outcome; Triazoles; Voriconazole | 2004 |
Deep sinus aspergillosis in a liver transplant recipient successfully treated with a combination of caspofungin and voriconazole.
Topics: Adult; Antifungal Agents; Aspergillosis; Caspofungin; Echinocandins; Female; Humans; Lipopeptides; Liver Transplantation; Peptides; Peptides, Cyclic; Pyrimidines; Sinusitis; Treatment Outcome; Triazoles; Voriconazole | 2004 |
Two cases of severe phototoxic reactions related to long-term outpatient treatment with voriconazole.
Topics: Adult; Ambulatory Care; Aspergillosis; Dermatitis, Phototoxic; Dose-Response Relationship, Drug; Drug Administration Schedule; Follow-Up Studies; Humans; Leg Dermatoses; Long-Term Care; Male; Middle Aged; Outpatients; Pyrimidines; Risk Assessment; Severity of Illness Index; Triazoles; Voriconazole | 2004 |
Challenges in designing animal studies to detect antagonism of polyene activity.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Polyenes; Research Design; Triazoles | 2004 |
Infections due to Aspergillus terreus: a multicenter retrospective analysis of 83 cases.
Topics: Antifungal Agents; Aspergillosis; Cohort Studies; Female; Graft vs Host Disease; Humans; Logistic Models; Male; Proportional Hazards Models; Pyrimidines; Retrospective Studies; Survival Rate; Triazoles; Voriconazole | 2004 |
Zygomycosis in neutropenic patients with past Aspergillus infection: a role for posaconazole?
Topics: Antifungal Agents; Aspergillosis; Humans; Neutropenia; Triazoles; Zygomycosis | 2004 |
Breakthrough fungal infections in stem cell transplant recipients receiving voriconazole.
Topics: Adult; Aspergillosis; Aspergillus; Candida glabrata; Candidiasis; Child; Drug Resistance, Fungal; Female; Fungemia; Fungi; Humans; Immunocompromised Host; Male; Microbial Sensitivity Tests; Middle Aged; Pyrimidines; Retrospective Studies; Stem Cell Transplantation; Triazoles; Voriconazole; Zygomycosis | 2004 |
Pharmacokinetics of voriconazole in the cerebrospinal fluid of an immunocompromised patient with a brain abscess due to Aspergillus fumigatus.
Topics: Aspergillosis; Aspergillus fumigatus; Brain Abscess; Cerebrospinal Fluid; Female; Humans; Immunocompromised Host; Middle Aged; Pyrimidines; Triazoles; Voriconazole | 2004 |
Diagnosing invasive aspergillosis during antifungal therapy by PCR analysis of blood samples.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Base Sequence; Bronchoalveolar Lavage Fluid; DNA Primers; DNA, Fungal; Humans; Leukemia; Middle Aged; Neoplasms; Polymerase Chain Reaction; Pyrimidines; Transplantation; Triazoles; Voriconazole | 2004 |
Efficacy of voriconazole plus amphotericin B or micafungin in a guinea-pig model of invasive pulmonary aspergillosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Colony Count, Microbial; Disease Models, Animal; Drug Therapy, Combination; Echinocandins; Female; Guinea Pigs; Lipopeptides; Lipoproteins; Lung; Lung Diseases, Fungal; Micafungin; Peptides, Cyclic; Pyrimidines; Survival Analysis; Triazoles; Voriconazole | 2004 |
Aspergillus terreus: an emerging amphotericin B-resistant opportunistic mold in patients with hematologic malignancies.
Topics: Adult; Aged; Amphotericin B; Aspergillosis; Aspergillus; Aspergillus fumigatus; Cross Infection; Drug Resistance, Fungal; Female; Humans; Leukemia; Male; Middle Aged; Neutropenia; Opportunistic Infections; Retrospective Studies; Risk Factors; Triazoles | 2004 |
Efficacy of posaconazole in a murine model of central nervous system aspergillosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Central Nervous System Fungal Infections; Male; Mice; Survival; Survival Analysis; Triazoles | 2004 |
Use of lung resection and voriconazole for successful treatment of invasive pulmonary Aspergillus ustus infection.
Topics: Adult; Antifungal Agents; Aspergillosis; Aspergillus; Humans; Lung Diseases, Fungal; Male; Pneumonectomy; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2004 |
Combination antifungal therapy for invasive aspergillosis.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Aspergillosis; Caspofungin; Drug Therapy, Combination; Echinocandins; Female; Humans; Lipopeptides; Male; Middle Aged; Opportunistic Infections; Peptides, Cyclic; Pyrimidines; Retrospective Studies; Salvage Therapy; Survival Analysis; Treatment Outcome; Triazoles; Voriconazole | 2004 |
Combination therapy for invasive aspergillosis.
Topics: Antifungal Agents; Aspergillosis; Caspofungin; Drug Therapy, Combination; Echinocandins; Humans; Lipopeptides; Opportunistic Infections; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2004 |
Adverse reactions to voriconazole.
Topics: Aged; Antifungal Agents; Aspergillosis; Humans; Male; Middle Aged; Pyrimidines; Triazoles; Voriconazole | 2004 |
Breakthrough zygomycosis during voriconazole treatment for invasive aspergillosis.
Topics: Antifungal Agents; Aspergillosis; Drug Resistance, Fungal; Humans; Leukemia, Myeloid, Acute; Lung Diseases, Fungal; Male; Middle Aged; Pyrimidines; Triazoles; Voriconazole; Zygomycosis | 2004 |
In vitro interactions between antifungals and immunosuppressants against Aspergillus fumigatus isolates from transplant and nontransplant patients.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Calcineurin Inhibitors; Caspofungin; Cyclosporine; Echinocandins; Humans; Immunosuppressive Agents; Lipopeptides; Organ Transplantation; Peptides, Cyclic; Pyrimidines; Tacrolimus; Triazoles; Voriconazole | 2004 |
Combined use of sirolimus and voriconazole in renal transplantation: a report of two cases.
Topics: Adult; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Candidiasis; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Lung Diseases, Fungal; Male; Middle Aged; Postoperative Complications; Pyrimidines; Sirolimus; Triazoles; Voriconazole | 2004 |
Superiority of voriconazole over amphotericin B in the treatment of invasive aspergillosis after heart transplantation.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Heart Transplantation; Humans; Lung Diseases, Fungal; Middle Aged; Myocardial Ischemia; Postoperative Complications; Pyrimidines; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2005 |
Emergence of invasive cerebral aspergillosis in an HIV-positive patient on voriconazole therapy.
Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Antiretroviral Therapy, Highly Active; Aspergillosis; Fatal Outcome; Humans; Male; Pyrimidines; Triazoles; Voriconazole | 2005 |
[Drugs used in prophylaxis and treatment of fungal infections in immunosuppressed children].
Topics: Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Child; Drug Resistance, Fungal; Echinocandins; Humans; Immunocompromised Host; Lipopeptides; Mycoses; Neoplasms; Peptides, Cyclic; Pyrimidines; Risk Factors; Triazoles; Voriconazole | 2004 |
Successful antifungal combination therapy with voriconazole and caspofungin.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Caspofungin; Child, Preschool; Drug Therapy, Combination; Echinocandins; Humans; Lipopeptides; Lung Diseases, Fungal; Male; Peptides, Cyclic; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Triazoles; Voriconazole | 2005 |
Economic evaluation of voriconazole compared with conventional amphotericin B for the primary treatment of aspergillosis in immunocompromised patients.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Cost Savings; Cost-Benefit Analysis; Deoxycholic Acid; Drug Combinations; Health Care Costs; Humans; Immunocompromised Host; Pyrimidines; Triazoles; Voriconazole | 2005 |
Successful treatment of disseminated aspergillosis with the combination of voriconazole, caspofungin, granulocyte transfusions, and surgery followed by allogeneic blood stem cell transplantation in a patient with primary failure of an autologous stem cell
Topics: Antifungal Agents; Aspergillosis; Caspofungin; Drug Therapy, Combination; Echinocandins; Granulocytes; Humans; Leukocyte Transfusion; Lipopeptides; Magnetic Resonance Imaging; Male; Melphalan; Middle Aged; Multiple Myeloma; Necrosis; Peptides, Cyclic; Pyrimidines; Radiography; Stem Cell Transplantation; Transplantation, Autologous; Transplantation, Homologous; Triazoles; Voriconazole | 2005 |
Combination antifungal therapy for invasive aspergillosis.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Caspofungin; Drug Therapy, Combination; Echinocandins; Humans; Lipopeptides; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2005 |
[Surveillance of invasive mold infections in lung transplant recipients: effect of antimycotic prophylaxis with itraconazole and voriconazole].
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Chemoprevention; Humans; Itraconazole; Lung Transplantation; Pyrimidines; Triazoles; Voriconazole | 2005 |
Increased frequency of non-fumigatus Aspergillus species in amphotericin B- or triazole-pre-exposed cancer patients with positive cultures for aspergilli.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Chemoprevention; Culture Media; Drug Resistance, Fungal; Humans; Microbial Sensitivity Tests; Neoplasms; Triazoles | 2005 |
Lack of efficacy of voriconazole therapy in 2 patients with pulmonary fungus balls.
Topics: Adult; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Female; Humans; Lung Diseases, Fungal; Male; Middle Aged; Paecilomyces; Pyrimidines; Treatment Failure; Triazoles; Voriconazole | 2005 |
Economic effects of aspergillosis management in high-risk patients.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Cost-Benefit Analysis; Hospitalization; Humans; Insurance, Health, Reimbursement; Pyrimidines; Triazoles; United States; Voriconazole | 2005 |
Rethinking the use of voriconazole therapeutic drug monitoring in allogeneic hematopoietic stem cell transplant recipients.
Topics: Antifungal Agents; Aspergillosis; Drug Monitoring; Female; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Male; Pyrimidines; Transplantation, Homologous; Triazoles; Voriconazole | 2005 |
Cost advantage of voriconazole over amphotericin B deoxycholate for primary treatment of invasive aspergillosis.
Topics: Administration, Oral; Amphotericin B; Antifungal Agents; Aspergillosis; Deoxycholic Acid; Drug Combinations; Economics, Pharmaceutical; Humans; Injections, Intravenous; Multicenter Studies as Topic; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles; Voriconazole | 2005 |
Improved outcome in central nervous system aspergillosis, using voriconazole treatment.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Central Nervous System Fungal Infections; Child; Child, Preschool; Female; Humans; Infant; Magnetic Resonance Imaging; Male; Middle Aged; Pyrimidines; Retrospective Studies; Risk Factors; Survival Rate; Treatment Outcome; Triazoles; Voriconazole | 2005 |
Treatment of disseminated aspergillosis with voriconazole/liposomal amphotericin B in a child with leukemia.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Burkitt Lymphoma; Child, Preschool; Humans; Male; Pyrimidines; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2005 |
Invasive pulmonary and cerebral aspergillosis in a patient with Weil's disease.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Brain Diseases; Drug Therapy, Combination; Humans; Lung Diseases, Fungal; Male; Middle Aged; Pyrimidines; Radiography; Treatment Outcome; Triazoles; Voriconazole; Weil Disease | 2005 |
Successful treatment of Aspergillus prosthetic valve endocarditis with oral voriconazole.
Topics: Adult; Antifungal Agents; Aspergillosis; Endocarditis; Heart Valve Prosthesis; Humans; Male; Pyrimidines; Triazoles; Voriconazole | 2005 |
Efficacy of caspofungin and voriconazole combinations in experimental aspergillosis.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Caspofungin; Chromatography, High Pressure Liquid; Drug Combinations; Drug Interactions; Echinocandins; Guinea Pigs; Kidney; Lipopeptides; Male; Microbial Sensitivity Tests; Peptides, Cyclic; Pyrimidines; Survival Analysis; Triazoles; Voriconazole | 2005 |
[Treatment of invasive fungal infections with voriconazole. Evaluation of experience with compassionate use of voriconazole in Spain].
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Child; Child, Preschool; Drug Resistance, Fungal; Female; Humans; Male; Middle Aged; Mycoses; Pyrimidines; Retrospective Studies; Spain; Treatment Outcome; Triazoles; Voriconazole | 2005 |
Epidemiology and outcome of infections due to Aspergillus terreus: 10-year single centre experience.
Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Austria; Caspofungin; Drug Resistance, Fungal; Echinocandins; Female; Genes, Fungal; Hematologic Neoplasms; Humans; Lipopeptides; Lung Diseases, Fungal; Male; Middle Aged; Opportunistic Infections; Organ Transplantation; Peptides, Cyclic; Prevalence; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole | 2005 |
Economic evaluation of voriconazole in the treatment of invasive aspergillosis in the Netherlands.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Cost-Benefit Analysis; Decision Trees; Humans; Markov Chains; Netherlands; Pyrimidines; Triazoles; Voriconazole | 2005 |
Voriconazole therapy in children with cystic fibrosis.
Topics: Adolescent; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Child; Child, Preschool; Cystic Fibrosis; Female; Humans; Lung Diseases, Fungal; Male; Pyrimidines; Retrospective Studies; Sputum; Statistics, Nonparametric; Treatment Outcome; Triazoles; Voriconazole | 2005 |
Retinal function assessed by ERG before and after induction of ocular aspergillosis and treatment by the anti-fungal, micafungin, in rabbits.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Disease Models, Animal; Echinocandins; Electroretinography; Endophthalmitis; Eye Infections, Fungal; Follow-Up Studies; Lipopeptides; Lipoproteins; Micafungin; Ophthalmoscopy; Peptides, Cyclic; Pyrimidines; Rabbits; Retina; Triazoles; Vitreous Body; Voriconazole | 2005 |
Successful treatment of aspergillus brain abscess in a child with acute lymphoblastic leukemia and liver failure.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Brain Abscess; Combined Modality Therapy; Drug Therapy, Combination; Female; Humans; Liver Failure, Acute; Magnetic Resonance Imaging; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Remission Induction; Triazoles; Voriconazole | 2005 |
To treat or not to treat with antifungal agents?
Topics: Adolescent; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Child; Child, Preschool; Cystic Fibrosis; Female; Humans; Lung Diseases, Fungal; Male; Pyrimidines; Sputum; Triazoles; Voriconazole | 2005 |
Breakthrough invasive infection due to Debaryomyces hansenii (teleomorph Candida famata) and Scopulariopsis brevicaulis in a stem cell transplant patient receiving liposomal amphotericin B and caspofungin for suspected aspergillosis.
Topics: Aged; Amphotericin B; Anemia, Aplastic; Ascomycota; Aspergillosis; Body Fluids; Caspofungin; Drug Therapy, Combination; Echinocandins; Fatal Outcome; Fungemia; Hematopoietic Stem Cell Transplantation; Humans; Lipopeptides; Male; Mycoses; Peptides, Cyclic; Pyrimidines; Saccharomycetales; Shock, Septic; Triazoles; Voriconazole | 2005 |
Hydroxylated analogues of the orally active broad spectrum antifungal, Sch 51048 (1), and the discovery of posaconazole [Sch 56592; 2 or (S,S)-5].
Topics: Alcohols; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Chemistry, Pharmaceutical; Dose-Response Relationship, Drug; Drug Design; Drug Evaluation, Preclinical; Haplorhini; Humans; Immunosuppressive Agents; Mice; Models, Chemical; Time Factors; Triazoles | 2006 |
[Aspergillus bronchitis and aspergilloma treated successfully with voriconazole].
Topics: Antifungal Agents; Aspergillosis; Bronchitis; Humans; Lung Diseases, Fungal; Male; Middle Aged; Pyrimidines; Triazoles; Voriconazole | 2005 |
Severe pustular eruption associated with imatinib and voriconazole in a patient with chronic myeloid leukemia.
Topics: Adult; Antifungal Agents; Antineoplastic Agents; Aspergillosis; Benzamides; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Drug Eruptions; Drug Interactions; Enzyme Inhibitors; Exanthema; Humans; Imatinib Mesylate; Irritants; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lung Diseases, Fungal; Male; Piperazines; Protein-Tyrosine Kinases; Pyrimidines; Triazoles; Voriconazole | 2005 |
Mediastinal mass due to Aspergillus fumigatus after lung transplantation: a case report.
Topics: Adult; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Caspofungin; Cystic Fibrosis; Drug Therapy, Combination; Echinocandins; Fatal Outcome; Female; Humans; Immunocompromised Host; Lipopeptides; Lung Transplantation; Magnetic Resonance Imaging; Mediastinal Diseases; Peptides, Cyclic; Postoperative Complications; Pyrimidines; Recurrence; Thoracoscopy; Triazoles; Voriconazole | 2005 |
Comparative efficacies of conventional amphotericin b, liposomal amphotericin B (AmBisome), caspofungin, micafungin, and voriconazole alone and in combination against experimental murine central nervous system aspergillosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Caspofungin; Central Nervous System Fungal Infections; Disease Models, Animal; Drug Combinations; Drug Therapy, Combination; Echinocandins; Lipopeptides; Lipoproteins; Liposomes; Micafungin; Mice; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2005 |
Aspergillus flavus scleritis: successful treatment with voriconazole and caspofungin.
Topics: Antifungal Agents; Aspergillosis; Aspergillus flavus; Caspofungin; Echinocandins; Eye Infections, Fungal; Female; Humans; Lipopeptides; Middle Aged; Peptides, Cyclic; Pyrimidines; Scleritis; Treatment Outcome; Triazoles; Voriconazole | 2005 |
Life-threatening toxic epidermal necrolysis during voriconazole therapy for invasive aspergillosis after chemotherapy.
Topics: Adult; Anticonvulsants; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Breast Neoplasms; Drug Interactions; Humans; Lung Diseases, Fungal; Male; Phenytoin; Pyrimidines; Stevens-Johnson Syndrome; Triazoles; Voriconazole | 2006 |
Voriconazole.
Topics: Antifungal Agents; Aspergillosis; Candidiasis; Drug Interactions; Humans; Pyrimidines; Triazoles; Voriconazole | 2005 |
The efficacy and tolerability of voriconazole in the treatment of chronic cavitary pulmonary aspergillosis.
Topics: Antifungal Agents; Aspergillosis; Chronic Disease; Female; Humans; Lung Diseases, Fungal; Male; Middle Aged; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole | 2006 |
[Invasive multisystemic aspergillosis in an immunocompetent child: case report].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Child; Deoxycholic Acid; Drug Combinations; Fatal Outcome; Humans; Immunocompromised Host; Male; Pyrimidines; Triazoles; Voriconazole | 2006 |
[Voriconazole at Saint Louis Hospital (Paris): Analysis of two-years of compassionate use].
Topics: Acute Disease; Antifungal Agents; Aspergillosis; Candidiasis; Cohort Studies; Fusarium; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Leukemia; Mycoses; Pyrimidines; Retrospective Studies; Time Factors; Treatment Outcome; Triazoles; Voriconazole | 2006 |
Pericardial and pleural diffusion of voriconazole during disseminated invasive aspergillosis: report of a case with successful outcome.
Topics: Antifungal Agents; Aspergillosis; France; Humans; Immunocompromised Host; Male; Middle Aged; Outcome Assessment, Health Care; Pericardium; Pleura; Pyrimidines; Triazoles; Ultrasonography; Voriconazole | 2006 |
Sequential or combination antifungal therapy with voriconazole and liposomal amphotericin B in a Guinea pig model of invasive aspergillosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Disease Models, Animal; Drug Therapy, Combination; Guinea Pigs; Liposomes; Male; Pyrimidines; Triazoles; Voriconazole | 2006 |
Aspergillus fumigatus tricuspid native valve endocarditis in a non-intravenous drug user.
Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Combined Modality Therapy; Endocarditis; Heart Valve Diseases; Humans; Male; Pulmonary Embolism; Pyrimidines; Sepsis; Triazoles; Tricuspid Valve; Voriconazole | 2006 |
[A case of resistant pulmonary and cerebral aspergillosis successfully treated with voriconazole].
Topics: Antifungal Agents; Aspergillosis; Diagnosis, Differential; Humans; Lung Diseases, Fungal; Magnetic Resonance Imaging; Male; Middle Aged; Neuroaspergillosis; Pyrimidines; Telencephalon; Triazoles; Voriconazole | 2006 |
Incidence of invasive aspergillosis among allogeneic hematopoietic stem cell transplant patients receiving voriconazole prophylaxis.
Topics: Adult; Antifungal Agents; Aspergillosis; Chi-Square Distribution; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Middle Aged; Pyrimidines; Retrospective Studies; Transplantation, Homologous; Triazoles; Voriconazole | 2006 |
Aspergillus brain abscess in a patient with acute myeloid leukaemia successfully treated with voriconazole.
Topics: Adult; Aspergillosis; Aspergillus fumigatus; Brain Abscess; Central Nervous System Fungal Infections; Humans; Leukemia, Erythroblastic, Acute; Male; Pyrimidines; Telencephalon; Triazoles; Voriconazole | 2006 |
Nodular erythema as early sign of systemic aspergillosis.
Topics: Adult; Antifungal Agents; Aspergillosis; Diagnosis, Differential; Erythema Nodosum; Humans; Immunocompromised Host; Male; Pyrimidines; Triazoles; Voriconazole | 2006 |
Intravitreal voriconazole for the treatment of endogenous Aspergillus endophthalmitis.
Topics: Adult; Antifungal Agents; Aspergillosis; Endophthalmitis; Eye Infections, Fungal; Female; Humans; Immunosuppressive Agents; Injections; Lung Transplantation; Opportunistic Infections; Pyrimidines; Triazoles; Visual Acuity; Vitrectomy; Vitreous Body; Voriconazole | 2006 |
In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Candida; Candidiasis; Cryptococcosis; Cryptococcus; Drug Resistance, Fungal; Fluconazole; Fungi; Humans; In Vitro Techniques; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2006 |
Unclear fever 7 weeks after renal transplantation in a 56-year-old patient.
Topics: Abscess; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Biopsy, Fine-Needle; Caspofungin; Contraindications; Cyclosporine; Delayed Graft Function; Drug Interactions; Echinocandins; Fever of Unknown Origin; Gram-Negative Bacterial Infections; Humans; Immunocompromised Host; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Lipopeptides; Male; Middle Aged; Mycophenolic Acid; Peptides, Cyclic; Postoperative Complications; Prednisone; Pyrimidines; Radionuclide Imaging; Stenotrophomonas maltophilia; Surgical Wound Infection; Thyroiditis; Triazoles; Ultrasonography; Voriconazole | 2006 |
Primary hepatic invasive aspergillosis with progression after rituximab therapy for a post transplantation lymphoproliferative disorder.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antifungal Agents; Antineoplastic Agents; Aspergillosis; Chemical and Drug Induced Liver Injury; Fatal Outcome; Female; Galactose; Graft vs Host Disease; Humans; Liver Diseases; Lymphoproliferative Disorders; Mannans; Middle Aged; Pyrimidines; Rituximab; Splenic Diseases; Stem Cell Transplantation; Transplantation, Homologous; Triazoles; Voriconazole | 2006 |
Efficacy of Abelcet alone, or in combination therapy, against experimental central nervous system aspergillosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Brain; Central Nervous System Infections; Colony Count, Microbial; Disease Models, Animal; Drug Combinations; Drug Therapy, Combination; Kidney; Mice; Phosphatidylcholines; Phosphatidylglycerols; Pyrimidines; Survival Analysis; Triazoles; Voriconazole | 2006 |
Amphotericin B is still the drug of choice for invasive aspergillosis.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Humans; Lung Diseases, Fungal; Pyrimidines; Research Design; Triazoles; Voriconazole | 2006 |
Interaction between posaconazole and caspofungin in concomitant treatment of mice with systemic Aspergillus infection.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus flavus; Aspergillus fumigatus; Caspofungin; Drug Interactions; Drug Therapy, Combination; Echinocandins; Lipopeptides; Male; Mice; Microbial Sensitivity Tests; Peptides, Cyclic; Triazoles | 2006 |
Topical voriconazole solution for cutaneous aspergillosis in a pediatric patient after bone marrow transplant.
Topics: Administration, Cutaneous; Adult; Amphotericin B; Anemia, Aplastic; Antifungal Agents; Aspergillosis; Aspergillus flavus; Bone Marrow Transplantation; Combined Modality Therapy; Debridement; Dermatomycoses; Disease Susceptibility; Female; Graft vs Host Disease; Humans; Immunocompromised Host; Injections, Subcutaneous; Nystatin; Postoperative Complications; Pyrimidines; Skin; Transplantation, Homologous; Triazoles; Voriconazole | 2006 |
Radiological resolution of cavitating Aspergillus fumigatus infection following treatment with oral voriconazole in two lung transplant recipients.
Topics: Administration, Oral; Adult; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Female; Humans; Lung Diseases, Fungal; Lung Transplantation; Male; Middle Aged; Pyrimidines; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2006 |
Successful treatment of breakthrough Trichosporon asahii fungemia with voriconazole in a patient with acute myeloid leukemia.
Topics: Acute Disease; Antifungal Agents; Aspergillosis; Echinocandins; Fungemia; Humans; Leukemia, Myeloid; Lipopeptides; Lipoproteins; Male; Micafungin; Middle Aged; Mycoses; Peptides, Cyclic; Pyrimidines; Triazoles; Trichosporon; Voriconazole | 2006 |
A case of pulmonary aspergillosis with lack of response to caspofungin.
Topics: Acute Disease; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Bone Marrow Diseases; Candidiasis; Caspofungin; Combined Modality Therapy; Contraindications; Echinocandins; Fatal Outcome; Female; Hematopoietic Stem Cell Transplantation; Hepatitis; Humans; Immunocompromised Host; Immunosuppressive Agents; Leukemia, Myeloid; Lipopeptides; Lung Diseases, Fungal; Middle Aged; Peptides, Cyclic; Postoperative Complications; Pyrimidines; Splenic Diseases; Triazoles; Voriconazole | 2006 |
Combination antifungal therapy in solid organ transplant recipients.
Topics: Antifungal Agents; Aspergillosis; Drug Therapy, Combination; Humans; Kidney Transplantation; Liver Transplantation; Organ Transplantation; Postoperative Complications; Pyrimidines; Triazoles; Voriconazole | 2006 |
Severe primary cutaneous aspergillosis refractory to amphotericin B and the successful treatment with systemic voriconazole in two premature infants with extremely low birth weight.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Dermatomycoses; Drug Resistance, Fungal; Female; Humans; Infant, Extremely Low Birth Weight; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Male; Pyrimidines; Triazoles; Voriconazole | 2006 |
Aspergillus infection limited to renal allograft: case report and review of literature.
Topics: Adult; Aspergillosis; Aspergillus; Female; Humans; Immunosuppression Therapy; Kidney Transplantation; Pyrimidines; Triazoles; Voriconazole | 2006 |
Disseminated invasive aspergillosis in a patient with acute leukaemia.
Topics: Acute Kidney Injury; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Bacteremia; Caspofungin; Chlamydophila Infections; Chlamydophila pneumoniae; Doxorubicin; Drug Resistance, Multiple, Fungal; Drug Therapy, Combination; Echinocandins; Fatal Outcome; Female; Humans; Immunocompromised Host; Lipopeptides; Liposomes; Lung Diseases, Fungal; Medical Futility; Methotrexate; Middle Aged; Neuroaspergillosis; Peptides, Cyclic; Pneumonia, Bacterial; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Streptococcal Infections; Triazoles; Vincristine; Voriconazole | 2006 |
Aspergillus meningitis following spinal anaesthesia for caesarean section in Colombo, Sri Lanka.
Topics: Abducens Nerve Diseases; Adult; Anesthesia, Obstetrical; Anesthesia, Spinal; Antifungal Agents; Aspergillosis; Brain; Cesarean Section; Diabetes, Gestational; Fatal Outcome; Female; Fluconazole; Glasgow Coma Scale; Humans; Meningitis, Fungal; Pregnancy; Pyrimidines; Respiration, Artificial; Sri Lanka; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2007 |
Susceptibility of fungi isolated from the respiratory tract of falcons to amphotericin B, itraconazole and voriconazole.
Topics: Air Sacs; Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus; Bird Diseases; Colony Count, Microbial; Dose-Response Relationship, Drug; Drug Resistance, Fungal; Falconiformes; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Species Specificity; Treatment Outcome; Triazoles; Voriconazole | 2006 |
Triazole-polyene antagonism in experimental invasive pulmonary aspergillosis: in vitro and in vivo correlation.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Drug Antagonism; Drug Therapy, Combination; Humans; Liposomes; Lung Diseases, Fungal; Microbial Sensitivity Tests; Models, Biological; Polyenes; Rabbits; Thiazoles; Triazoles | 2006 |
Posaconazole for treatment of refractory invasive fungal disease.
Topics: Antifungal Agents; Aspergillosis; Aspergillus nidulans; Central Nervous System Fungal Infections; Child; Child, Preschool; Diabetes Mellitus, Type 1; Drug Resistance, Fungal; Female; Granulomatous Disease, Chronic; Humans; Immunocompromised Host; Lung Diseases, Fungal; Male; Mucormycosis; Rhizopus; Sinusitis; Treatment Outcome; Triazoles | 2006 |
Use of voriconazole in a patient with aspergilloma caused by an itraconazole-resistant strain of Aspergillus fumigatus.
Topics: Adult; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Drug Resistance, Fungal; Humans; Hydroxycorticosteroids; Itraconazole; Lung Diseases, Fungal; Male; Microbial Sensitivity Tests; Pyrimidines; Sarcoidosis; Treatment Outcome; Triazoles; Voriconazole | 2006 |
Successful treatment of an Aspergillus fumigatus Infection with voriconazole via a nasogastric tube.
Topics: Administration, Intranasal; Aged; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Female; Humans; Intubation, Gastrointestinal; Lung Diseases, Fungal; Pyrimidines; Triazoles; Voriconazole | 2006 |
Severe infectious complications in a patient treated with rituximab for idiopathic thrombocytopenic purpura.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antifungal Agents; Aspergillosis; Aspergillus niger; Humans; Immunologic Factors; Male; Purpura, Thrombocytopenic, Idiopathic; Pyrimidines; Rituximab; Treatment Outcome; Triazoles; Voriconazole | 2007 |
Multi-azole resistance in Aspergillus fumigatus.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Caspofungin; Cytochrome P-450 Enzyme System; Drug Resistance, Multiple, Fungal; Echinocandins; Fungal Proteins; Humans; Itraconazole; Lipopeptides; Lung Diseases, Fungal; Male; Microbial Sensitivity Tests; Middle Aged; Mutation, Missense; Peptides, Cyclic; Pyrimidines; Thiazoles; Triazoles; Voriconazole | 2006 |
Voriconazole prophylaxis in lung transplant recipients.
Topics: Antifungal Agents; Aspergillosis; Chemoprevention; Female; Humans; Lung Transplantation; Male; Middle Aged; Mycoses; Postoperative Complications; Probability; Pyrimidines; Retrospective Studies; Survival Analysis; Time Factors; Triazoles; Voriconazole | 2006 |
Comparative in vivo activity of BAL4815, the active component of the prodrug BAL8557, in a neutropenic murine model of disseminated Aspergillus flavus.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus flavus; Brain; Caspofungin; Colony Count, Microbial; Disease Models, Animal; Echinocandins; Fluorescence Resonance Energy Transfer; Immunocompromised Host; Immunosuppression Therapy; Itraconazole; Kidney; Lipopeptides; Liver; Lung; Male; Mice; Neutropenia; Nitriles; Peptides, Cyclic; Polymerase Chain Reaction; Pyrimidines; Survival Analysis; Triazoles; Voriconazole | 2006 |
Successful early voriconazole treatment of Aspergillus infection in two non immunocompromised patients in Intensive Care Unit.
Topics: Antifungal Agents; Aspergillosis; Critical Care; Humans; Male; Middle Aged; Pyrimidines; Triazoles; Voriconazole | 2007 |
Invasive aspergillosis: is treatment with "inexpensive" amphotericin B cost saving if "expensive" voriconazole is only used on demand?
Topics: Acute Kidney Injury; Amphotericin B; Antifungal Agents; Aspergillosis; Cost-Benefit Analysis; Decision Trees; Humans; Models, Economic; Pyrimidines; Triazoles; Voriconazole | 2006 |
[Successful treatment by voliconazole for pulmonary and adductor magnus muscle aspergillosis induced by immunosuppressive therapy for hypersensitivity pneumonia].
Topics: Aged; Alveolitis, Extrinsic Allergic; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cyclosporine; Female; Humans; Immunocompromised Host; Immunosuppressive Agents; Lung Diseases, Fungal; Myositis; Opportunistic Infections; Prednisolone; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2006 |
Posaconazole enhances the activity of amphotericin B against Aspergillus hyphae in vitro.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Drug Synergism; Drug Therapy, Combination; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2007 |
Invasive sphenoidal aspergillosis: successful treatment with sphenoidotomy and voriconazole.
Topics: Adult; Aged; Antifungal Agents; Aspergillosis; Combined Modality Therapy; Endoscopy; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Otorhinolaryngologic Surgical Procedures; Pyrimidines; Severity of Illness Index; Sphenoid Sinus; Sphenoid Sinusitis; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2007 |
Susceptibility of environmental versus clinical strains of pathogenic Aspergillus.
Topics: Air Microbiology; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Aspergillus flavus; Aspergillus fumigatus; Caspofungin; Cross Infection; Echinocandins; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole; Water Microbiology | 2007 |
Quinupristin/dalfopristin and voriconazole controlled Staphylococcus epidermidis pneumonia and chronic necrotizing aspergillosis in a patient with severe lung degradation consequent to multiple treatments for Hodgkin's lymphoma.
Topics: Adult; Anti-Bacterial Agents; Antifungal Agents; Aspergillosis; Aspergillus niger; Chronic Disease; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Lung Diseases, Fungal; Lymphatic Irradiation; Necrosis; Pneumonia, Bacterial; Pyrimidines; Radiation Injuries; Radiography; Staphylococcal Infections; Staphylococcus epidermidis; Triazoles; Virginiamycin; Voriconazole | 2006 |
Prophylaxis and aspergillosis--has the principle been proven?
Topics: Antifungal Agents; Aspergillosis; Fluconazole; Graft vs Host Disease; Humans; Itraconazole; Mycoses; Neutropenia; Opportunistic Infections; Triazoles | 2007 |
Economic evaluation of voriconazole versus caspofungin for the treatment of invasive aspergillosis in Spain.
Topics: Administration, Oral; Antifungal Agents; Aspergillosis; Body Weight; Caspofungin; Cost-Benefit Analysis; Echinocandins; Health Care Costs; Humans; Injections, Intravenous; Lipopeptides; Multivariate Analysis; Peptides, Cyclic; Pyrimidines; Severity of Illness Index; Spain; Treatment Outcome; Triazoles; Voriconazole | 2007 |
Torsades de pointes associated with voriconazole use.
Topics: Administration, Oral; Anthracyclines; Antifungal Agents; Antineoplastic Agents; Aspergillosis; Cardiomyopathies; Dermatomycoses; Drug Synergism; Female; Humans; Injections, Intravenous; Leukemia, Myeloid, Acute; Middle Aged; Pyrimidines; Risk Factors; Torsades de Pointes; Triazoles; Voriconazole | 2007 |
Posaconazole.
Topics: Antifungal Agents; Aspergillosis; Europe; Humans; Mycoses; Triazoles | 2007 |
Voriconazole concentrations in synovial fluid and bone tissues.
Topics: Aged, 80 and over; Antifungal Agents; Arthritis, Infectious; Aspergillosis; Aspergillus fumigatus; Bone and Bones; Chromatography, High Pressure Liquid; Female; Humans; Microbial Sensitivity Tests; Pyrimidines; Synovial Fluid; Triazoles; Voriconazole | 2007 |
Invasive Aspergillus fumigatus associated with liver and bone involvement in a patient with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Bone Diseases; Humans; Liver Diseases; Male; Pyrimidines; Triazoles; Voriconazole | 2007 |
Posaconazole.
Topics: Administration, Oral; Antifungal Agents; Aspergillosis; Candidiasis; Capsules; Drug Approval; Drug Design; Economics, Pharmaceutical; Fluconazole; Humans; Injections, Intravenous; Itraconazole; Molecular Structure; Randomized Controlled Trials as Topic; Suspensions; Technology, Pharmaceutical; Treatment Failure; Triazoles; United States | 2007 |
Chronic invasive sinus aspergillosis in an immunocompetent patient: a case report.
Topics: Adult; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Chronic Disease; Endoscopy; Humans; Immunocompetence; Male; Paranasal Sinus Diseases; Pyrimidines; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2007 |
Multiple-triazole-resistant aspergillosis.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Drug Resistance, Multiple, Fungal; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mutation, Missense; Pyrimidines; Tandem Repeat Sequences; Triazoles; Voriconazole | 2007 |
Successful medical treatment of cutaneous aspergillosis in a premature infant using liposomal amphotericin B, voriconazole and micafungin.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Dermatomycoses; Echinocandins; Humans; Infant, Extremely Low Birth Weight; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Lipopeptides; Lipoproteins; Micafungin; Peptides, Cyclic; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2007 |
Successful treatment with voriconazole of Aspergillus meningitis in a patient with acute myeloid leukemia.
Topics: Acute Disease; Adult; Aspergillosis; Aspergillus; Humans; Leukemia, Myeloid; Male; Meningitis, Fungal; Pyrimidines; Sarcoma, Myeloid; Thyroid Neoplasms; Treatment Outcome; Triazoles; Voriconazole | 2007 |
Successful management of Aspergillus liver abscess in a patient with necrotizing fasciitis.
Topics: Adult; Antifungal Agents; Aspergillosis; Caspofungin; Echinocandins; Fasciitis, Necrotizing; Female; Humans; Lipopeptides; Liver Abscess; Peptides, Cyclic; Pregnancy; Pyrimidines; Triazoles; Voriconazole | 2007 |
Diagnostic and therapeutic challenge of Aspergillus flavus scleritis.
Topics: Antifungal Agents; Aspergillosis; Aspergillus flavus; Caspofungin; Drug Therapy, Combination; Echinocandins; Eye Infections, Fungal; Female; Humans; Lipopeptides; Middle Aged; Peptides, Cyclic; Pyrimidines; Scleritis; Substance Abuse, Intravenous; Triazoles; Voriconazole | 2007 |
Posaconazole prophylaxis in hematologic cancer.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Humans; Mucositis; Mycoses; Opportunistic Infections; Oxidoreductases; Point Mutation; Pyrimidines; Sterol 14-Demethylase; Triazoles; Voriconazole | 2007 |
Economic evaluation of targeted treatments of invasive aspergillosis in adult haematopoietic stem cell transplant recipients in the Netherlands: a modelling approach.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Caspofungin; Cost-Benefit Analysis; Costs and Cost Analysis; Data Interpretation, Statistical; Decision Trees; Drug Combinations; Echinocandins; Hematopoietic Stem Cell Transplantation; Humans; Lipopeptides; Models, Economic; Models, Statistical; Netherlands; Pyrimidines; Reproducibility of Results; Survival Analysis; Triazoles; Voriconazole | 2007 |
[Breakthrough pulmonary mucormycosis during voriconazole treatment after reduced-intensity cord blood transplantation for a patient with acute myeloid leukemia].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Cord Blood Stem Cell Transplantation; Echinocandins; Fatal Outcome; Graft vs Host Disease; Humans; Immunocompromised Host; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Lipopeptides; Lipoproteins; Lung Diseases, Fungal; Male; Micafungin; Middle Aged; Mucormycosis; Peptides, Cyclic; Pyrimidines; Transplantation Conditioning; Triazoles; Voriconazole | 2007 |
[A case of orbital apex syndrome caused by localized invasive aspergillosis successfully treated with voriconazole].
Topics: Aged; Antifungal Agents; Aspergillosis; Humans; Male; Orbital Diseases; Pyrimidines; Triazoles; Voriconazole | 2007 |
Breakthrough fungal infections after allogeneic hematopoietic stem cell transplantation in patients on prophylactic voriconazole.
Topics: Antifungal Agents; Aspergillosis; Candidiasis; Data Collection; Drug Evaluation; Female; Hematopoietic Stem Cell Transplantation; Humans; Male; Mycoses; Premedication; Pyrimidines; Transplantation, Homologous; Triazoles; Voriconazole; Zygomycosis | 2007 |
Caspofungin-resistant Aspergillus flavus after heart transplantation and mechanical circulatory support: a case report.
Topics: Antifungal Agents; Aspergillosis; Aspergillus flavus; Caspofungin; Drug Resistance, Fungal; Echinocandins; Extracorporeal Membrane Oxygenation; Female; Heart Transplantation; Heart-Assist Devices; Humans; Lipopeptides; Middle Aged; Pyrimidines; Triazoles; Voriconazole | 2008 |
The use of voriconazole in the treatment of Aspergillus fumigatus keratitis.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Humans; Keratitis; Male; Middle Aged; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2007 |
[Case of pulmonary aspergillosis associated with inappropriate antidiuretic hormone syndrome caused by voriconazole therapy].
Topics: Aged; Antifungal Agents; Aspergillosis; Chronic Disease; Cytochrome P-450 Enzyme System; Humans; Lung Diseases, Fungal; Male; Pituitary ACTH Hypersecretion; Polymorphism, Genetic; Pyrimidines; Triazoles; Voriconazole | 2007 |
Voriconazole: a broad spectrum triazole for the treatment of serious and invasive fungal infections.
Topics: Administration, Oral; Antifungal Agents; Aspergillosis; Candidiasis; Drug Evaluation; Drug Resistance, Fungal; Fluconazole; Humans; Injections, Intravenous; Molecular Structure; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2006 |
Images in HIV/AIDS. Invasive aspergillosis presenting as a neck mass in a person with HIV/AIDS.
Topics: Adult; Antifungal Agents; Antiretroviral Therapy, Highly Active; Aspergillosis; Fatal Outcome; HIV Infections; Humans; Male; Neck; Pyrimidines; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2007 |
Posaconazole for invasive aspergillosis?
Topics: Antifungal Agents; Aspergillosis; Case-Control Studies; Humans; Reproducibility of Results; Salvage Therapy; Selection Bias; Triazoles | 2007 |
Lack of cross-hepatotoxicity between voriconazole and posaconazole.
Topics: Aged; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Chemical and Drug Induced Liver Injury; Humans; Pyrimidines; Triazoles; Voriconazole | 2007 |
Plasma concentrations of voriconazole in falcons.
Topics: Animals; Antifungal Agents; Aspergillosis; Biological Availability; Bird Diseases; Dose-Response Relationship, Drug; Falconiformes; Female; Male; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2007 |
Successful treatment of refractory chronic necrotizing pulmonary aspergillosis with micafungin.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Chronic Disease; Drug Resistance, Multiple, Fungal; Echinocandins; Humans; Lipopeptides; Lipoproteins; Lung Diseases, Fungal; Male; Micafungin; Middle Aged; Necrosis; Pyrimidines; Radiography; Triazoles; Voriconazole | 2007 |
Comparison of 2 studies of treatment of invasive aspergillosis.
Topics: Amphotericin B; Aspergillosis; Humans; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2007 |
Aspergillus fumigatus keratitis following laser in situ keratomileusis.
Topics: Adult; Amputation, Surgical; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Corneal Ulcer; Debridement; Eye Infections, Fungal; Female; Humans; Keratomileusis, Laser In Situ; Microbial Sensitivity Tests; Pyrimidines; Surgical Flaps; Triazoles; Voriconazole | 2007 |
Secondary prophylaxis with voriconazole in a leukemic patient with pulmonary aspergillosis.
Topics: Antifungal Agents; Aspergillosis; Child, Preschool; Female; Humans; Immunocompromised Host; Leukemia; Lung Diseases, Fungal; Pyrimidines; Triazoles; Voriconazole | 2007 |
In vitro susceptibilities of Aspergillus spp. causing otomycosis to amphotericin B, voriconazole and itraconazole.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Drug Resistance, Fungal; Ear Diseases; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2007 |
Aspergillus fumigatus-related spondylodiscitis in a heart transplant patient successfully treated with voriconazole.
Topics: Adolescent; Antifungal Agents; Antilymphocyte Serum; Aspergillosis; Aspergillus fumigatus; Discitis; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Postoperative Complications; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2007 |
[Case of invasive sino-orbital aspergillosis developing orbital apex syndrome].
Topics: Aged; Antifungal Agents; Aspergillosis; Cavernous Sinus; Cranial Nerve Diseases; Female; Headache; Humans; Orbit; Orbital Diseases; Otorhinolaryngologic Surgical Procedures; Paranasal Sinus Diseases; Pyrimidines; Syndrome; Treatment Outcome; Triazoles; Vision Disorders; Voriconazole | 2007 |
Invasive tracheal aspergillosis treated successfully with voriconazole: clinical report and review of the literature.
Topics: Adult; Antifungal Agents; Aspergillosis; Aspergillus flavus; Fatal Outcome; Female; Humans; Laryngoscopy; Leukemia, Myeloid, Acute; Opportunistic Infections; Pyrimidines; Tracheitis; Triazoles; Voriconazole | 2007 |
Breakthrough invasive aspergillosis in allogeneic haematopoietic stem cell transplant recipients treated with caspofungin.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Caspofungin; Drug Resistance, Fungal; Echinocandins; Hematopoietic Stem Cell Transplantation; Humans; Lipopeptides; Pyrimidines; Transplantation, Homologous; Triazoles; Voriconazole | 2007 |
Adjuvant endobronchial amphotericin B for refractory invasive pulmonary aspergillosis: evidence is scarce but promise does exist.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Caspofungin; Chemotherapy, Adjuvant; Drug Evaluation; Drug Therapy, Combination; Echinocandins; Humans; Lipopeptides; Lung Diseases, Fungal; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2007 |
Comparative cost-effectiveness of voriconazole and amphotericin B in treatment of invasive pulmonary aspergillosis.
Topics: Amphotericin B; Aspergillosis; Cost-Benefit Analysis; Decision Trees; Humans; Lung Diseases, Fungal; Models, Economic; Pyrimidines; Survival Rate; Triazoles; Voriconazole | 2007 |
A case of successful resection after long-term medical treatment of invasive pulmonary aspergillosis following living donor liver transplantation.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Female; Humans; Liver Transplantation; Living Donors; Lung Diseases, Fungal; Middle Aged; Postoperative Complications; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2007 |
Improving outcomes of acute invasive Aspergillus rhinosinusitis in patients with hematologic malignancies or aplastic anemia: the role of voriconazole.
Topics: Acute Disease; Adolescent; Adult; Aged; Anemia, Aplastic; Aspergillosis; Child; Cohort Studies; Female; Hematologic Neoplasms; Humans; Male; Middle Aged; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2008 |
Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes.
Topics: Adult; Aged; Antifungal Agents; Aspergillosis; Candidiasis; Chromatography, High Pressure Liquid; Drug Monitoring; Female; Humans; Male; Middle Aged; Mycoses; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole | 2008 |
[Successful treatment by voriconazole for pulmonary aspergilloma of elderly patient].
Topics: Aged; Antifungal Agents; Aspergillosis; Humans; Lung Diseases, Fungal; Male; Pyrimidines; Triazoles; Voriconazole | 2007 |
Treatment of scedosporiosis with voriconazole: clinical experience with 107 patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Child; Child, Preschool; Clinical Trials as Topic; Female; Health Surveys; Humans; Infant; Male; Middle Aged; Pyrimidines; Scedosporium; Treatment Outcome; Triazoles; Voriconazole | 2008 |
The pharmacokinetic profile of voriconazole during continuous high-volume venovenous hemofiltration in a critically ill patient.
Topics: Acute Kidney Injury; Aged; Antifungal Agents; Area Under Curve; Aspergillosis; Critical Illness; Fatal Outcome; Half-Life; Hemofiltration; Humans; Male; Metabolic Clearance Rate; Pyrimidines; Triazoles; Voriconazole | 2008 |
Use of voriconazole in fungal keratitis.
Topics: Administration, Oral; Administration, Topical; Antifungal Agents; Aspergillosis; Chloramphenicol; Contact Lenses; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Bacterial; Eye Infections, Fungal; Female; Humans; Middle Aged; Pyrimidines; Staphylococcal Infections; Triazoles; Visual Acuity; Voriconazole | 2008 |
Voriconazole plasma monitoring.
Topics: Antifungal Agents; Aspergillosis; Child; Child, Preschool; Drug Administration Schedule; Drug Monitoring; Humans; Leukemia; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole | 2008 |
Beta-D-glucan detection test: a step toward preemptive therapy for fungal infections in leukemic patients?
Topics: Antifungal Agents; Antigens, Fungal; Aspergillosis; beta-Glucans; Candidiasis; Chemoprevention; Humans; Leukemia; Proteoglycans; Triazoles | 2008 |
Aggressive cutaneous squamous cell carcinoma associated with prolonged voriconazole therapy in a renal transplant patient.
Topics: Aged; Antifungal Agents; Aspergillosis; Carcinoma, Squamous Cell; Humans; Kidney Failure, Chronic; Kidney Transplantation; Lymphatic Metastasis; Male; Neoplasm Invasiveness; Postoperative Complications; Pyrimidines; Skin Neoplasms; Triazoles; Voriconazole | 2008 |
Invasive Aspergillus terreus sinusitis with orbitocranial extension: case report.
Topics: Antifungal Agents; Aspergillosis; Humans; Male; Middle Aged; Pyrimidines; Sphenoid Sinusitis; Triazoles; Voriconazole | 2008 |
Aspergillus "fungus ball" of the bladder after hematopoietic transplantation in a pediatric patient: successful treatment with intravesical voriconazole and surgery.
Topics: Administration, Intravesical; Adolescent; Anemia, Sickle Cell; Antifungal Agents; Aspergillosis; Cystitis; Hematopoietic Stem Cell Transplantation; Humans; Male; Pyrimidines; Triazoles; Urinary Bladder Diseases; Voriconazole | 2008 |
Neuromuscular painful disorders: a rare side effect of voriconazole in lung transplant patients under tacrolimus.
Topics: Adolescent; Adult; Aspergillosis; Cohort Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Rejection; Humans; Lung Transplantation; Male; Middle Aged; Neuromuscular Diseases; Pain; Postoperative Complications; Pyrimidines; Retrospective Studies; Risk Assessment; Severity of Illness Index; Tacrolimus; Treatment Outcome; Triazoles; Voriconazole | 2008 |
[Clinical case of the month. Pulmonary aspergillosis: chimic necrotizing aspergillosis].
Topics: Anti-Inflammatory Agents; Antifungal Agents; Aspergillosis; Chronic Disease; Glucocorticoids; Humans; Lung Diseases, Fungal; Male; Methylprednisolone; Middle Aged; Necrosis; Pneumonia; Pulmonary Disease, Chronic Obstructive; Pyrimidines; Sputum; Triazoles; Voriconazole | 2007 |
The use of voriconazole for the treatment of aspergillosis in falcons (Falco species).
Topics: Administration, Oral; Animals; Antifungal Agents; Aspergillosis; Bird Diseases; Dose-Response Relationship, Drug; Falconiformes; Female; Male; Pyrimidines; Time Factors; Treatment Outcome; Triazoles; Voriconazole | 2007 |
Successful treatment of invasive Aspergillus sinusitis with caspofungin and voriconazole.
Topics: Aged, 80 and over; Antifungal Agents; Aspergillosis; Caspofungin; Drug Therapy, Combination; Echinocandins; Female; Humans; Lipopeptides; Pyrimidines; Sinusitis; Treatment Outcome; Triazoles; Voriconazole | 2008 |
Voriconazole in newborns.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Candida; Candidiasis; Critical Illness; Humans; Infant, Newborn; Pyrimidines; Triazoles; Voriconazole | 2008 |
[Cutaneous, pulmonary and bone aspergillosis in a patient presumed immunocompetent presenting subacute cutaneous lupus erythematosus].
Topics: Adult; Antifungal Agents; Aspergillosis; Aspergillosis, Allergic Bronchopulmonary; Aspergillus fumigatus; Bone Diseases, Infectious; Caspofungin; Echinocandins; Humans; Lipopeptides; Lung; Lung Diseases, Fungal; Lupus Erythematosus, Systemic; Male; Pyrimidines; Skin; Treatment Outcome; Triazoles; Voriconazole | 2008 |
Successful control of an outbreak of invasive aspergillosis in a regional haematology unit during hospital construction works.
Topics: Antifungal Agents; Aspergillosis; Chemoprevention; Cross Infection; Disease Outbreaks; Environmental Exposure; Hematology; Hospital Design and Construction; Hospital Units; Humans; Infection Control; Pyrimidines; Triazoles; Voriconazole | 2008 |
Evaluation of intrastromal injection of voriconazole as a therapeutic adjunctive for the management of deep recalcitrant fungal keratitis.
Topics: Adult; Antifungal Agents; Aspergillosis; Aspergillus; Corneal Stroma; Corneal Ulcer; Eye Infections, Fungal; Fusarium; Humans; Injections, Intralesional; Male; Middle Aged; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2008 |
[Diagnosis and treatment of pulmonary aspergillosis. Role of voriconazole (discussion)].
Topics: Antifungal Agents; Antigens, Fungal; Aspergillosis; Biomarkers; Clinical Trials as Topic; Galactose; Humans; Immunoglobulin E; Lung Diseases, Fungal; Lung Diseases, Interstitial; Mannans; Practice Guidelines as Topic; Pyrimidines; Serologic Tests; Triazoles; Voriconazole | 2007 |
Epidemiological cutoffs and cross-resistance to azole drugs in Aspergillus fumigatus.
Topics: Amino Acid Substitution; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Azoles; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fungal Proteins; Genes, Fungal; Humans; Itraconazole; Microbial Sensitivity Tests; Molecular Epidemiology; Molecular Sequence Data; Pyrimidines; Thiazoles; Triazoles; Voriconazole | 2008 |
Assessment of Aspergillus fumigatus burden in pulmonary tissue of guinea pigs by quantitative PCR, galactomannan enzyme immunoassay, and quantitative culture.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Base Sequence; Colony Count, Microbial; Disease Models, Animal; DNA Primers; DNA, Fungal; Galactose; Guinea Pigs; Humans; Immunoenzyme Techniques; Lung; Lung Diseases, Fungal; Male; Mannans; Mycology; Polymerase Chain Reaction; Pyrimidines; Triazoles; Voriconazole | 2008 |
Disseminated aspergillosis in an adolescent with acute lymphoblastic leukemia.
Topics: Adolescent; Aspergillosis; Aspergillus fumigatus; Caspofungin; Central Nervous System Fungal Infections; Echinocandins; Female; Humans; Lipopeptides; Lung Diseases, Fungal; Opportunistic Infections; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Thyroid Diseases; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2008 |
Treatment of experimental murine aspergillosis with BAY n7133.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Female; Ketoconazole; Lung; Male; Mice; Mice, Inbred BALB C; Triazoles | 1983 |
Antimycotic activity of BAY N 7133 in animal experiments.
Topics: Administration, Oral; Administration, Topical; Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; Female; Flucytosine; Guinea Pigs; Hair; Infusions, Parenteral; Ketoconazole; Male; Mice; Mycoses; Triazoles | 1984 |
Efficacy of D0870 compared with those of itraconazole and amphotericin B in two murine models of invasive aspergillosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Colony Count, Microbial; Female; Immunosuppression Therapy; Itraconazole; Leukocyte Count; Lung Diseases, Fungal; Mice; Mice, Inbred Strains; Microbial Sensitivity Tests; Neutrophils; Triazoles | 1995 |
Evaluation of SCH51048 in an experimental model of pulmonary aspergillosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Colony Count, Microbial; Dose-Response Relationship, Drug; Drug Evaluation; Female; Itraconazole; Lung Diseases, Fungal; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Survival Rate; Triazoles | 1995 |
Structure-activity relationships of 3-methyl and 3,3-dimethyl analogs of 2-(2,4-difluorophenyl)-3-(omega-substituted alkyl)sulfonyl-1-(1H-1,2,4-triazol-1-yl)-2-propanols.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Candida albicans; Candidiasis; Male; Mice; Mice, Inbred Strains; Microbial Sensitivity Tests; Structure-Activity Relationship; Triazoles | 1996 |
Efficacy of UK-109496, a new azole antifungal agent, in an experimental model of invasive aspergillosis.
Topics: Animals; Antifungal Agents; Antigens, Fungal; Aspergillosis; Aspergillus fumigatus; Azoles; Female; Kidney Diseases; Liver Diseases; Lung Diseases, Fungal; Pyrimidines; Rabbits; Triazoles; Voriconazole | 1996 |
Synthesis and antifungal activity of alkylthio and alkylsulfonyl derivatives of SM-8668.
Topics: Alkylation; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Disease Models, Animal; Magnetic Resonance Spectroscopy; Male; Mice; Structure-Activity Relationship; Sulfur; Triazoles | 1996 |
In vitro and in vivo antifungal activities of ER-30346, a novel oral triazole with a broad antifungal spectrum.
Topics: Animals; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; Female; Fluconazole; Fungi; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Thiazoles; Triazoles | 1996 |
Efficacy of ER-30346, a novel oral triazole antifungal agent, in experimental models of aspergillosis, candidiasis, and cryptococcosis.
Topics: Animals; Antifungal Agents; Aspergillosis; Brain Diseases; Candidiasis; Candidiasis, Oral; Cryptococcosis; Female; Fluconazole; Lung Diseases, Fungal; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Rats; Rats, Sprague-Dawley; Thiazoles; Triazoles | 1996 |
Comparison of voriconazole (UK-109,496) and itraconazole in prevention and treatment of Aspergillus fumigatus endocarditis in guinea pigs.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Disease Models, Animal; Dose-Response Relationship, Drug; Endocarditis; Guinea Pigs; Itraconazole; Male; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 1997 |
T-8581, a new orally and parenterally active triazole antifungal agent: in vitro and in vivo evaluations.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Candida; Candidiasis; Cryptococcus neoformans; Dogs; Fluconazole; Hydroxybutyrates; Itraconazole; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Rabbits; Rats; Triazoles | 1997 |
Successful treatment of cerebral aspergillosis with a novel triazole (voriconazole) in a patient with acute leukaemia.
Topics: Acute Disease; Adolescent; Antifungal Agents; Aspergillosis; Brain Diseases; Humans; Leukemia; Male; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole | 1997 |
Efficacy of SCH-56592 in a temporarily neutropenic murine model of invasive aspergillosis with an itraconazole-susceptible and an itraconazole-resistant isolate of Aspergillus fumigatus.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Drug Resistance, Microbial; Itraconazole; Mice; Mice, Inbred Strains; Microbial Sensitivity Tests; Neutropenia; Survival Rate; Time Factors; Triazoles | 1997 |
Microgranulomatous aspergillosis in a patient with chronic granulomatous disease: cure with voriconazole.
Topics: Adult; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Granulomatous Disease, Chronic; Humans; Lung Diseases, Fungal; Male; Pyrimidines; Triazoles; Voriconazole | 1998 |
New azole antifungals. 2. Synthesis and antifungal activity of heterocyclecarboxamide derivatives of 3-amino-2-aryl-1-azolyl-2-butanol.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Candidiasis; Colony Count, Microbial; Fungi; Male; Mice; Molecular Conformation; Pyrimidinones; Rats; Stereoisomerism; Structure-Activity Relationship; Thiazoles; Thiophenes; Triazoles | 1998 |
New azole antifungals. 3. Synthesis and antifungal activity of 3-substituted-4(3H)-quinazolinones.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Candidiasis; Colony Count, Microbial; Fungi; Male; Mice; Molecular Conformation; Quinazolines; Rabbits; Rats; Rats, Sprague-Dawley; Stereoisomerism; Structure-Activity Relationship; Triazoles | 1998 |
Successful treatment with voriconazole of invasive aspergillosis in chronic granulomatous disease.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus nidulans; Child, Preschool; Granulomatous Disease, Chronic; Humans; Lung Diseases, Fungal; Male; Pyrimidines; Triazoles; Voriconazole | 1998 |
Granulocyte colony-stimulating factor and azole antifungal therapy in murine aspergillosis: role of immune suppression.
Topics: Adrenal Cortex Hormones; Animals; Antifungal Agents; Aspergillosis; Granulocyte Colony-Stimulating Factor; Immunosuppression Therapy; Male; Mice; Mice, Inbred ICR; Triazoles | 1998 |
SCH56592 treatment of murine invasive aspergillosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Colony Count, Microbial; Lung; Lung Diseases, Fungal; Male; Mice; Mice, Inbred ICR; Triazoles | 1998 |
Aspergillus meningitis: diagnosis by non-culture-based microbiological methods and management.
Topics: Aged; Amphotericin B; Antibodies, Fungal; Antifungal Agents; Antigens, Fungal; Aspergillosis; Aspergillus fumigatus; DNA, Fungal; Drug Resistance, Microbial; Female; Galactose; Humans; Mannans; Meningitis, Fungal; Mycology; Polymerase Chain Reaction; Pyrimidines; Time Factors; Triazoles; Voriconazole | 1999 |
In vitro amphotericin B resistance in clinical isolates of Aspergillus terreus, with a head-to-head comparison to voriconazole.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Drug Resistance, Microbial; Humans; Microbial Sensitivity Tests; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 1999 |
Microdilution susceptibility testing of amphotericin B, itraconazole, and voriconazole against clinical isolates of Aspergillus and Fusarium species.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Fusarium; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole | 1999 |
Voriconazole. UK 109496.
Topics: Animals; Antifungal Agents; Aspergillosis; Drug Interactions; Drugs, Investigational; Fungi; Guinea Pigs; Humans; Mycoses; Pyrimidines; Triazoles; Voriconazole | 1999 |
Efficacy of SCH56592 in a rabbit model of invasive aspergillosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus; Colony Count, Microbial; Disease Models, Animal; Female; Immunosuppression Therapy; Itraconazole; Microbial Sensitivity Tests; Rabbits; Triazoles | 2000 |
Efficacy of voriconazole against invasive pulmonary aspergillosis in a guinea-pig model.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Disease Models, Animal; Female; Fungemia; Guinea Pigs; Humans; Lung Diseases, Fungal; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2000 |
Synthesis and antifungal activities of R-102557 and related dioxane-triazole derivatives.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus flavus; Aspergillus fumigatus; Cryptococcosis; Cryptococcus neoformans; Dioxanes; Mass Spectrometry; Mice; Microbial Sensitivity Tests; Rats; Rats, Inbred F344; Spectrophotometry, Infrared; Stereoisomerism; Structure-Activity Relationship; Triazoles | 2000 |
[Therapy of deep seated mycoses--Timing of administration and selection of antifungal agents].
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Fluconazole; Humans; Immunocompromised Host; Itraconazole; Mycoses; Nystatin; Pyrimidines; Triazoles; Voriconazole | 2000 |
In vitro and in vivo activities of SCH 56592 (posaconazole), a new triazole antifungal agent, against Aspergillus and Candida.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus; Candida; Candidiasis; Disease Models, Animal; Lung Diseases, Fungal; Male; Mice; Microbial Sensitivity Tests; Treatment Outcome; Triazoles | 2000 |
A comparative study of the in vitro susceptibilities of clinical and laboratory-selected resistant isolates of Aspergillus spp. to amphotericin B, itraconazole, voriconazole and posaconazole (SCH 56592).
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Itraconazole; Microbial Sensitivity Tests; Mutation; Pyrimidines; Triazoles; Voriconazole | 2000 |
Voriconazole: a new triazole antifungal.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Candida; Candidiasis; Controlled Clinical Trials as Topic; Drug Interactions; Drug Resistance, Microbial; Humans; Pyrimidines; Retrospective Studies; Tissue Distribution; Triazoles; Voriconazole | 2000 |
Efficacy of voriconazole in a guinea pig model of disseminated invasive aspergillosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Fluocinolone Acetonide; Glucocorticoids; Guinea Pigs; Immunocompromised Host; Immunosuppressive Agents; Male; Organ Culture Techniques; Pyrimidines; Triazoles; Voriconazole | 2000 |
Failure to detect circulating Aspergillus markers in a patient with chronic granulomatous disease and invasive aspergillosis.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Biopsy, Needle; Child, Preschool; Diagnostic Errors; DNA, Fungal; Galactose; Granulomatous Disease, Chronic; Humans; Itraconazole; Lung Abscess; Lung Diseases, Fungal; Male; Mannans; Pyrimidines; Triazoles; Voriconazole | 2000 |
Efficacies of two new antifungal agents, the triazole ravuconazole and the echinocandin LY-303366, in an experimental model of invasive aspergillosis.
Topics: Anidulafungin; Animals; Antibiotic Prophylaxis; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Brain; Disease Models, Animal; Echinocandins; Liver; Lung; Peptides, Cyclic; Rabbits; Thiazoles; Triazoles | 2000 |
Successful treatment of invasive aspergillosis in chronic granulomatous disease by granulocyte transfusions followed by peripheral blood stem cell transplantation.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Child, Preschool; Combined Modality Therapy; Drug Resistance, Microbial; Flucytosine; Granulocyte Colony-Stimulating Factor; Granulocytes; Granulomatous Disease, Chronic; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Itraconazole; Leukocyte Transfusion; Lung Diseases, Fungal; Male; Neutrophils; Osteomyelitis; Pyrimidines; Respiratory Burst; Ribs; Triazoles; Voriconazole | 2000 |
Antifungal activity and pharmacokinetics of posaconazole (SCH 56592) in treatment and prevention of experimental invasive pulmonary aspergillosis: correlation with galactomannan antigenemia.
Topics: Animals; Antibiotic Prophylaxis; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Disease Models, Animal; Female; Galactose; Itraconazole; Lung Diseases, Fungal; Mannans; Neutropenia; Rabbits; Treatment Outcome; Triazoles | 2001 |
[Invasive aspergillosis on a surgical intensive care unit].
Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Drug Therapy, Combination; Fatal Outcome; Female; Flucytosine; Humans; Intensive Care Units; Itraconazole; Male; Middle Aged; Pyrimidines; Risk Factors; Triazoles; Voriconazole | 2000 |
Clinical activity of the new triazole drug voriconazole (UK 109, 496) against disseminated hepatosplenic aspergillosis in a patient with relapsed leukemia.
Topics: Antifungal Agents; Antineoplastic Agents; Aspergillosis; Child; Humans; Immunosuppression Therapy; Leukemia, Myeloid; Liver Diseases; Male; Pyrimidines; Splenic Diseases; Triazoles; Voriconazole | 2001 |
Antigen detection in the diagnosis and management of a patient with probable cerebral aspergillosis treated with voriconazole.
Topics: Adolescent; Antifungal Agents; Aspergillosis; Aspergillus; Bone Marrow Transplantation; Drug Therapy, Combination; Humans; Male; Maxillary Sinus; Neuroaspergillosis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Triazoles; Voriconazole | 2000 |
In vitro and in vivo activities of syn2836, syn2869, syn2903, and syn2921: new series of triazole antifungal agents.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus; Candida albicans; Candidiasis; Disease Models, Animal; Mice; Microbial Sensitivity Tests; Piperazines; Treatment Outcome; Triazoles | 2001 |
Muco-cutaneous retinoid-effects and facial erythema related to the novel triazole antifungal agent voriconazole.
Topics: Adult; Antifungal Agents; Aspergillosis; Cheilitis; Erythema; Female; Humans; Lung Diseases, Fungal; Lupus Erythematosus, Discoid; Male; Middle Aged; Pyrimidines; Retinoids; Sinusitis; Triazoles; Voriconazole | 2001 |
Aspergillus: rising frequency of clinical isolation and continued susceptibility to antifungal agents, 1994-1999.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Aspergillus flavus; Aspergillus fumigatus; Aspergillus niger; Humans; Itraconazole; Pyrimidines; Triazoles; Voriconazole | 2001 |
Efficacy of ravuconazole (BMS-207147) in a guinea pig model of disseminated aspergillosis.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Disease Models, Animal; Drug Evaluation, Preclinical; Guinea Pigs; Humans; Male; Organ Culture Techniques; Organ Specificity; Thiazoles; Triazoles | 2002 |
Antifungal activities of posaconazole, ravuconazole, and voriconazole compared to those of itraconazole and amphotericin B against 239 clinical isolates of Aspergillus spp. and other filamentous fungi: report from SENTRY Antimicrobial Surveillance Program
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Canada; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Quality Control; Thiazoles; Triazoles; United States; Voriconazole | 2002 |
Nationwide survey of in vitro activities of itraconazole and voriconazole against clinical Aspergillus fumigatus isolates cultured between 1945 and 1998.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Drug Resistance, Fungal; Humans; In Vitro Techniques; Itraconazole; Microbial Sensitivity Tests; Netherlands; Pyrimidines; Time Factors; Triazoles; Voriconazole | 2002 |
Comparison of azoles against aspergilli in vitro and in an experimental model of pulmonary aspergillosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillosis, Allergic Bronchopulmonary; Aspergillus; Aspergillus flavus; Aspergillus fumigatus; Disease Models, Animal; Itraconazole; Ketoconazole; Male; Rats; Rats, Inbred Strains; Triazoles | 1992 |
Comparison of SCH 39304, fluconazole, and ketoconazole for treatment of systemic infections in mice.
Topics: Administration, Oral; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Drug Evaluation, Preclinical; Fluconazole; Injections, Intravenous; Ketoconazole; Kidney; Male; Mice; Triazoles | 1992 |
In vitro and in vivo activities of SCH 42427, the active enantiomer of the antifungal agent SCH 39304.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus flavus; Candidiasis; Candidiasis, Vulvovaginal; Cricetinae; Dermatomycoses; Female; Fungi; Guinea Pigs; Male; Mesocricetus; Mice; Microbial Sensitivity Tests; Rats; Rats, Inbred Strains; Stereoisomerism; Triazoles; Trichophyton | 1992 |
Efficacy of SCH 39304 in treatment of experimental invasive aspergillosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Antigens, Fungal; Aspergillosis; Enzyme-Linked Immunosorbent Assay; Immunosuppression Therapy; Leukopenia; Rabbits; Triazoles | 1991 |
Preclinical antimycotic activity of SDZ 89-485: a new orally and topically effective triazole.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Candida albicans; Candidiasis; Candidiasis, Vulvovaginal; Culture Media; Disease Models, Animal; Female; Guinea Pigs; Histoplasmosis; Humans; Mice; Mycoses; Nephritis; Rats; Sporotrichosis; Tinea; Triazoles | 1990 |
Evaluation of Bay R 3783 in rodent models of superficial and systemic candidiasis, meningeal cryptococcosis, and pulmonary aspergillosis.
Topics: Administration, Oral; Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; Disease Models, Animal; Drug Administration Schedule; Evaluation Studies as Topic; Female; Fluconazole; Itraconazole; Ketoconazole; Lung Diseases, Fungal; Male; Meningitis; Mice; Pharmaceutical Vehicles; Rats; Rats, Inbred Strains; Triazoles | 1990 |
Pulmonary aspergillosis in mice: treatment with a new triazole SCH39304.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Female; Fluconazole; Lung Diseases, Fungal; Male; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Triazoles | 1990 |
In vivo efficacy of SM-8668 (Sch 39304), a new oral triazole antifungal agent.
Topics: Administration, Cutaneous; Administration, Oral; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Candidiasis, Vulvovaginal; Cryptococcosis; Female; Fluconazole; Guinea Pigs; Male; Mice; Mice, Inbred Strains; Rats; Rats, Inbred Strains; Tinea; Triazoles | 1990 |
[The clinical study of fluconazole against pulmonary mycosis. Effects of fluconazole on pulmonary cryptococcosis and aspergillosis, and its pharmacokinetics in patients].
Topics: Adult; Aged; Antifungal Agents; Aspergillosis; Cryptococcosis; Drug Evaluation; Fluconazole; Half-Life; Humans; Lung Diseases, Fungal; Male; Middle Aged; Triazoles | 1989 |
[Clinical efficacy of fluconazole in the patient with pulmonary mycosis].
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anorexia; Antifungal Agents; Aspergillosis; Cryptococcosis; Drug Evaluation; Female; Fever; Fluconazole; Humans; Infusions, Intravenous; Lung Diseases, Fungal; Male; Middle Aged; Nausea; Triazoles | 1989 |
[Clinical evaluation of fluconazole in patients with mycotic infection].
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Aspergillus; Candidiasis; Candidiasis, Oral; Drug Evaluation; Female; Fluconazole; Humans; Lung; Lung Diseases, Fungal; Male; Microbial Sensitivity Tests; Mycoses; Sepsis; Tissue Distribution; Triazoles | 1989 |
[A clinical study of fluconazole in pulmonary aspergillosis].
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antibodies, Fungal; Antifungal Agents; Aspergillosis; Aspergillus; Drug Evaluation; Drug Tolerance; Female; Fluconazole; Humans; Lung Diseases, Fungal; Male; Middle Aged; Radiography, Thoracic; Sputum; Triazoles | 1989 |
Combination therapy of experimental candidiasis, cryptococcosis, aspergillosis and wangiellosis in mice.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; Drug Therapy, Combination; Exophiala; Fluconazole; Flucytosine; Itraconazole; Ketoconazole; Mice; Mycoses; Triazoles | 1987 |
[Experimental renal infection with Aspergillus fumigatus in mice: a chemotherapeutic model of an organic mycosis].
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Disease Models, Animal; Female; Flucytosine; Itraconazole; Ketoconazole; Kidney Diseases; Mice; Mice, Inbred Strains; Miconazole; Triazoles | 1985 |
Efficacy of fluconazole (UK-49,858) against experimental aspergillosis and cryptococcosis in mice.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus flavus; Aspergillus fumigatus; Brain Diseases; Cryptococcosis; Female; Fluconazole; Ketoconazole; Lung Diseases, Fungal; Mice; Opportunistic Infections; Triazoles | 1987 |